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A. Introduction 
 
1. Organometallic Chemistry  
 
Metal complexes are essential instruments in the toolbox of organic chemists, which are 
studied under the roof of organometallic chemistry. Organometallic chemistry lies at the 
interface between organic and inorganic chemistry because it deals with the interaction 
between inorganic metal ions and organic molecules.1 This field has provided some powerful 
new synthetic methods in organic chemistry. The fastest growing area of organic chemistry is 
the application of organometallic reagents and catalysts to synthetic problems. 
Organometallic catalysts have long been used in industrial processes but are now being 
routinely applied in organic synthetic problems as well. With the continuing rise in 
environmental concerns and green chemistry, pressure has grown to maximize the ratio of 
product to waste. This has, in turn, led to an increasing interest in catalytic reactions, where 
the metal catalyst is present in minimal quantity and the selectivity of the reaction is 
enhanced, so the waste product is minimized. Much of the interests in organometallic 
compounds have been due to their efficiency as catalysts for organic synthesis. 
 
                                               
 
 
 
 
 
 
 
 
 
 
Figure 1: Basic structure of an organometallic compound 
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In turn, this efficacy originates from infinite number of derivatives, which can be obtained by 
varying the ligands and metals of organometallic complexes. A transition metal 
organometallic compound is composed of one or more metal centers surrounded by a set of 
ligands (Figure 1). In simple terms, the ligand (L) may act as a Lewis base that donates pair 
of electrons to the central metal atom (M), which acts as a Lewis acid. 
Compounds of metal ions coordinated by ligands are referred to as metal complexes.1 Most 
ligands are neutral or anionic substances but cationic species, such as the tropylium cation, 
are also known. Neutral ligands, such as ammonia (NH3) or carbon monoxide (CO) are 
independently stable molecules in their free states, whereas anionic ligands, such as Cl- or 
C5H5-, are stabilized only when they are coordinated to central metals. Representative ligands 
are listed in Table 1 according to the ligating elements. Ligands with a single ligating atom 
are called monodentate ligands, and those with more than one ligating atoms are referred to 
as polydentate ligands, which are also called chelate ligands. The number of atoms bonded to 
a central metal is the coordination number. 
 
Table 1: Representative ligands1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Abbreviation Formula
hydrido H-
carbonyl CO
cyano CN-
cyclopentadiene Cp C5H5-
carbonato CO32-
amine NH3
pyridine py C5H5N
triphenylphosphine PPh3 P(C6H5)3
aqua aq H2O
acetylacetonato acac CH3C(O)CH2C(O)CH3-
thiocyanato SCN-
chloro Cl-
ethylenediaminetetraaetato edta (OOCCH2)2NCH2CH2N(CH2COO)24-
Common ligands or those with complicated chemical formula are expressed in abbreviated forms
 
Introduction 
3 
 
The relative stability of each complex is directly proportional to the valence electron count of 
the metal. Thus, the 18-electron rule predicts that a complex will be relatively stable if it has 
eighteen valence electrons associated with each metal center (i.e., in the non bonding orbitals 
of the metal and in the metal-ligand bonds). There are some exceptions to the rule, but metals 
in the middle of the transition series in low formal oxidation states generally obey the rule. 
Isonitrile ligands are perhaps not the most common ligands in transition metal organometallic 
chemistry. Their bonding in linear geometry is typical of other linear π-acidic ligands such as 
N2+, NO+, and CO. 
Being similar to carbon monoxide as a ligand, isonitriles are more versatile as they tend to 
stabilize metals in both high and low oxidation states.2, 3 The electronic and steric properties 
of isonitriles (CNR) are tunable by means of varying the substituent R at nitrogen. However, 
isonitriles are less electronegative than CO and the lobes of the π*-antibonding orbitals on 
N≡C are less polarized towards carbon. Thus, isonitriles are generally better net electron 
donors than carbonyls. In terms of Dewar-Chatt-Duncanson model (Figure 2), there is σ-
donation from the lone pair of electrons on the carbon (i.e., the sp hybrid orbital) to an empty 
σ-symmetry orbital of the metal (i.e. d2sp3 in octahedral complexes). There is also π-back 
donation from a pair of filled orbital of π-symmetry on the metal (i.e. dxy, dxz or dyz orbitals in 
octahedral metals) to a pair of empty π-symmetry orbitals on the isonitrile ligands (i.e. π* 
orbitals localized on N≡C). 
 
 
 
 
 
 
 
 
 
Figure 2: Representation of bonding interactions of organic isonitriles and transition metal 
ions 
 
C NM
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Valence Bond Theory (Figure 3) provides an alternative and complementary explanation of 
the bonding that occurs during the coordination of an isonitrile to a transition metal. In 
Valence Bond terms, the coordination is explained via resonance. Thus, greater back bonding 
results in an increased contribution from the second resonance (II) form and hence a 
decreased CN-R bond angle due to sp2 hybridization of the nitrogen atom on the latter.4 
 
 
 
 
Figure 3: Valence bond theory representation of the bonding of isonitrile ligand 
 
Both the Dewar-Chatt-Duncanson and Valence Bond Theory explanation can be used to 
rationalize the same experimental observations. The electron richness of the metal centre 
affects the bond orders for the metal-carbon and carbon-nitrogen bonds as well as the CN-R 
angles. If the electron richness of the metal is increased, there is more back bonding and the 
second resonance form is favored. The metal-carbon bond order therefore increases and 
carbon-nitrogen bond order decreases while the CN-R angle decreases. The electron richness 
of isonitriles complex can be measured through infrared spectroscopy. The CN stretching 
frequency for isonitrile complexes is 250-350 wave number (cm-1) lower than the stretching 
frequency for the free isonitrile, reflecting the weakening of the net N≡C σ and π- bonds upon 
co-ordination.5, 6  
Isonitriles play an important role in organic and organometallic synthesis, catalysis, material 
science, drug discovery and diagnostic medicine. Since 1995, organic isonitriles are widely 
used in multi-component reactions (MCR) and have become a powerful method for 
developing new drugs for the pharmaceutical industry.7-9 For example, the preparation of 
Crixivan® (Figure 4), an HIV protease inhibitor produced by Merck & Co8b via one pot, four 
component reaction. 
M C N R M C N
R
I II
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Figure 4: Four component synthesis of Crixivan® 
 
In the field of medicine, isonitrile complexes of 99m-technetium were widely used as 
radiotracers for diverse diagnostic purposes.10 [99Tc(2-methoxyisobutylisocynide)6]+ also 
known as Tc-99m-MIBI and Cardiolite®  is used as a non invasive marker for the diagnosis 
of P-glycoprotein and related multi drug resistant protein over-expressions in tumors.11, 12  
The list of applications of isonitriles in organic chemistry is quite extensive and their diverse 
reactivities can be advantageous in both organic and organometallic applications13, 14. 
Isonitriles are recognized as valuable synthons in organic synthesis, but have been less 
frequently applied as ligands in metal catalysis, although isonitriles act as unique ligands for 
a broad variety of transition metal complexes. The development in metal-isonitrile complex 
catalyzed reactions is undertaken in the next section. 
 
2. Palladium-isonitrile complexes 
 
2.1  Bissilylation of unsaturated C-C bonds 
 
Introduction of silicon into organic molecules is an interesting methodology, which leads to 
synthetic elaboration of organic molecules via organosilicon compounds and synthesis of 
new silicon containing materials. Ito and coworkers15 have reported that tert-alkyl isonitriles 
were effective ligands for a wide range of bissilylation of alkynes and alkenes. Remarkable 
development has been done in bissilylation of alkenes and alkynes by using combination of 
commercially available isonitriles (1a-e) (Figure 5) and Pd(II).  
BocHN
NH2
Cl CHO
Cl
NC
U-4CR
N
CHO
H
N
BocHN Cl Cl
O
N
N
N
OH H
N
OH
O
OHN
Crixivan
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Figure 5: Examples of tert-isonitrile ligands 
 
The intermolecular and intramolecular bissilylation of alkynes,16, 17 catalyzed by palladium-
tert-alkyl isonitrile catalyst gives bissilylated alkenes and ring closure product in good yields 
and selectivity. The palladium-tert-alkyl isonitrile catalyst is very effective in such reactions, 
whereas the conventional palladium-phosphine complexes showed only low catalytic 
activity18. Intermolecular bissilylation of phenylacetylene (Scheme 1) was carried out with 
hexamethyldisilane using palladium (II) acetate-tert-octyl-isonitrile catalyst to give 
bissilylated alkenes (3) in yields upto 98% and excellent Z:E ratio. 
 
             
 
 
 
 
 
Scheme 1: Intermolecular bissilylation of alkynes with disilanes 
 
An important feature of this reaction is that excess use of isonitrile ligands such as 1-
adamanthyl (1e) and tert-octyl (1a) isonitriles efficiently promotes the catalytic activity of 
Pd(OAc)2 and hence the reaction rate, while in the absence of isonitrile the reaction fails to 
occur. 
 
1d
NC
i-Pr
i-Pr
NC
NC
1e 1f
NC NC
NC
1a 1b 1c
Si
Me
Me
R1 Si R1
Me
Me
R2 H
2 mol% Pd(OAc)2
toluene, reflux
H
SiMe2R1R1Me2Si
R2
2 3
R1 = Me, Ph
R2 = Ph, n-Hex, H
81-98 %
Z:E = 95:5 - 100:0
1a
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Scheme 2: Intramolecular bissilylation of alkynes 
 
An alkyne tethered to a disilanyl group (4), upon treatment with Pd(OAc)2 and tert-octyl 
isonitrile (1a), furnished exocyclic bis-silylated olefin17 (5) via intramolecular bissilylation 
(Scheme 2). Subsequent addition of hydrogen to double bond occurred from the less hindered 
side of the ring to give cis- disubstituted oxasilolanes (6) with good diastereoselectivity. 
Oxidation of the two C-Si bonds of the hydrogenated oxasilolane led to the stereo- and 
regioselective synthesis of 1,2,4-triols (7).  
Similarly, stereoselective intramolecular bissilylation of terminal alkenes (8) tethered to 
disilanyl group by chains of two and three atoms promoted by palladium-tert-alkyl isonitrile 
catalyst was studied.19, 20 However, this catalyst failed to promote the intermolecular 
bissilylation of alkenes. The bissilylation was carried out in the presence of catalytic amount 
of Pd(OAc)2 (0.01-0.05 equiv.) and tert-alkyl isonitrile (0.15-0.75 equiv.) (1a-f) in toluene, 
under reflux conditions. Intramolecular regioselective addition of the Si-Si linkage to the 
alkenes took place to furnish an exo-ring product, i.e. 1,2-oxasilolane (9) (Scheme 3) in 
excellent chemical yield.  
 
 
 
 
 
 
 
Scheme 3: Intramolecular bissilylation of terminal alkene 
Si Si O
R
intramolecular
bis-silylation
cat. Pd(OAc)2
1a
Si OSi
R
syn hydrogenation
Si OSi
R
oxidation
OHHO
R
OH
4 5
6 7
Si OSi
R
Pd(OAc)2 (0.01- 0.05 equiv.)
t-alkyl isoyanide (9) (0.15 - 0.75 equiv.)
Si O
Si R
R = Me, OBn, CO2Me, Et, i-Pr
9
upto 98 %
8
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The 1,2-oxasilolanes (8) thus produced steresoselectively were oxidized to corresponding 
1,2,4-triols. Among the tert-alkyl isonitriles, 1,1,3,3-tetramethylbutyl isonitrile (1a) showed 
best reaction rate and stereoselectivity. An excess of isonitrile (6–15 times to Pd (OAc)2 was 
used. Use of less than 6 equiv. of isonitrile to Pd(OAc)2 did not furnish the reaction. 
Palladium (0) isonitrile complex is the active catalyst species for bissilylation reaction. 
In 1995, Ito and coworkers reported an application of distereoselective intramolecular 
bissilylation of alkene in stereocontrolled synthesis of (-)-avanaciolide (10)21 (Scheme 4).  
 
 
 
 
 
 
 
Scheme 4: Reterosynthetic analysis of (-)-avanaciolide (10) 
 
The intramolecular bissilylation of enatiomerically rich 12 proceeded with high 
diasteroselectivity in the presence of 0.02 equiv of Pd(OAc)2 and 0.3 equiv of 1,1,3,3-
tetramethylbutyl isonitrile (1a) in toluene to furnish a five membered cyclic product (11) with 
highly controlled stereogenic centers. The presence of iBu group in disilanyl ether was 
preferable to obtain high chemical yield (92%) and diastereoselectivity (90:10). The major 
isomer was separated and used for further steps towards the synthesis of (-)-avanaciolide 
(10). 
Intramolecular bissilylation of (Z)- and (E)- disilanyl alkenes (Table 2) tethered to disilanyl 
group was also carried out in the presence of 1,1,3,3-tetramethylbutyl isonitrile (1a, 0.45 
equiv.) and Pd(OAc)2 (0.03 equiv.) in refluxing toluene, which proceeded with stereospecific 
cis- addition to give 5-exo ring closure product22 (14). The choice of appropriate disilanyl 
group is essential to obtain high yields such as the presence of phenyl substituents at the 
silicon atom proximal to the ether oxygen in the bissilylation of (Z)-13, which led to 
enhanced yield and reaction rate (Table 2, entry 5). 
 
 
 
O
O
O
C8H17
n
O
C8H17n
OSi
Me2PhSi
iBu2
Si O
C8H17
n
Me2PhSi
iBu2
(R, R, R)
(-) Avanaciolide
Intramolecular
bis-silylation
10 11 12
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Table 2:  Bissilylation of vicinally disubstituted internal alkenes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the first time optically active chiral isonitriles were employed by the same group in the 
enantioselective intramolecular bissilylation of alkenes (15)23 (Scheme 5).  
 
 
                          
 
 
 
 
Scheme 5: Stereoselctive bissilylation of alkenes 
 
Chiral tert-alkyl isonitriles 17 and 15 (Figure 6) with the rigid skeleton derived from D-
camphor provides moderate enantioselectivities for the intramolecular bissilylation. However, 
the isonitrile exo-17, bearing exo-siloxy group provided higher enantioselectivity than endo-
17, bearing an endo-siloxy group, which showed opposite enantioselection. The best ee was 
achieved by ligand 18 with two exo-siloxy groups.  
 
SiO SiMe2Ph
Me
Ar2
15
Ar = o-Tol
exo, exo-18
Pd(OAc)2
Toluene, 80 °C
Si
O
SiMe2Ph
Ar2
Me SiPh
16
78% ee (59%)
O Si Si
Et
t-OcNC (1a)
Pd(OAc)2
toluene, reflux
O Si
Si
Et
entry disilanyl group yield %
1 -SiMe2SiMe3 no reaction
2 -SiMe2SiMe2Ph 56
3 -SiMe2SiPh3 66
4 -SiMePhSiMe2Ph 75
5 -SiPh2SiMe2Ph 91
6 -SiPh2SiMe3 56
(Z)-13 14
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Figure 6: Chiral tert-alkyl isonitriles                        
 
The stereoselective synthesis of allylsilanes (24) was achieved via intramolecular 
bissilylation of enantiomerically pure allylic alcohol (19) 24, 25 (Scheme 6). Palladium (II) tert-
octyl isonitrile catalyzed intramolecular bis-silylation furnished two new Si-C bonds in regio 
and stereoselective manner. The intramolecular bissilylation of disilanyl ether initially 
furnished eight membered ring 22 in refluxing hexanes, which may be obtained from 
cyclodimerization of oxasiletane 21. Subsequent heating of 22 under refluxing toluene led to 
the allylsilane 24 (upto 99% ee) along with the six memebered ring 23. The 23 was 
transformed into the allylsilane 24 via Peterson type elimination using nBuLi.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 6: Synthesis of allylsilanes via intramolecular bissilylation 
 
The active specie in the above mentioned reactions is believed to be (RNC)nPd(0), where the 
coordination number (n) may vary from 2 to 4. The active species are generated from Pd(II) 
precursors with tert-alkyl isonitriles and Pd(OAc)2, Pd(acac)2 and PdCp(π-allyl) have been 
R3
R2CN
R1
exo-17 (R1 = OSiMe3, R2 = R3 = H)
endo-17 (R1 = OSiMe3, R2 = R3 = H)
exo,exo-18 (R1 = R2 = OSiMe3, R3 = H)
R1 R2
OH
O R2
R1
R3Si
SiR4
O R2
R1 SiR4
SiR3
R1 R2
SiR3
intamolecular
bis-silylation
19 20 21
Si
O
Si
O
R1
R1
R4Si
R2
SiR4
R2
R3
R3 toluene
ref lux
Si O
Si
OR4Si
R2
R1
R3
R3
eliminationupto 99% ee
22
23
24
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used as palladium precursors. Typically 4–15 equivalents (to Pd) of isonitrile were employed 
because part of the isonitriles may be consumed for the Pd(II) – Pd(0) reduction. The excess 
isonitriles do not interfere with the bissilylation reaction. It was explained that Pd(OAc)2 is 
reduced by isonitriles initially to form Pd(0) species ligated isonitrile. Next the oxidative 
insertion of Pd(0) species into the Si-Si linkage takes place to give a 
bis(organisilyl)palladium (II) complex. Insertion of the double bond into Pd-Si bond followed 
by reductive elimination of the Pd(0) species would complete the catalytic cycle. Excess of 
isonitrile was required to hinder the palladium(0) isonitrile complex from decomposing 
during the reaction course. 
 
2.2 Suzuki Miyaura coupling 
 
Isonitrile palladium complexes [(RNC)2PdCl2] were also tested by Villemin and co-workers26 
for Suzuki Miyaura reaction of bromoaromatic or heteroaromatic substrates and activated 
chloroaromatic and  p-deficient heteroaromatic substrates (Scheme 7). It was explained that 
isonitriles are isoelectronic with Arduengo’s carbenes (NHC) and hence can promote Suzuki 
coupling reaction. Palladium complexes of hindered isonitriles [(RNC)2PdCl2] such as tert-
butylisonitrile (tBuNC, 1b), 1,1,3,3-tetramethylbutylisonotrile (tOcNC, 1a), 
cyclohexylisonitrile (CyNC, 1d), 2,6-didiopropylphenylisonotrile [(iPr)2PhNC), 1e] and 
adamantylisonitrile (AdNC, 1f) were prepared by the reaction of isonitriles with PdCl2 in 
DMF at room temperature. 
(AdCN)2PdCl2 complex showed the maximum reactivity in Suzuki Miyaura coupling of 4-
halogenanisoles (25) in comparison to other palladium-isonitrile complexes. Moderate to 
excellent yields of isolated phenylated products were obtained by the reaction of 
phenylboronic acid and aryl halides. Heteroaromatic substrates were also coupled in 
moderate yield with the same catalyst.  
 
 
 
 
 
 
Scheme 7: Suzuki Miyaura coupling employing Pd-isonitrile catalyst 
X B(OH)2
(AdNC)2PdCl2 (5 mol %)
Cs2CO3
dioxane, reflux, 18 h
X = Cl, Br, I
R = p-OCH3, p-CHO, p-COCH3, p-CO2CH3, p-CN
R
X = Br, R = p-OCH3, 81%
R
25 26
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2.3 Bisstannylation of alkynes 
 
Bisstannylation of terminal and internal alkynes (27) was also achieved using palladium-
isonitrile complex27 and hexaalkylditin as stannyl source under mild conditions (Scheme 8). 
Generally, good yields were obtained with different types of alkynes, and functional groups 
such as amine, carbamate, silyl, ether and ester were tolerated very well. For example, silyl 
homopropargylic ether showed lower reactivity versus propargylic substrates, giving a 
modest yield (40%). Sterically bulky alcohol also underwent smooth conversion indicating 
the catalysts’ tolerance towards steric substrates. Terminal alkynes were found to be more 
reactive than the internal alkynes in bisstannylation, nevertheless, in latter case the reaction is 
feasible only with activated alkynes. 
 
 
 
 
 
 
 
Scheme 8: Bisstannylation of alkynes using Pd-isonitrile complex 
 
3. Low valent transition metal isonitrile complexes (M = W, Mo, Ni) 
 
3.1  Hydrostannylation and bisstannnylation of alkynes 
 
Hydrometalation is an important category of reactions catalyzed by transition metals such as 
hydrostannation of alkynes, used for the synthesis of vinylstannanes, which can be subjected 
to Stille coupling for further reactions. Regioselective hydrostannation of alkynes catalyzed 
by Mo(tBuNC)3(CO)3 was reported by Kazmaier et. al (Scheme 9).28 Substitution of three CO 
ligands in Mo(CO)6 by isonitrile ligands resulted in Mo(tBuNC)3(CO)3, which catalyzed 
hydrostannylation of propargylic alcohol derivatives (29) with excellent yield and 
regioselectivity to afforded α-stannylated allylic alcohols or their derivatives as a major 
product (30). MoBr-(allyl)(CO)2(CH3CN)2 and Mo(CO)6 (Table 3) were also found to be 
R
(Bu3Sn)2
Pd(tBuNC)2Cl2
THF, rt
Bu3Sn SnBu3
R
40 - 83%
R = NHBoc, NHTs, OMe, CO2Me, OH, OTBDMS
27 28
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suitable for the hydrostannation of propargylic alcohol derivatives, but without significant 
regioselectivity (Table 3). 
 
 
 
 
                   R = THP                                          α                              ß 
 
Scheme 9: Hydrostannylation of unsymmetric alkynes 
 
tBuNC was chosen as the best ligand because of the sterically demanding t-butyl group, 
which may have an influence on the regioselectivity of the reaction. Indeed, 
Mo(tBuNC)3(CO)3 transfers the stanne to the sterically more hindered position of the triple 
bond. An additional isonitrile ligand Mo(tBuNC)4(CO)2 , has no significant effect on the 
reaction. The lower yield might have resulted from  the lower stability of Mo(tBuNC)4(CO)2 
in comparison to that of  Mo(tBuNC)3(CO)3 (Table 3). Hydrostannation of terminal alkynes 
proceeded very well at room temperature, whereas high temperature (50-70 °C) was required 
for sterically hindered alkynes.  
 
Table 3: Hydrostannylation of alkynes 29 
 
 
 
 
 
 
 
Kazmaier has also shown that tungsten based isonitrile complex W(CO)5(CNC6H4-pNO2) can 
achieve the same bisstannylation reaction using Bu3SnH,29 whereas Mo(tBuNC)3(CO)3 allows 
regioselective hydrostannation of terminal alkynes (30) with Bu3SnH28 (Scheme 10). Both 
hydrostannylation product (31) and bisstannnylation product (32) further underwent 
intramolecular Stille coupling to afford compound 33 and 34, respectively. Hydrostannylation 
OR
Bu3SnH
2%
Mo(tBuNC)3(CO)3
SnBu3
OR RO SnBu3
29 30 31
Catalyst yield % selectivity
PdCl2(PPh3)2 68 67:33
MoBr(allyl)(CO)2(MeCN)2 nr 64:36
Mo(CO)3(tBuNC)3 98 98:2
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of alkynes catalyzed by Mo(tBuNC)3(CO)3  can be used for the construction of a heterocyclic 
system30 via subsequent intramolecular Stille coupling. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 10: Hydro- and Bisstannylation of propargylic ethers 30 
 
3.2 Polymerization reactions 
 
Low valent transition metal isonitrile complexes can function as catalysts in certain 
polymerization processes.31-34 For example, polymerization of butadiene by M(CNAr)6 ( M = 
Cr, Mo, W) which produces either isotactic or syndiotactic polybutadienes. The nature of the 
polybutadiene is determined by the nature of the metal center and the aryl group of the 
isonitrile.33 Moreover, Ni isonitriles Ni4(tBuNC)7 have been shown to effect efficient 
dimerization of butadiene to form cyclooctadiene, as well as trimerization of substituted 
acetylenes to give highly functionalized benzenes.34 Isonitrile complexes of Ni, 
NiBr2(ArNC)2 (35) (Scheme 11) were reported by Nagashima and co-workers35 and 
employed as catalysts for ethylene polymerization in the presence of methylaluinoxane 
(MAO). Substituents on the aryl group of isonitriles especially at the 2- or 2, 6-positions 
I
O
I
O
SnBu3
I
O SnBu3
SnBu3
3% Mo(tBuNC)3(CO)3
3 equiv. Bu3SnH
2.4% W(CO)5(CNC6H4-pNO2)
4 equiv. Bu3SnH
10% Pd(PPh3)4 10% Pd(PPh3)4
O O
SnBu3
30
31 32
33 34
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affect the catalytic activity, molecular weight and number of methyl branches of the formed 
polymer. The nickel-isonitrile complexes having 2,6-diphenylphenylisonitrile and its 
analogues showed moderate activity and furnished high molecular weight polyethylene (Mv > 
106), whereas isonitrile bearing 2-phenylphenylisonitrile and its analogue gave polyethylene 
with Mw = 103 – 104. 
 
 
 
 
  
 
 
 
 
 
Scheme 11: Synthesis of NiBr2(ArNC)2 complex 35  
 
3.3 Cyclopropanation of olefins 
 
Ibers et. al36 reported the structure and catalytical activity of (Diazofluorene)bis( tert-butyl 
isonitrile)nickel(0) complex, which was prepared by the low temperature reaction of 
Ni(tBuNC)2 and diazofluorene. This kind of complex was used for cyclopropanation of 
substituted olefins (methyl acrylate or diethyl maleate, 36) at 100 °C (Scheme 12). Although 
good yield of cyclopropanation product was obtained with methyl acrylate and ethyl acrylate, 
but only trace yield was obtained with alkyl or arylethylenes. The absence of Ni-isonitrile 
catalyst in the thermal reaction of free diazofluorene with diethyl maleate readily gives 1-
pyrazoline derivative (37) at room temperature, which subsequently undergoes nitrogen 
elimination at 30 °C to give trans-cyclopropane derivative (38). Therefore, the trans-
cyclopropane derivative obtained from the nickel complex may result from the thermal 
reaction of free diazofluorene with diethyl maleate. 
NC
R2R1NiBr2(dme)
N
C
Ni
C
N
R1
R2
R1
R2
CH2Cl2
r.t
Br
Br
R1 = R2 = Me, Et, iPr, Ph, 4-tBuC6H4,
2-MeC6H4, 2,6-Me2C6H3
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Scheme 12: Ni(tBuNC)2(diazofluorene) catalyzed cyclopropanation of olefins 
 
In the case of diazomethane, rapid reaction of diazomethane with Ni-isonitrile catalyst 
produces the carbene, which further reacts with the ethylacrylate, and hence no formation of 
2-pyrazoline. However, 2-pyrazoline derivatives are formed in the absence of nickel isonitrile 
complex but it does not undergo ring contraction to yield the cyclopropane derivatives. Thus, 
the presence of Ni-isonitrile complex hinders the formation of the pyrazoline derivatives of 
both diazomethane and diazofluorene. 
 
3.4 Allylic allylation 
 
Highly reactive Molybdenum-isonitrile complexes were prepared by Trost and co-workers37 
for the allylic alkylation reaction (Scheme 13). Mo(tBuNC)4(CO)2 was proven to be a 
superior catalyst in comparison to Mo(CO)6 and also furnished enhanced reactivity as well as 
chemo-, region-, and stereoselectivity in allyl alkylation reaction. Alkylation at the less 
substituted allylic carbon (41) with net retention stereochemistry was observed. 
 
 
 
 
 
 
 
 
 
Scheme 13: Allylic allylation catalyzed by Mo(tBuNC)4(CO)2 complex 
Ni(tBuNC)2(diazofluorene)
100 °C
CO2Et
CO2Et
CO2Et
CO2Et
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30 °C
36
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38
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OMe
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Toluene, reflux
Mo(tBuNC)4(CO)2 (40%) 93 : 7
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4. Rhodium, Ruthenium and Rhenium isonitrile complexes 
 
4.1 Hydrogenation 
 
Efraty et. al38 prepared an insoluble matrix of [RhCl(CO)(1,4-(CN)2C6H4)]n using 
[Rh(CO)2Cl]2 and an equimolar amount of 1,4-diisocyanobenzene and its activity was 
investigated with respect to 1-hexene hydrogenation and isomerization in dark conditions as 
well as under irradiation. The insoluble matrix may exist as a linear polymer, non linear 
polymer, or a tetranuclear cyclic oligomer (Figure 7). 
 
 
 
 
 
 
 
 
Figure 7: Types of insoluble matrix of [RhCl(CO)(1,4-(CN)2C6H4)]n 
 
The hydrogenation and isomerization of 1-hexene was carried out using the insoluble catalyst 
under hydrogen pressure of 0.5 atm at 25 °C. Under dark conditions, hydrogenation of 1-
hexene to n-hexane also involves isomerization to trans- and cis- hexenes which 
subsequently hydrogenated to n-hexane. While in the presence of UV radiation, the formation 
of n-hexane slowed down. Isomerization was observed at an early stage in the presence of 
light but no hydrogenation of isomers was observed. 
The TCSM (tethered complexes on supported metal) (Figure 8) catalysts Rh-CNR2/Pd-SiO2, 
Rh-CNR3/M-SiO2(M) Pd, Pt, Ru) and Pt-CNR2/Pd-SiO2 were synthesized by Angelici et al.39 
to catalyze hydrogenation of arenes and cyclohexanone under mild conditions. These TCSM 
were prepared using rhodium and platinum complexes RhCl(CO)[CN(CH2)3Si(OC2H5)3]2 
(Rh-CNR2), RhCl[CN(CH2)3Si(OC2H5)3]3 (Rh-CNR3), and PtCl2[CN(CH2)3Si(OC2H5)3]2 (Pt-
CNR2) tethered to the silica supported metal heterogeneous catalysts M-SiO2 (M ) Pd, Pt, 
Ru). Rhodium complex Rh-CNR3/Pd-SiO2 exhibits highest activity for the toluene 
hydrogenation (TOF 5.5 mol H2/mol Rh min and TO 2420 mol H2/mol Rh during 8.5 h) as 
RhOC
Cl
Rh Cl
CO
RhCl Rh CO
ClOC
RhOC Rh Cl
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OC Rh
Cl
ClRh
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compared to Rh-CNR3/M-SiO2(M) Pt, Ru). The catalytic activity of TCSM  are higher than 
those of the separate homogenous Rh or Pt isonitrile complex, the separate silica supported 
metal heterogeneous catalyst or the Rh or Pt complex catalyst tethered on just SiO2. IR 
(DRIFT) spectral studies of the TCSM catalysts showed that the isonitrile ligands remain 
coordinated to the rhodium (or platinum) center even after catalysis. Atomic emission 
spectroscopic analysis of hydrogenation solutions shows that there is no rhodium (or 
platinum) leaching into the solutions. 
 
 
 
 
 
 
 
 
 
 
Figure 8: TCSM catalyst consisting of homogenous catalyst tethered to silica supported 
heterogeneous catalyst 
 
The bis(isonitrile)-ruthenium(II) complexes40 trans,cis,cis-[RuX2(CNR)2(dppf)] (44) have 
been synthesized by reaction of bis(allyl)-ruthenium(II) derivative [Ru(η3C3H4Me)2(dppf)] 
(43) with the appropriate isonitrile ligand, in dichloromethane at room temperature and in the 
presence of the corresponding hydrogen halide HX (Scheme 14). Among these bis(isonitrile)-
ruthenium(II) complexes, trans,cis,cis-[RuCl2(CNCH2Ph)2(dppf)] was found to be the most 
active catalyst and used as catalyst in the transfer hydrogenation of a large variety of ketones 
in  basic propan-2-ol. It has been shown to be particularly efficient in the reduction of dialkyl 
ketones (TOF upto 1500 h-1) in comparison to arylalkyl ketones (TOF upto 500 h-1). 
O Si
O O
L' M L'
L'
X
SiO2
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Scheme 14: Synthesis of trans,cis,cis-[RuX2(CNR)2(dppf)] (44) 
 
In addition, the monohydride derivative cis,cis-[RuHCl(CN-2,6-C6H3Me2)2(dppf)] (45) and 
dihydride derivative cis,cis,cis-[RuH2(CN-2,6-C6H3Me2)2(dppf)] (46) (Figure 9) have been 
isolated and characterized. Both hydride complexes catalyze the transfer hydrogenation of 
acetophenone in the absence of base. The catalytic activity of dihydride species is much more 
than monohydride as well as dichloride species, indicating that the real active species are 
dihydride-ruthenium complexes. 
 
 
 
 
 
 
 
 
Figure 9: Monohydride (45) and Dihydride (46) derivatives of trans,cis,cis-
[RuX2(CNR)2(dppf)] 
 
4.2 Hydrosilylation 
 
Rhodium and platinum complexes of sterically hindered 2,6-disubstituted phenylisonitriles 
were reported by Nile et al.41 for hydrosilylation reaction. The optimum yield of 1-
octyltriethylsilane from 1-octene and triethylsilane was obtained at XNC/Rh ratio of 2:1 
(Yields. 1:1, 69%. 2:1, 82%, 3:1, 61%, 4:1, 0%), while with the bulky ArNC, the catalyst 
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remained active even at a higher ratio of  10:1. The Rh-isonitrile complexes showed higher 
reactivity towards alkylsilanes as compared to alkoxysilanes such as the yield of 1-octylsilane 
follows the trend HSiMe2Ph (81%) > HSiEt3 (66%) > HSi(OEt)3 (40%) (Ta 
ble 4). 
 
Table 4: Hydrosilylation of 1-octene catalyzed by Rh-isonitrile complexes 
  
 
 
 
 
 
 
 
 
 
 
 
 
Hydrosilylation of acetophenone with dimethylphenylsilane was also achieved using 
PtCl2(2,6-Me2C6H3NC)2 at room temperature42. The catalytic activity of the platinum 
isonitrile complexes was higher than the phosphines. 
The rhodium complexes of bulky isonitrile ligands having a meta-terphenyl backbone (Figure 
10) were synthesized by Sawamura et al.43 and their catalytic activity was examined in 
hydrosilylation of cyclohexanone with dimethylphenyl silane in benzene at room temperature 
(Table 5). 
 
 
 
 
 
 
Figure 10: Bulky isonitrile ligands with meta-terphenyl backbone 
isocyanide silane isocyanide/Rh temp. °C 1-octylsilane yield %
XNC HSiEt3 1:1 100 69
XNC HSiEt3 2:1 100 82
XNC HSiEt3 3:1 100 61
XNC HSiEt3 4:1 100 0
ArNC HSiEt3 2:1 20 66
ArNC HSi(OEt)3 2:1 20 40
ArNC HSiPhMe2 2:1 20 81
ArNC HSiEt3 10:1 20 53
XNC = 2,6-dimethylphenyisocyanide; ArNC = 2,6-diisopropylphenylisocyanide
Me
NC
R
R
R
R
R = H, Me, Me3Si, tBuMe2Si
47
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The highest activity was obtained with Rh/L ratio 1:1. The acceleration effect on 
hydrosilylation reaction which varied with bulkiness of ligands was evaluated with each 
ligand. Sterically less demanding isonitriles (47) (R = H, Me, 2,6-diisopropylphenylisonitrile) 
exhibited less acceleration effect compared to sterically more demanding ligands (47) (R = 
Me3Si, tBuMe2Si) due to their concave steric features. 
 
 Table 5: Hydrosilylation of cyclohexanone using Rh-isonitrile complex 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Very recently, insertion of acetylene into C-C single bond next to carbonyl group of 
nonstrained cyclic compounds was achieved by Takai and coworkers44 using rhenium-
isonitrile complex (Scheme 15). The reaction of cyclohexanone-2-carboxylic acid ethyl ester 
(48) with phenylacetylene in the presence of rhenium complex [(ReBr(CO)3(thf)]2 and 
benzylisonitrile at 50 °C under solvent free conditions gave an eight membered ring product 
(49). In the absence of isonitrile, rhenium catalyzed reaction of a ß-keto ester with 
phenylacetylene afforded compound 50 in quantitative yield. 
O [RhCl(CH2=CH2)2]2 1 mol%
Ligand 1 mol%
benzene, rt, 3h
HSiMe2Ph
OSiMe2Ph
ligands (R) yield %
- 15
H 48
Me3Si 97
2,6-diisopropylphenylisocyanide 63
PPh3 24
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Scheme 15: Re-isonitrile complex catalyzed synthesis of eight membered rings 50 
 
5. Copper isonitrile complexes 
 
5.1 Esterification of carboxylic acid and cyclopropanation 
 
Ito and co-workers45-47 have reported a number of reactions catalyzed by Cu-isonitrile 
complexes. For example, esterification of carboxylic acid45 was performed in the presence of 
Cu2O-isonitrile complex (51) (Scheme 16). 
 
 
 
 
Scheme 16: Esterification of carboxylic acid 
 
Cu(I) carboxylate-isonitrile complex (52) was generated from Cu2O-isonitrile complex and 
carboxylic acid, which on reaction with alkyl halide produced the corresponding carboxylic 
ester. The reaction of α-halocarbonyl or α-halonitrile46 was performed with α, ß-unsaturated 
carbonyl or nitrile in the presence of Cu2O-isonitrile complex to produce cyclopropane 
derivatives (53) (Scheme 17). The key intermediate of this reaction was assumed to be a Cu-
O
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carbenoid which may be formed via an oxidative addition of the C-Cl bond to the Cu2O-
isonitirle complex. 
 
 
 
 
 
 
Scheme 17: Cyclopropanation of alkenes using Cu2O-isonitirle complex   
 
Similarly, the reaction of 1,3-diiodopropane with methylacrylate afforded 
cyclopentanecarboxylic acid methyl ester47 (54) (Scheme 18). In this reaction the formation 
of 3-iodopropylcopper-isonitirle complex was proposed, which was followed by the 
subsequent addition to an, α, ß-unsaturated carbo ester and the final cyclization via the 
intramolecular elimination of the copper halogen-isonitrile complex.  
 
 
 
 
Scheme 18: Cu2O-isonitirle complex catalyzed preparation of cyclopentanecarboxylic acid 
methyl ester (54) 
 
6. Conclusion 
 
Till now, the development mainly has been done on metal complexes of monodentate 
isonitriles and their chemistry, where they have been widely used in catalysis. Multidentate 
ligands being a sibling of their monodentate analogs have special properties in terms of steric 
and electronic properties, which make them an attractive candidate for further exploration in 
catalysis. Nevertheless, chelated complexes are more stable than similar complexes with 
unidentate ligands, as dissociation of the complex involves breaking two bonds rather than 
one. The goal of this research work was to synthesize chiral bis(isonitrile) ligands and 
employ them in catalysis.  
XCH2Y
Cu2O-R'NC XCHY
Cu(R'NC)n
Y
+ CuX(R'NC)n
X = Cl, Br
Y = COR, CO2R, CN
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B. Synthesis of Bis-(isonitrile) (BINC) Ligands 
 
1. Introduction 
 
Isonitriles are extraordinary functional groups which can act as nucleophiles as well as 
electrophiles in the course of a reaction. The chemistry of isonitriles is fundamentally 
different from the rest of organic chemistry, since they are one of the chemical compounds 
with divalent carbon atoms CII, and all of their chemical reactions correspond to conversions 
of the divalent carbon atoms CII into the tetravalent carbon atoms CIV. 
Isonitriles play a vital role in radical reactions and in several total and combinatorial 
synthesis.1 Since they  are isoelectronic with carbon monoxide, they can substitute the 
gaseous and poisonous carbon monoxide in organometallic reactions.2 Isonitriles polymerize 
under Lewis acid catalysis to form polyiminomethylenes having cylindrical helical structure.3 
Hundreds of isonitrile groups containing natural products were isolated, especially from 
marine species (Figure 11).4 Many natural isonitriles show  strong antibiotic, fungicidal, or 
antineoplastic effects.5 Isonitriles are also used as versatile building blocks for the synthesis 
of heterocyclic systems.6  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Selective bioactive natural products with isonitrile functionality 
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Isonitriles were first synthesized in 1859 by Lieke7 (Table 6) employing a substitution 
reaction of reactive alkyl halides with silver cyanide, which was further developed by 
Gautier8 in 1867. At the same time Hoffmann9 found a new approach towards isonitriles with 
the reaction of primary amines with potash and chloroform. During this period, the methods 
for preparation of isonitriles were facing a number of problems such as their cumbersome 
preparation, poor substrate tolerance and low yields of products. 
In 1921, Passerini10, 11 introduced the first MCRs (multi component reactions) of isonitriles. 
Isonitriles reacted with carboxylic acids and carbonyl compounds into the acyloxy-
carbonamides. In 1958, isonitriles became generally well available12, 13, and shortly after, Ugi 
et al.14 introduced a four-component reaction of isonitriles, which is referred to as the Ugi 
reaction (U-4CR). The U-4CRs are one-pot reactions of amines, carbonyl compounds, acids, 
and isonitriles. Many natural products have been formed by the U-4CR, for example a great 
variety of ®-lactam antibiotics and related compounds has been produced by the U-4CR15. 
Although several methods have been reported for the synthesis of isonitriles16, the reaction of 
N-formamides with phosgene or its synthetic equivalents such as diphosgene and triphosgene 
is the method of choice considering cost, yield, and implementation.10a, b Dehydration of N-
formamides was also achieved using POCl3,10c chlorodimethylformiminium chloride,17 
DABCO,18 aryl chlororthionformate,19 supported sulfonyl chlorides under microwave 
irradiation,20 and 2,4,6-trichloro[1,3,5]triazine (cyanuric chloride, TCT).21 Unfortunately, 
most of these methods have limited utility and applicability due to extreme toxicity, 
unmanageable handling, and high costs in the availability of the reagents. Purification of the 
reaction product can be problematic due to the reactivity of the isonitriles. 
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Table 6: Methods for Isonitrile preparation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Another barrier to the use of isonitriles is their piercing and well known odor. Almost all 
commercially available isonitriles are volatile and carry repulsive odor. Ugi states “The 
development of the chemistry of isonitriles has probably suffered ... through the 
characteristic odor of volatile isonitriles, which has been described by Hofmann and Gautier 
as highly specific, almost overpowering’, ‘horrible’, and ‘extremely distressing’. It is true 
that many potential workers in this field have been turned away by the odor.” They are 
sufficiently intolerable to have been included in nonlethal weapons.22  
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Pirrung and coworkers23d developed a new family of fragrant isonitriles by treating oxazole 
(55) or benzoxazole (57) with n-butyllithium and various acyl chlorides to generate a series 
of (Z)-isocyanovinyl esters (56)  (Scheme 19) and 2-isocyanylphenyl esters (58), which smell 
of mild isonitrile at their worst and like taffy or cherry at their best. The sweet-smelling 
compounds are easy to make and react just like their fragrant cousins. 
 
 
 
 
 
 
 
 
 
 
Scheme 19: Synthesis of fragrant isonitriles from oxazoles 
 
The approach towards the preparation of chiral bis(isonitrile) ligands is inspired from the 
synthesis of monoisonitriles via metallation of oxazoles (59).23 The three C-H groups in 
oxazole exhibit different acidity. The 2-H is the most acidic with pKa = 20 ± 2. An 
equilibrium mixture of C-2 anion (60) and the open chain isomer, α-isocyano enolate (61) 
was achieved via lithiation of oxazoles (Scheme 20). The existence of facile ring chain 
tautomerism of 2-lithiooxazoles was first proposed by Schoellkopf and co-workers.24 
Oxazoles can be converted into isonitriles upon metalation followed by trapping of the 
resulting anion with hard electrophiles such as acetyl chloride or trimethylsilyl chloride. 
Selective trapping of this equilibrium anion (60, 61) is electrophile dependent, for example, 
treatment of lithiated 2-H oxazoles with D2O25, 26 or carbonyl electrophiles23a, 24 leads to the 
corresponding 2-substituted oxazoles 62 whereas quenching with chlorotrimethylsilane,24 
acyl halides23c or alkyl halides26 affords the open chain products 63 and 64. 
 
N
O
OCN
O
R
N
O
OCN
O
R
nBuLi
RCOCl
nBuLi
RCOCl
R = Me, tBu, O-tBu, Ph, C6H4CN
55 56
57 58
 
Synthesis of Bis-(isonitrile ) Ligands
31 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 20: Chemistry of metallated oxazoles 
 
2. Synthesis of Bis(isonitrile) Ligands 
 
2.1 Bis(isonitrile) Ligands derived from amino alcohol 
 
A broad variety of sterically and electronically different bis(isonitrile) ligands (65) were 
prepared by structural variations at R1, R2 and R3. Substituted phosphorus oxide acted as a 
linker between two isonitrile arms (Figure 12). By fixing the stereochemistry at R1, which 
arrives from natural amino acid such as valine and tert-leucine, stereochemistry at R2 can be 
adjusted using synthetic methods.  
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Figure 12: Representative structure of Bis(isonitrile) ligands 
 
We envisioned to develop a synthetic protocol that would provide an easy and short access to 
a wide array of ligands 66-69 (Figure 13). Our synthetic plan called for 2-oxazolines 71a-e as 
common intermediates, which are among the most ubiquitous motifs in ligand design.27 This 
strategy, which differs from known synthetic approaches to isonitriles, is attractive because 
simple and readily accessible oxazolines 71 can be used as precursors. A wide variety of 
sterically and electronically different bis(isonitrile) ligands can be prepared by structural 
variations of the oxazolines 71 and phosphorus chloride. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Structural variation of bis(isonitrile) ligands 
 
In the forward sense, the synthesis commenced with a two step conversion of the 
commercially available and inexpensive amino alcohols 70a-d, f and 70e (Scheme 25 and 26) 
into substituted bis(isonitriles) 72 via oxazoline lithiation as outlined in scheme 21-24. When 
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treated with DFM-DMA (N,N-dimethylformamide dimethylactal) under reflux condition, 
amino alcohols 70a-d gave corresponding 2-oxazolines 71a-d in 40-50% yields28 whereas the 
synthesis of 2-oxazoline 71e, f with additional chiral centre at C-2 was accompanished by 
refluxing amino alcohols 70e, f with triethylformate and trifluroacetic acid in 1,2-
dichloroethane (Scheme 22 and 23). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 21: Synthesis of BINC ligands 72a-d 
 
With the 2-oxazolines 71 in hand, preparation of the requisite bis(isonitrile) ligands 72 was 
achieved via lithiation of 2-oxazolines (71) following the procedure of Meyers and 
Novachek28 and subsequent treatment with 0.6 equivalent of phenylphosphonic dichloride at 
low temperature (Scheme 21-24). These compounds were isolated in analytically pure form 
as colorless solids or oils, depending upon the nature of the substituents at C-2 and C-3. 
 
 
 
 
 
Scheme 22: Synthesis of BINC ligands 72e 
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The best results for the valine- and tert-leucine-derived ligands 72 b, c were observed when 
lithium diisopropylamide (LDA) was used as a base (Table 7, entry 3, 5), while 72a could 
only be obtained in lower yield by applying nBuLi for deprotonating 71a at -78 °C (Table 7, 
entry 2). It was observed that the synthesis of bis(isonitrile) ligands 72d and 72e was 
achieved at   -10 °C using LHMDS and LDA as bases, respectively (Table 7, entry 12, 13), 
whereas all attempts of performing the reaction at -78 °C were unsuccessful (Table 7, entry 9-
11).  
 
Table 7: Effect of base on the synthesis of BINC ligands 72a-e  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Moreover, bis(isonitrile) ligand derived from (1R,2S)-2-amino-2,3-dihydro-1H-inden-1-ol 
(70f) (Scheme 23) was also prepared using the synthetic route explained in Scheme 21 and 
22. Amino alcohol 70f was transformed into the oxazoline 71f in excellent yield as described 
base temp. (°C) yield (%)entry time (h)ligand
1 72a LDA - 78 12 -
2 72a nBuLi - 78 2 33
3 72b LDA - 78 2 59
4 72b nBuLi - 78 12 20
5 72c LDA - 78 2 61
6 72c nBuLi - 78 12 20
7 72c tBuLi - 78 12 traces
8 72c LHMDS - 78 12 -
9 72d LDA - 10 2 70
10 72e LDA - 78 4 <10
11 72e nBuLi - 78 12 -
12 72e LHMDS - 78 2 10
13 72e LHMDS - 10 2 77
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earlier, which was subjected to lithiation with nBuLi followed by trapping of lithiated 
oxazoline with PhPOCl2 to give rise to BINC 72f. All efforts to purify the ligand 72f were not 
fruitful because of its instability on silica, which may arise from the presence of very acidic 
benzylic proton proximal to isonitrile group. However, a pure sample for NMR studies was 
obtained by preparative HPLC. 
 
 
 
 
Scheme 23: Synthesis of BINC ligand 72f 
 
A different bis(isonitrile) ligand  72g in contrast to other BINC ligand 72a-e was planned to 
be prepared by changing the source of phosphorus dichloride. The reaction of 
admantylbromide (73), with aluminiumtribromide in refluxing phosphortrichloride furnished 
admantylphosphonic dichloride (74) in 93% yield (Scheme 24). Lithiation of oxazoline (71c) 
using LDA, followed by treatment with admantylphosphonic dichloride (74) afforded the 
desired BINC ligand (72g) in 40% yield.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 24: Synthesis of BINC ligands 72g 
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The preparation of ß-amino alcohol 70d, precursor for BINC 72d (Scheme 22) synthesis was 
achieved via well defined Reetz methodology.29 Valine, after treatment with benzylbromide 
and potassium carbonate in ethanol/water solvent mixture at reflux was transformed into N, 
N-dibenzylamino benzyl esters (76) in 73% yield, subsequently followed by its reduction to 
optically active alcohol (77) in quantitative yield. Aldehyde (78) prepared by Swern 
oxidation of 2-(dibenzylamino) alcohol (77) was used without further purification for the next 
step, as summarized in Scheme 25.  
 
 
 
 
 
 
 
 
 
 
Scheme 25: Synthesis of ß-amino alcohols syn-79 and anti-80 
 
Treatment of the N,N-dibenzylamino aldehydes (78) with 2 equiv of MeMgCl in ether at 0 °C 
gave the corresponding syn amino alcohols (79) in good chemical yields and excellent 
stereoselectivity (Scheme 25). The degree of stereoselection was moderately affected by the 
size of the substituent at the stereogenic center in the R-amino aldehyde.  
After purification by flash chromatography syn-79 was debenzylated to the final ß-amino 
alcohols syn-81 by hydrogenolysis on Pearlman’s catalyst in excellent chemical yields 
(Scheme 26). Assignment of the absolute stereochemistry of amino alcohol (81) was done by 
1H NMR spectroscopy. 
 
 
 
 
 
Scheme 26: Debenzylation of ß-amino alcohols syn-79  
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No erosion of stereochemistry was observed in the course of the reaction, which gave rise to 
the new BINC ligands 72 as odorless compounds in enantiomerically pure form. The 
structure of 72b was unambiguously established by X-ray analysis (Figure 14), which 
revealed a dissymmetric arrangement of the two diastereotopic isonitrile arms in the solid 
state that are also clearly distinguishable, in both the 1H and 13C NMR spectra. 
 
 
 
 
 
 
 
 
 
 
Figure 14: X-ray structure of BINC 72b 
 
2.2 1,1’-binaphthyls and H8-1,1’-binaphthyl based bis(isonitrile) ligands 
 
Optically active 1,1’-bi-2-naphthylamine (BINAM) (82), and their numerous derivatives (83) 
have established extensive application as chiral ligands for asymmetric catalysis.30 During the 
last years, it was found that several ligands based on the H8- binaphthalene core (84) (Figure 
15) show higher asymmetric induction than those based on parent 1,1’-binaphthyls in 
asymmetric hydrogenations, alkylations of aldehydes, hetero-Diels-Alder, and Morita-Baylis-
Hillman reactions.31 Higher efficiency and enantioselectivity was gained by using  chiral 
catalysts derived from optically active H8-1,1’-bi-2-naphthylamine (H8-BINAM) (84) for 
asymmetric reactions than those prepared from their parent ligands, (82) due to the steric and 
electronic modulation in the binaphthyl backbone.32 Therefore, optically active H8-1,1’-bi-2-
naphthylamine (H8-BINAM) represent extremely useful starting materials for the synthesis of 
relevant chiral ligands. 
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Figure 15: BINAM derivatives 82-84 
 
Inspired by the current course of interest in the development of 1,1’-binaphthyls and H8-1,1’-
binaphthyl based ligands, we have prepared structurally related bis(isonitrile) ligands 
incorporating the parent 1,1’-binaphthyls and H8-1,1’-binaphthyl core. In this part, the 
syntheses of isonitriles were achieved by classical method i.e. dehydration of N-formamides 
using diphosgene and triethylamine.  Commercially available (R)-BINAM (82) was chosen as 
starting material for the synthesis of 1,1’-binaphthyls and  H8-1,1’-binaphthyl based 
bis(isonitrile) ligands (Scheme 27 and 28). The formylation of enantiopure (R)-1,1’-bi-2-
naphthylamine (BINAM) (82) was carried out with acetic formic anhydride (85) in THF at 
room temperature (Scheme 27). Under these conditions the reaction proceeds very cleanly 
and furnished (R)-N,N'-(1,1'-binaphthyl-2,2'-diyl)diformamide (86) products in nearly 
quantitative yield, which further transformed into (R)-2,2'-diisocyano-1,1'-binaphthyl (87) 
with diphosgene under basic conditions in good isolated yields. 
 
 
 
 
 
 
 
Scheme 27: Synthesis of (R)-2,2'-diisocyano-1,1'-binaphthyl (87) 
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In analogy to synthesis of (R)-2,2'-diisocyano-1,1'-binaphthyl (87), synthesis of (R)-2,2'-
diisocyano-H8-1,1'-binaphthyl (89) was undertaken by similar strategy. (R)-2,2’-diamino-
1,1’-binaphthyl (82) was quantitatively reduced to its H8-derivative (84) under 50 bar H2 at 
100 °C with Pd/C (10 mol %) within 60 min (Scheme 28). No traces of the starting material 
or the opposite enantiomer of 84 could be detected by HPLC. Formylation of (R)-2,2’-
diamino-H8-1,1’-binaphthyl (84) with acetic formic anhydride (85), followed by treatment 
with diphosgene and triethylamine afforded (R)-2,2'-diisocyano-H8-1,1'-binaphthyl (89) in 
86% yield. 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 28: Synthesis of (R)-2,2'-diisocyano-H8-1,1'-binaphthyl (89) 
 
Following the protocol developed by Maruoka and coworkers,33 chiral 3,3′-diphenyl 
derivatives× of (R)-2,2'-diisocyano-1,1'-binaphthyl (94) was palnned to be synthesized as 
summarized in scheme 29. 3,3′-dibromo BINAM (91) acts as a key intermediate for the 
derivatization of BINAM (82).  Dibromination was achieved on partially hydrogenated H8-
BINAMA (84) at 3,3’ position by treatment with two equivalents of N-bromosuccinimide in 
THF at 0 °C in excellent yield. Subsequently, 90 was rearomatized with DDQ in benzene 
under reflux condition to give the desired (R)-3,3'-dibromo-1,1'-binaphthyl-2,2'-diamine (91) 
in good yield. No loss of enatioselectivity was observed, as confirmed by HPLC analysis. 
Finally, the Suzuki-Miyaura coupling of (R)-3,3'-dibromo-1,1'-binaphthyl-2,2'-diamine (91) 
with phenylborornic acid furnished 3,3′-diphenyl BINAM (92) in  good chemical yield, 
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which subsequently could be subjected to formylation followed by dehydration of formamide 
to yield chiral 3,3′-diphenyl derivatives of (R)-2,2'-diisocyano-1,1'-binaphthyl (94). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 29: Synthesis of 3,3’-diphenyl-(R)-2,2'-diisocyano-1,1'-binaphthyl (94) 
 
2.3 Carbohydrate based bis(isonitrile) ligands 
 
Carbohydrates are the most abundant compounds of the chiral pool, but unlike amino acids, 
they are far less frequently employed for the preparation of chiral ligands for metal-catalyzed 
asymmetric synthesis.34, 35 Carbohydrates have many advantages: they are readily available, 
are highly functionalized and have several stereogenic centers. This enables series of chiral 
ligands to be synthesized and screened in the search for high activities and selectivities for 
each particular reaction. However, the presence of both stereocentres and functional groups in 
great quantities is regarded rather more of an obstacle than an advantage. In contrast, efficient 
examples of carbohydrate-based ligands have been reported, many interesting structures have 
emerged and application of such complex agents has recently met with increasing attention.  
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Attracted by the impressive results that have been obtained using carbohydrate derivative 
ligands in a wide range of catalytic asymmetric reactions, we have also the synthesis of new 
chiral bis(isonitrile) ligands 95 (Figure 16) with carbohydrate backbone, which are accessible 
from inexpensive D-glucose. 
 
 
 
 
 
Figure 16: Basic structure of carbohydrate based chiral bis(isonitrile) ligands 95 
 
Our reterosynthetic strategy towards the carbohydrate based chiral bis(isonitrile) ligands (95) 
is illustrated in Scheme 30. We envisaged that 96 could be converted into 95 through 
hydrolysis of azide group followed by amine formylation. Synthesis of 96 was anticipated 
from the glycosidation of fragments 97 and 98,36 which could be easily accessed from D-
glucal (99). 
 
 
 
 
 
 
 
 
 
 
 
Scheme 30: Reterosynthetic analysis of 95 
 
We therefore devised a synthetic route towards carbohydrate based BINC ligands with D-
glucal (99) as key intermediates. The use of D-glucal has several advantages, as they are 
easily accessible from D-glucose and highly stable against all conditions.  
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Starting from glucal, 1,6-anhydro-2-deoxy-2-iodo-ß-D-glucopyranose (100) was prepared in 
good yield by refluxing D-glucal (99) with bis(tributylstannyl)oxide in acetonitrile followed 
by iodine treatment (Scheme 31). Upon treatment with sodium azide in DMF-H2O at 120 °C, 
the azide (101) was obtained in 80% yield from iodo (100). The diol (101) was easily 
transformed into monobenzylated (103) via benzylation followed by TiCl4 mediated 
debenzylation at position 4 of (102). By this method, the target, 1, 6-anhydro-2-azido-3-O-
benzyl-2-deoxy-ß-D-glucopyranose (103) was obtained in 82% yield. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 31: Synthesis of 1, 6-anhydro-2-azido-3-O-benzyl-2-deoxy-ß-D-glucopyranose 
(103) 
 
Next, the synthesis of fragment 106 was achieved from 102 (Scheme 32). Opening of the 
anhydro ring in 102 using CF3COOH-Ac2O gave the anomeric mixture of the diacetate (104) 
in excellent yield which was converted to the anomeric alcohol (105) using benzylbromide in 
THF. The anomeric mixture of alcohol (105) was allowed to react with the 
trichloroacetonitrile and DBU in dichloromethane to obtain imidate 106 in 60% yields. 
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Scheme 32: Synthesis of imidate 106 
 
Towards the end, glycosidation of 103 with 106 using catalytic amount of BF3.OEt2 as an 
activator in toluene at -78 °C led to the formation of disaccharide (107) (Scheme 33), which 
can be transformed into bis(isonitrile) ligand (95) via three more steps including azide 
hydrolysis to amine, amine formylation and finally dehydration of foramide. 
 
 
 
 
 
 
 
Scheme 33: Glycosidation of 103 and 106 
 
3. Conclusion 
 
In summary, a convenient, short and facile method for synthesis of enantiopure bis(isonitrile) 
ligands was developed. A wide range of bis(isonitrile) ligands 72 were prepared in moderate 
to good yields by structural variation of the oxazolines 71 and phosphorus chloride. Further, 
bis(isonitrile) ligands 87, 89, 94 and 95 were also synthesized having binaphthyl and 
carbohydrate backbone respectively using conventional methods.  
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C. Synthesis and Application of Pd-bis(isonitrile) catalysts 
 
1. Introduction 
 
The increasing number of synthetic transformations facilitated by transition metal catalysts 
shows no sign of abating. Of all the organometallic compounds known, those derived from 
palladium have become the most important catalysts for an array of synthetic reactions. 
Generally, palladium has achieved a prominent role in catalysis and synthesis due to its 
electronegativity ( χ = 2.2), which facilitates the formation of relatively strong Pd–H and Pd–
C bonds, but also gives rise to polarized Pd–X bonds. It also allows easy access to 0 and +2 
oxidative states, where palladium-centered reactions such as oxidative addition, 
transmetallation and reductive elimination processes occur with dynamic changes in 
geometry of palladium.1 
 Pd-isonitrile complexes were widely used as catalyst precursors by Ito and co-workers in 
intra- and intermolecular bissilylation of alkynes and alkenes (Chapter A.2.1). Villemin and 
co-workers also reported palladium-isonitrile complexes and their use in Suzuki Miyaura 
coupling (Chapter A.2.2). More interestingly, Kazmaier has reported the Pd(tBuNC)2Cl2 
catalyzed bisstannylation of asymmetric alkynes (Chapter A.2.3). Owing to their electronic 
properties, being also strong σ-donor ligands like N-heterocyclic carbenes (NHC) and 
Arduengo’s carbenes (Figure 17), the palladium isonitrile complexes are good candidates for 
cross-coupling reactions and aerobic Wacker oxidations. Especially, large bite angles of these 
chelated metal complexes have proven to be beneficial for activity and selectivity in cross-
coupling reactions.2  
 
 
 
 
 
 
 
Figure 17: Analogy between carbenes and isonitriles 
Ar Ar N NAr Ar Ar = 2,6-diisopropylphenyl (IiPr)
2,4,6-triisopropylphenyl (IMes)
CNR
Arduengo's
carbenes Isonitriles
N-heterocyclic
carbenes
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2. Synthesis of [PdCl2(BINC)] complexes 
 
We prepared [PdCl2(BINC)] complexes to study their catalytic activity in Suzuki-Miyaura 
coupling as well as in aerobic Wacker oxidation. Complexation of 72a, b, c with 
[PdCl2(PhCN)2] in dichloromethane at room temperature gave rise to PdII complexes 105a, b, 
c in excellent yields, which were characterized by NMR and IR spectroscopy as well as by  
X-ray structure analysis of 105b (Scheme 34, figure 18). 
 
  
 
 
 
 
 
 
Scheme 34: Synthesis of 105a, b, c complexes 
 
The latter revealed that 72b indeed acts as a bidentate ligand forming a 12-membered ring 
with palladium. Nevertheless, the bite angle between the isonitrile arms at the palladium 
center is 88°, quite normal for a square-planar d8 complex. The two carbons of isonitrile 
moiety in the complex 105b are bonded to the Pd center with bond distances of 1.9365 Ǻ 
(C8) and 1.9435 Ǻ (C1), respectively (Figure 18, table 8), which indicates a dissymmetric 
arrangement of the two isonitrile moieties around the metal center. This geometry is also 
reflected in solution, as can be seen from 1H NMR spectrum of 105b, which displays one set 
of signals for each isonitrile arm. 
 
 
 
 
 
 
 
P
OPh
O O
R
NC
R
CN
72a: R = Bn
72b: R = tBu
72c: R = iPr
P
OPh
O O
R
N
R
N
C C
Pd
Cl Cl
[PdCl2(PhCN)2]
CH2Cl2, 16 h ,rt
105a,b,c
90%
 
Synthesis and Application of Pd‐bis(isonitrile) catalysts
49 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: X-ray structure of 105b complex 
 
1H NMR studies were also performed to observe any changes in the geometry of complex 
with respect to temperature. However, no remarkable changes were observed at high as well 
as at low temperature NMR spectrum. The IR spectrum of [PdCl2(tBu-BINC)] (105b) 
showed a broad ν (N≡C)  absorption at 2237 cm-1. The blue shift of 97cm-1 indicated isonitrile 
complexation with palladium. The two weak Pd-Cl vibrational bands at 343 (w) and 321 (w) 
cm-1 were also observed in IR spectrum which is indicative of a square planar complex with 
cis configuration as confirmed by X-ray analysis.  
 
Table 8: Selected bond lengths [Ǻ] and angles [°] of 105b. 
 
 
 
 
 
 
 
 
Bond lengths [A°] Bond angles [°]
Pd-Cl1 2.296 C1-Pd-C8 88.2
Pd-Cl2 2.299 C11-Pd-C12 93.7
Pd-C1 1.943 Pd-C1-N1 177.2
Pd-C8 1.935 Pd-C8-N2 174.4
C1-N1 1.128 C1-N1-C2 177.6
C8-N2 1.136 C8-N2-C9 171.8
N1-C2 1.457 C1-N1-C2-C3 62.5
N2-C9 1.453 C8-N2-C9-C10 43.6
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3. Suzuki-Miyaura coupling 
 
The palladium-catalyzed Suzuki cross-coupling reaction of aryl bromides, aryl iodides, and 
pseudohalides (e.g. triflates) is a general method employed for the formation of C-C bonds.3 
The use of aryl chlorides in coupling reactions has proven difficult but would economically 
benefit a number of industrial processes.4  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 35: Reaction mechanism for Suzuki coupling 
 
The first step in the mechanism of Suzuki cross-coupling is oxidative addition (a) of 
palladium to the halide forming intermediate (A). A transmetallation (b) with boronate forms 
the organopalladium specie (B). The last step is a reductive elimination (c) which results in 
the product (C) and regeneration of the catalyst (Scheme 35). The mechanism shown above 
indicates only the main steps proposed for Suzuki coupling, because the details may vary 
with conditions.5 
Inspired by the results reported by Villemin and co-workers (Scheme A.2.2), palladium-
bis(isonitrile) complexes were tested for Suzuki-Miyaura coupling. An initial screening 
revealed that 105b showed best activity in the presence of a solution of K3PO4 in DMA at 
120°C for 16 h as compared to 106a and 106b for Suzuki coupling of activated 4-
PdL
PdL
R
X
R X
PdL
R
Nu
E X Nu E
Nu R
oxidative
addition
transmetallation
reductive
elimination
R = aryl or vinyl; Nu = aryl; E = B(OH)2
(A)
(B)
(C)
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chloronitrobenzene with phenylboronic acid (Table 9, entry 4-6). Homocoupled product (B) 
was obtained as a side product on employment of 106a as catalyst in the presence of toluene 
and THF (Table 9, entry 1-3), whereas changing the solvent to DMA does not lead to any 
side products. However, it was found that 106b was inactive under optimized conditions 
(Table 9, entry 5). The activity of catalyst 105b was found to be the best in the presence of 
two equivalent of K3PO4 compared to Cs2CO3 and KF (Table 9, entry 6-8). Byproducts 
resulted from the insertion of isonitriles in the reaction were not observed.  
   
Table 9: Optimization for phenylation of 4-chloronitrobenzene by phenylborornic acid  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[PdCl2(tBuNC)] (105b) is also considerably more stable to air and moisture than the 
corresponding 106a and 106b. Consequently, catalyst 105b was used for all subsequent 
coupling reactions (Table 10). Having obtained the optimized conditions, a variety of 
substituted aryl chlorides and aryl bromides were investigated for Suzuki coupling reaction 
catalyzed by 105b (Table 10). A variety of functional groups on the aryl halides were well 
tolerated by catalyst 105b. Electron donating and electron withdrawing substituents were 
Cl
O2N
(HO)2B catalyst (5 mol%)
Base (2 equiv.),
16 h O2N
entry catalyst base solvent temp. yield (%)
(°C) A B
1 [Pd(OAc)2(tBu-BINC)] (106a)a K3PO4 Toluene 100 20 32
2 (106a) K3PO4 THF 70 28 25
3 (106a) KF THF 70 27 31
4 (106a) K3PO4 DMA 120 46 -
5 [Pd(dba)2(tBu-BINC)] (106b)a K3PO4 DMA 120 - -
6 [PdCl2(tBu-BINC)] (105b) K3PO4 DMA 120 94 -
7 (105b) Cs2CO3 DMA 120 57 -
8 (105b) KF DMA 120 51 -
A B
Homocoupled
product
a prepared in situ
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both well tolerated by the catalytic system and provided the corresponding coupling product 
in good yields. 4-chlorobenzaldehyde showed diminished reactivity allowing only 10 % yield 
(Table 10, entry 3). However, activated 4-bromobenzaldehyde afforded a coupled product in 
good yield (Table 10, entry 6).  
 
Table 10: Complex 105b catalyzed Suzuki-Miyaura coupling reaction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
X
R
(HO)2B catalyst 105b (5 mol%)
K3PO4 (2 equiv.), DMA
120 °C, 16 h R
Entry Aryl halide Product Yield (%)
1 O2N Cl NO2
NC Cl CN
OHC Cl CHO
MeO Br OMe
MeOC Br COMe
OHC Br CHO
2
3
4
5
6
94
80
10
75
81
87
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4. Aerobic Wacker oxidation 
 
The palladium(II)-catalyzed oxidation of alkenes to methyl ketones, known as the Wacker 
oxidation, is one of the most important catalytic applications in industry.6  
The first oxidation of alkenes using Pd(II) Chloride solution was discovered in late 19th 
century by Phillips7 (1894), where this reaction was used as a test for alkenes (Pd black was 
the indicator) (Equation 1). 
 
 
 
Later, Smidt and co-workers8 (1962) employed cupric chloride to regenerate the Pd(0) 
catalyst (Equation 2). 
 
 
 
 
Recycling of CuCl back to CuCl2 by air made this process applicable for large scale 
production (Equation 3). 
 
 
 
Adding the above three reactions gives Wacker oxidation reaction. 
 
 
 
 
 
 
 
 
C2H4 + Pd(II)Cl2 + H2O C2H4O + Pd(0) + 2 HCl (1)
C2H4 + Pd(II)Cl2 + H2O C2H4O + Pd(0) + 2 HCl
(2)
Pd(0) + 2 CuCl2 Pd(II)Cl2 + 2 CuCl
2 CuCl + 1/2 O2 + 2 HCl 2 CuCl2 + H2O (3)
C2H4 + PdCl42- + H2O CH3CHO + Pd(0) + 2 HCl + 2 Cl-
(2)Pd(0) + 2 CuCl2 + 2 Cl- PdCl4
2- + 2 CuCl
2 CuCl + 1/2 O2 + 2 HCl 2 CuCl2 + H2O (3)
(1)
Net : C2H4 + 1/2 O2 CH3CHO
Wacker oxidation reaction
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Scheme 36: General catalytic cycle of Wacker oxidation 
 
The catalytic cycle (Scheme 36) involves the coordination of alkenes to Pd(II) and,× 
subsequently, the nucleophilic attack of water on η2-Pd-alkene complex followed by ß-
hydride elimination afford in majority of cases methyl ketones from terminal alkenes. 
Catalytic amounts of copper chloride are used with oxygen to regenerate the active Pd(II) 
species. 
The original protocol calls for stoichiometric amounts of copper (II) chloride as co catalyst, 
which has been recognized as a considerable limitation for the overall process. Sustainable 
alternatives have been developed, notably the application of tert-butylhydroperoxide for the 
oxidation of styrenes9 or molecular oxygen for the oxidation of alkyl-substituted terminal 
alkenes.10 The coordination of palladium with strong σ-donor ligands, that is, N-heterocyclic 
carbenes or sparteine proved to be crucial for these successful developments. 
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Recently, Sigman and Cornell discovered the direct palladium-catalyzed Wacker oxidation of 
terminal alkenes without the need for employing copper cocatalysts.10 1 mol% Palladium [(-)-
sparteine] dichloride with 0.2 M substrate in a 4:1 DMA/H2O solvent system proved to be 
efficient for the conversion of aliphatic alkenes to methyl ketones using molecular oxygen as 
the terminal oxidant (Table 11, entry 1-5). This palladium complex also proved to be 
applicable for the oxidation of 4-methylstyrene to the corresponding methyl ketone when an 
excess of tert-butylhydroperoxide (TBHP, 5.5 equiv) was employed (Table 11, entry 6).  
 
Table 11: Palladium [(-)-sparteine]Cl2 catalyzed Wacker oxidation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alternatively, a palladium (II)–NHC complex in the presence of catalytic amounts of AgOTf 
as co catalyst, again using TBHP as the terminal oxidant, was reported by the same authors to 
be efficient for the generally more challenging oxidation of styrenes, a process that is often 
R R
O
Pd[(-)sparteine]Cl2 (1 mol%)
O2 (1 atm), 70 °C
0.2 M DMA/H2O 4:1
entry substrate reaction time (h) yield(%)a
1 dodecene 18 85b
2 tridecene 18 83b
3 18 72
4 24 73
5 24 62c
6 24 92d
HO 8
MeO2C
8
a Average isolated yield of multiple experiments. b Isolated yield reflects purity
of SM (internal olefins). c 2.5 mol % Pd-[(-)sparteine]Cl2. d 5 mol% Pd-[(-)sparteine]Cl2,
5 equiv. TBHP, 0.25 M DMA or NMP.
O
O
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hampered by competing C=C bond cleavage (scheme 37).9 High selectivity for the oxidation 
of primary aryl olefins to ketones (>95%) is demonstrated with minimal observed aldehyde 
formation. Different substitution patterns on the aryl ring lead to similar yields Moreover, 
Kaneda and co-workers disclosed that PdCl2 is a Wacker catalyst that can be used under 6 
atm oxygen pressure.11  
 
 
 
 
 
 
 
 
 
 
 
Scheme 37: NHC catalyzed Wacker oxidation of styrenes× derivatives reported by Sigman 
and co-workers. 
 
Catalysts 105c, b demonstrated its efficacy in the oxidation of terminal alkenes in the absence 
of any further co catalysts using molecular oxygen at ambient pressure. An initial screening 
revealed that both complexes gave very similar yields and selectivities in Wacker oxidation 
(Table 13, entries 5 and 11). Therefore, subsequently we evaluated 105b, which can be 
isolated in high purity by recrystallization and stored without signs of decomposition. 
Compound 105b effectively catalyzed the oxidation of terminal aliphatic alkenes (Table 12) 
by using dimethylacetamide (DMA)/water9 as the solvent system. Careful GC analysis 
revealed that no isomerization or C=C bond cleavage had occurred, and that the 
corresponding methyl ketones were generated in high yields and excellent purity.  
 
O
H
O
N N ArAr
Ar = 2,6-diisopropylphenyl
Pd
ClPrIi
Cl Cl
Pd
Cl
IiPr
NHC catalyst
0.75 mol% NHC catalyst
3 mol% AgOTf
5.5 equiv. TBHP(aq)
0.5 M in MeOH
35 °C, air
IiPr =
Conversions (90 - >99%)
A:B (22:1 - >150:1)
A B
R R R
R = H, 2-Me, 3-Me, 4-Me, 3-NO2
2,4,6-trimethyl, 3-Cl
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Table 12: Wacker oxidation of aliphatic alkenes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The  
 
 
 
Oxidation of long chain olefins 1-octene occurred efficiently to give ketones with 98% 
conversion (Table 12, entry 1). Terminal alkenes possessing oxygenated functional groups 
were found to be suitable substrates as well, and notably, hydroxyl groups were not oxidized 
under the reaction conditions (Table 12, entry 3). In case of 1,7-octadiene, diketone and 
monoketone products were obtained in 4:3 ratio (Table 12, entry 8). 
R R
Ocatalyst (5 mol%)O2 (1 atm), 70 °C
0.2 M DMA/H2O 4:1 NC
OAc
107
entry catalyst substrate reaction time (h) conversion (%)a
1 105b 1-octene 24 98 (75)
2 [PdCl2(107)2]b,c 1-octene 24 98
3 105b 48 97d (77)
4 105b 48 92 (71)
5 105b 48 75e
6 105b 48 84e
7 105b 48 98e
8 105b 48 93f
HO 8
O
MeO2C
8
a Determined by GC using decane as the internal standard; isolated yields in parentheses, b 5 mol%
PdCl2, 10 mol% 107, c 3 % isomerized alkene oxidation products, d reaction conditions: 0.125 M
concentration of substrate, 6:1 DMA/ H2O, e reaction conditions: 0.125 M concentration of substrate, 6:1
DMA/ H2O, f diketone/monoketone ratio 4/3
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As a control experiment, we performed the oxidation of 1-octene also with the palladium(II) 
complex of the monodentate isonitrile ligand 107,12 which also proceeded well but gave 
around 3% of oxidation products stemming from alkene isomerizations. 
Turning to the more challenging styrenes because of their propensity for C=C bond cleavage 
under oxidative conditions, we were delighted to find that for these substrates also, 105b is 
effective at ambient oxygen pressure in the absence of any further co catalyst (Table 13). A 
reaction temperature of 70 °C and a DMA/water mixture of 6:1 was found to give the highest 
ratios between methyl ketones and aldehydes (Table 13, entry 5). As shown for the oxidation 
of 4-methylstyrene, the bidentate bis(isontrile) ligand 72b is clearly superior to the 
monodentate isonitrile ligand 107 (Table 13, entry 2) or palladium chloride alone (Table 13, 
entry 1). Electron-rich styrenes showed higher reactivity, but also better selectivity towards 
methyl ketone formation than electron-poor derivatives. Nevertheless, good yields and 
selectivities could be obtained for the latter also (Table 13, entries 8–11).  
Increasing the catalyst loading had no beneficial effect on the reaction (Table 13, entry 10). 
On the other hand, attempts to lower the catalyst concentration were also not successful. 
While the conversion of substrates still proceeds well even at 1 mol% 105b, substantially 
higher amounts of aldehydes are observed due to carbon–carbon bond cleavage (Table 13, 
entries 7–9), suggesting that the palladium isonitrile complexes are not stable under the 
reaction conditions and that background reactions involving palladium(0) alone occur over 
time. Control experiments showed that 72b is stable in a 6:1 DMA/water mixture even at 100 
°C for elongated times. However, 72b showed appreciable decomposition in a 6:1 
DMA/water mixture at a reaction temperature of 70 °C when palladium (II) chloride is 
present. In addition, when 72b is employed in excess with respect to palladium, complete 
decomposition of 72b is observed over time. Judged by the disappearance of the isonitrile 
band in the IR spectrum, we speculate that palladium (II) is capable of activating 72b towards 
the attack of nucleophiles such as water present in the reaction; however, we did not observe 
the corresponding formamides that would result from addition of water to 72b. 
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Table 13: Wacker oxidation of aromatic alkenes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
R R
O
H
R
Ocatalyst (5 mol%)
O2 (1 atm), 70 °C
0.125 M, DMA/H2O 6:1
entry catalyst R reaction time conversion ketone/
(h) (%)a aldehyde
1 PdCl2 4-Me 70 >99 4
2 [PdCl2(107)2] 4-Me 70 >99 6
3b 105b 4-Me 70 91 18
4c 105b 4-Me 40 >99 21
5 105b 4-Me 40 >99 26
6d 105b 4-Me 70 81 14
7e 105b 4-Me 40 98 14
8f 105b 4-Me 40 96 6
9g 105b 4-Me 40 90 8
10h 105b 4-Me 40 90 20
11 105c 4-Me 40 98 23
12 105b H 70 84 17
13 105b 2-methyl 70 88 11
naphthalene
14 105b 3-Cl 96 72 7
15 105b 4-Cl 96 98 7
16 105b 4-Br 96 50 9
17 105b 4-OMe 48 >99 (75) 21
a Determined by GC using decane as internal standard; isolated yields in parentheses,
bDMA/water 2:1, c DMA/water 4:1, d Reaction temperature 100 °C, e 2.5 mol% 105b, f 1 mol%
105b, g 1 mol% 105b + 2 mol% 72b, h 10 mol% 105b
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5. Conclusion 
 
The most relevant conclusion that could be drawn from these results is that palladium-
bis(isonitrile) complex 105b can be considered as a highly versatile catalyst for the Suzuki 
coupling and aerobic Wacker oxidation. Complex 105b catalyzed Suzuki coupling of 
activated aryl chlorides and deactivated aryl bromides with phenylboronic acid proceeded 
very well. Wacker oxidation of terminal aliphatic and aromatic alkenes catalyzed by complex 
105b proceeded in good yields and chemoselectivities in the absence of further co catalyst at 
ambient pressures of oxygen. Palladium bis(isonitrile) catalyst was characterized by NMR 
spectroscopy and X-ray structure analysis, revealing a dissymmetric coordination of 
palladium by the two isonitrile moieties. 
 
6. References 
 
1) a) Dupont, J.; Consorti, C. S.; Spencer, J. Chem. Rev. 2005, 105, 2527. b) Sherer, E. 
C.; Kinsinger, C. R.; Kormos, B. L.; Thompson, J. D.; Cramer, C. J. Angew. Chem. 
Int. Ed. Engl. 2002, 41, 1953 and 1956. 
2) Leeuwen van, P. W. N. M.; Kamer, P. C. J.; Reek, J. N. H.; Dierkes, P. Chem. Rev. 
2000, 100, 2741. 
3) a) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457. b) Hamann, B. C.; Hartwig, J. 
F. J. Am. Chem. Soc. 1998, 120, 7369. c) Reetz, M. T.; Lohmer, G.; Schwickardi, R. 
Angew. Chem. Int. Ed. Engl. 1998, 37, 481. 
4) Cornils, B.; Herrmann, W. A.; Eds. Applied Homogenous Catalysis with 
Organometallic Compounds; VCH: Weinheim, 1996. 
5) Crabtree, R. H. The organometallic chemistry of transition metals, 3rd edition, Wiley-
Interscience publication.  
6) Leading reviews: a) Smidt, J.; Hafner, W.; Jira, R.; Sieber, R.; Sedlmeier, J.; Sabel, A. 
Angew. Chem. Int. Ed. Engl. 1962, 1, 80. b) Hintermann, L. Handbook of C-H 
Transformations (Ed: F. Dyker), Wiley-VCH, Weinheim, 2005, pp. 287-302. c) 
Takacs, J. M.; Jiang, X. T. Curr. Org. Chem. 2003, 7, 369. d) Muzart, J. Tetrahedron 
2007, 63, 7505. 
7) Phillips, F.C. Am. Chem. J. 1894, 16, 255. 
 
Synthesis and Application of Pd‐bis(isonitrile) catalysts
61 
 
8) Smidt, J. et al. Angew. Chem. 1962, 74, 93. 
9) Sigman, M. S.; Cornell, C. N. J. Am. Chem. Soc. 2005, 127, 2796. 
10) Sigman, M. S.; Cornell, C. N. Org. Lett. 2006, 8, 4117. 
11) Mitsudome, T.; Umetani, T.; Nosaka, N.; Mori, K.; Mizugaki, T.; Ebitani, K.; 
Kaneda, K. Angew. Chem. Int. Ed. Engl. 2006, 45, 481. 
12) Pirrung, M. C.; Ghorai, S. J. Am. Chem. Soc. 2006, 128, 11772. 
 
 
 
Iron (II)‐Bis(isonitrile) Catalyzed Asymmetric Transfer Hydrogenation
62 
 
 
D.  Iron (II)-bis(isonitrile) Catalyzed Asymmetric Transfer 
Hydrogenation 
 
1. Introduction 
 
Catalysis is the key solution for clean, fast, efficient and selective processes in organic synthesis. 
Approximately, 80% of the chemical and pharmaceutical products in the industry are prepared 
by catalysts. During the last few decades, heavy or rare metals such as palladium (Pd), iridium 
(Ir), rhodium (Rh) and ruthenium (Ru) have dominated the research area of transition metal 
catalysis. However, their toxicity, low accessibility and high costs (Figure 19) are the main 
barriers for large scale applications1 and thus, it is obligatory to explore more environment 
friendly and economical alternatives. Iron is the second most abundant metal on earth (4.7 wt%) 
and consequently, one of the most inexpensive and environmental friendly. Various iron salts 
and iron complexes are commercially accessible on a large scale or easy to synthesize.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: Market prices of transition metals (Pt, Pd, Rh, Ir, Ru) from 1993-2007.1 
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Despite its advantages, it is surprising that until recently, iron was relatively unexplored in 
the field of catalysis in comparison to other transition metals.  
However, in the last few years, a number of examples demonstrated the potential usage of 
Iron2 and a broad range of synthetic transformations, e.g. addition, substitution, 
cycloaddition, hydrogenation, reduction, oxidation, coupling reaction, isomerization, 
rearrangement and polymerization were catalyzed by iron. 
In addition to metal catalysis, iron takes part in a number of important biochemical and 
biological activities. It is an integral part in human body where it binds to the oxygen 
transporting agent, hemoglobin, in the red blood corpuscles, and to the muscle oxygen storage 
protein myoglobin, and is stored by ferritin and haemosiderin. Iron also binds to the various 
metalloenzymes, redox proteins and is transported through the blood by transferrin. In nature, 
many redox reactions are dependent on iron-containing enzymes whereby electron transport is 
facilitated by changes in the oxidation state of the metal. Nitrogen fixation and photosynthesis 
are examples of processes in which iron-containing enzymes play vital roles.3 
 
2. Asymmetric Transfer Hydrogenation 
 
Chiral hydrogen transfer of prochiral ketones are widely used in the pharmaceutical 
industries4 and has emerged as a convenient methodology to give enantiomerically pure 
secondary alcohols, based on the simplicity of the process and the safety regulations of the 
reagents.5 However, these processes are mainly catalyzed by Ru, Rh or Ir bearing catalysts. 
Therefore, the use of iron catlysts is most desirable in this regard because of its low toxicity 
and low prices.  
Transfer hydrogenation of ketones is one of the most appealing and interesting synthetic 
routes to alcohols and constitutes a good alternative to the widely used catalytic 
hydrogenation. In nature, oxidoreductases such as horse liver alcohol dehydrogenase catalyze 
transfer hydrogenation of carbonyl compounds to alcohols using some cofactors like NADH 
or NADPH.6 Such biochemical reactions are normally very stereoselective. Transfer 
hydrogenation is a simple operation but the stereo-, chemo-, and regioselectivity are often 
different from well-established asymmetric hydrogenation. 
 
Iron (II)‐Bis(isonitrile) Catalyzed Asymmetric Transfer Hydrogenation
64 
 
Based on mechanistic point of view, three alternatives have been proposed for metal catalyzed 
hydrogen transfer of ketones (Figure 20), (i) direct transfer of a hydrogen atom of the alcohol to 
the carbonyl carbon through a concerted process involving a six-membered cyclic transition state 
(A), a mechanism accepted for aluminum-catalyzed Meerwein-Ponndorf-Verley (MPV) 
reductions and generally for main group elements7, (ii) stepwise mechanism through the 
formation of a hydride metal intermediate and the migratory insertion of a C=O into a M–H bond 
(B), a mechanism suggested for rhodium(I) and ruthenium free-arene systems8 and (iii) a 
concerted mechanism where a proton and a hydride are simultaneously transferred to the 
unsaturated substrate (C), a mechanism proposed by Noyori for the Ru arene derivatives.9 
 
 
 
 
 
 
 
Figure 20: Key species involved in the three main mechanisms (A) concerted mechanism, (B) 
stepwise mechanism, (C) concerted mechanism of metal-catalyzed hydrogen transfer 
 
In the original version of MPV reduction, aluminum isopropoxide was used to promote transfer 
of hydrogen from isopropanol to a ketone (Scheme 38). The aluminium-catalyzed shift of the 
hydride from the carbon of an alcohol component to the carbonyl carbon of a second component 
proceeds via a six-membered transition state (A). This reaction can also be reversed, which is 
commonly referred as the Oppenauer oxidation, after its discoverer.
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Scheme 38: Meerwein-Ponndorf-Verley reduction of ketones using isopropanol in excess 
These hydrogen transfer reactions are equilibrium reactions that can be pushed to either direction 
by the use of an excess of either alcohol or ketone in the starting material. Thus, for the MPV 
reduction of a ketone, isopropanol is employed in excess because the resulting acetone may be 
continuously removed from the reaction mixture by distillation. For the Oppenauer oxidation 
acetone as ketone is used in excess.  
 
 
 
 
 
 
 
 
 
 
 
Figure 21: Representative Ru catalysts bearing 1,2-diamine or alcohols  
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Later, Noyori and Ikariya and co-workers developed conceptually new chiral Ru catalysts 
bearing 1,2-diamines and amino alcohols as chiral ligands 106-108 (Figure 21) for highly 
efficient asymmetric transfer hydrogenation of ketones and imines.9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 39: Transfer hydrogenation mechanism involving interconversion of the Amido and 
Amine hydrido Ru complex via transition state 111 
 
Detailed structural studies, both in solid and in solution confirmed amido Ru complex as 
catalyst intermediate. Amido Ru complex (110) readily accepts a hydride from isopropanol 
to produce an amine hydrido Ru complex (109) (Scheme 39). The NH unit bound to Ru is 
acidic enough to activate ketones via hydrogen bonding. During the interconversion of amido 
and amine hydrido Ru complex, hydride is transfered from isopropanol to ketone reversibly 
via a six-membered transition state (111).  
Most of the efficient and enantioselective catalysts for this reaction are based on ruthenium 
and rhodium10 with high turnover frequencies (TOF’s) in the range of 100 – 4000 h-1. There 
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have been several attempts to develop an iron catalyst for these kinds of reactions, because 
these would be cheaper, relatively non toxic, using mild reaction conditions, and bearing 
operational simplicity and therefore, synthesis of chiral secondary alcohols via iron catalyzed 
asymmetric transfer hydrogenation has gained considerable attention.1, 11 In this regard, 
Chirik’s, Beller’s and Nishiyama’s groups have recently reported iron catalysts as useful for 
hydrosilylation of aldehydes and ketones.12 
Also, Bianchini and co-workers13 reported well defined dihydrogen complex 112 catalyzed 
chemoselective transfer hydrogenation of α,ß-unsaturated ketone in a mixture of dioxane and 
isopropanol (Scheme 40). However, the trend of this reduction was found to be quite irregular as 
the reaction was substrate-dependant. Thus, 3-methyl-2-cyclohexenone was reduced to the 
unsaturated alcohol with 31% conversion after 7 h, while 72% of 2-cyclohexenone was reduced 
to a mixture of unsaturated alcohol and saturated alcohol in 5 h. Other α, ß-unsaturated ketones 
were either reduced at the C=C double bond to the saturated ketone or were not reduced at all. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 40: Transfer hydrogenation of α,ß-unsaturated ketones catayzed by dihydrogen 
complex 112 
 
Beller and coworkers reported transfer hydrogenation of ketones catalyzed by 1 mol% 
[Fe3(CO)12]/terpy/PPh3 or FeCl2/terpy/PPh3 (Scheme 41).14 According to their report, sterically 
hindered and basic monodentate phosphines were found to be better than diphosphine ligands 
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and the aryl ketones as well as dialkyl ketones were reduced to alcohols with excellent yields. 
Exact structural analysis was not observed with IR spectroscopy and NMR, but kinetic studies 
proposed a monohydride pathway from the alcohol to ketones. 
 
 
 
 
Scheme 41: [Fe3(CO)12]/terpy/PPh3 or FeCl2/terpy/PPh3 catalyzed ketone reduction 
 
The same group also used a catalyst system comprising of iron porphyrin15, that mimics the 
nature. The corresponding alcohols were isolated from 22% to 99% yields at 100 °C in the 
presence of 1 mol% of catalyst. 
Despite tremendous progress in hydrogenations and transfer hydrogenations using Ru and Rh 
catalysts, only one catalytic asymmetric hydrogenation with iron catalysts was avaiable in 
literature.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22: Structure of chiral iron complexes 113, 114, 115 and 116 described by Morris et 
al. 
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Complexes 113, 114, 115 and 116 (Figure 22) were prepared by exchanging acetonitrile in the 
precursor complexes trans-[Fe(NCMe)2(P–N–N–P)]2+ with CO in acetone. Complexes 113, 114 
and 116 (Figure 22) were derived from o-diphenyl-phosphinobenzaldehyde, enantiopure 1,2–
diamine and iron(II) precursor and found to have similar activity. Complex 115 was established 
to be the most active catalyst compared to complexes 113, 114 and 116 and was prepared via an 
economical template synthesis route (Scheme 42). The synthesis consists of the deprotonation of 
dimeric phosphonium compound cyclo-[PPh2CH2CH(OH)]2(Br)2 to yield a very unstable 
diphenylphosphinoacetalaldehyde which is then trapped by [Fe(H2O)6](BF4)2 through 
coordination. Subsequent elimination of water from the metal complex yields an 
enantiomerically pure imine complex [Fe(PPh2CH2CH=NCHPhCHPhNH2)2](BF4)2 followed by 
formation of bisacetonitrile complex 117 , isolated as tetraphenylborate salt16. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 42: Synthesis of Complex 115 via a template synthesis of the bis(acetonitrile) P-N-
N-P complex 117. 
 
Complexes 113, 114 and 116 are thermally stable as compared to complex 115 and thus can be 
handled in air for a few hours without appreciable decomposition. The enantiopure complexes 
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have diastereotopic phosphorus nuclei that are coupled to each other producing two doublets in 
their 31P{1H} NMR spectra. The CO infrared absorption occurs at around 2000 cm_1, indicating 
little backdonation from the dicationic iron centre. The structure of complex 114 has been 
verified by single crystal X-ray diffraction.18 
Complexes 113-115 are active at room temperature towards transfer hydrogenation of 
ketones in the presence of potassium tert-butoxide in isopropanol (Table 14). 
Enanatioselectivities up to 76% ee were obtained in the presence of complex 114 using 2-
propanol as the hydrogen source. In addition, high catalyst activities (TOF up to 995 h-1) 
were attained.17  Morris et al. reported TOF up to 4900 h-1 and 99% ee for the transfer 
hydrogenation of ketones with complex 115.16 
In the reduction of acetophenone, complex 115 showed very high activity (4 times more 
active) compared to complex 113 and 114. Excellent results were obtained for a range of 
ketones and the enantioselectivity of the complexes increases as 113< 114< 115. For the 
phenyl-alkyl-ketones PhCOR, the rate of reduction decreases with the size of R, while the ee 
increases in the opposite order (Table 14, entry 1–8). Electron withdrawing groups in the 
para position accelerate the reaction relative to that of electron donating groups (Table 14, 
entry 9-13). Reduction of isomers of acetonaphthone were carried out very effectively using 
complex 115. 
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Table 14: Catalytic transfer hydrogenation of ketones catalyzed by Complexes 113-115 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
R R'
O Catalyst, tBuOK, iPrOH
22 - 24 °C R R'
OH
*
entry substrate time (h) conv % ee %catalyst cat./base/ketone
1 113 Ph-CO-Me 1 : 8 : 400 0.4 95 29 (S)
2 114 " 1 : 8 : 600 0.5 68 63 (S)
3 115 " 1 : 8 : 2000 0.5 90 82 (S)
4 113 Ph-CO-Et 1 : 8 : 200 3.6 95 61(S)
5 114 " 1 : 8 : 600 0.5 75 70 (S)
6 115 " 1 : 8 : 1500 0.4 90 94 (S)
7 114 Ph-CO-tBu 1 : 8 : 200 0.25 93 96 (S)
8 115 " 1 : 8 : 500 3.3 35 99 (S)
9 113 (4'-Cl-C6H4)-CO-Me 1 : 8 : 200 0.2 94 26 (S)
10 114 " 1 : 8 : 600 0.5 81 38 (S)
11 115 " 1 : 8 : 1500 0.3 96 86 (S)
12 113 (4'-OMe-C6H4)-CO-Me 1 : 8 : 200 0.5 69 23 (S)
13 115 " 1 : 8 : 1000 0.66 65 54 (S)
14 113 2-aceto-naphthone 1 : 8 : 200 0.3 94 25 (S)
15 114 " 1 : 8 : 600 0.5 61 52 (S)
16 115 " 1 : 8 : 1000 0.17 90 84 (S)
17 114 iPr-CO-Me 1 : 8 : 600 0.25 63 12 (S)
18 115 " 1 : 8 : 1500 1 86 50 (S)
19 113 Me-Ph(CH2)2-CO-Me 1 : 8 : 200 0.6 100 29 (S)
20 114 " 1 : 8 : 200 0.25 91 57 (S)
21 115 " 1 : 8 : 1000 0.5 98 14 (S)
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The carbonyl compounds, 113-115 also showed very impressive reactivity but poor selectivity 
for dialkylketone reduction (Table 14, entry 17-21). The reduction of trans-4-phenyl-3-buten-2-
one to trans-4-phenyl-3-buten-2-ol using the precatalyst 114 shows the highest chemoselectivity 
toward the reduction of carbonyl group to produce allyl alcohol (Table 15).  
 
Table 15: Transfer hydrogenation of trans-4-phenyl-3-buten-2-one 
 
 
 
 
A mechanism was suggested on the basis of above mentioned results. It was assumed that the 
imine linkage in the tetradentate ligand complex is reduced by the action of base and isopropanol 
to an amine intermediate such as [FeH(CO){(R,R)-cyP2(NH)2}]+. This could suggest that an 
outer sphere attack by an H–Fe–N–H motif on the ketone group might be possible and the 
complex might be expected to transfer a hydride from iron and a proton from nitrogen to polar 
bonds. However, other catalysts that do not utilize an outer sphere H–M–N–H attack still provide 
this selectivity in certain cases (complexes 113 and 114). The mechanism of action of these 
catalysts is currently under investigation. 
 
3. Iron(II) Bis(isonitrile) complexes 
 
3.1 Synthesis 
 
Our investigations began with the synthesis of iron complexes containing enantiopure 
bidentate bis(isonitrle) ligands (BINC). Chiral oxazolines (71a-e) were transformed to 
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entry catalyst cat./KOtBu/ketone time (h) A (% ee) B (% ee) C (% ee)
1 113 1 : 8 : 200 23 18 (45) 0 82 (27)
2 114 1 : 8 : 55 23 71 (68) 3 14 (61)
3 115 1 : 8 : 1000 0.5 82 (60) 1 4 (25)
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bis(isonitrile) upon metallation followed by trapping of resulting anion with 
phenylphosphonic dichloride (Section B, Scheme 21 and 22).19 
The reaction of FeCl2.4H2O with BINC (72a-e) in methanol led to the formation of orange to 
yellowish colored FeCl2(BINC)2 complexes (118a-e) with good yields at room temperature 
(Scheme 43)20. FeCl2(BINC)2 complexes are quite stable in air and completely soluble in 
dichloromethane, chloroform, methanol, acetonitrile, THF and isopropanol.  
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 43: Synthesis of Iron Bis(isonitrile) complexes 118a-e. 
 
The presence of broad intense absorption in the higher energy region of IR spectrum 
compared to free bis(isonitrile) ligands and the broad signals  in 1H NMR is the evidence for 
the formation of iron-bis(isonitrile) complexes (118a-e). Attempts to grow X-ray quality 
crystals of complex 118b from several solvents failed. However, exchange of chlorides with 
trichlorotin resulted in growth of suitable yellow colored crystals of [Fe(tBuBINC)2(SnCl3)2] 
(119d) (Figure 23) from methanol-pentane mixture in two weeks. [Fe(tBuBINC)2(SnCl3)2] 
was prapared at room temperature reaction of FeCl2(tBuBINC)2 (118b) with excess of 
SnCl2.2H2O in chloroform for 12 h.  
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Figure 23: X-ray structure of complex 119d (Cl atoms on Sn were omitted for clarity) 
 
X-ray analysis of the so obtained Fe(118b)2(SnCl3)2 revealed that the bidentante isontrile ligands 
had coordinated iron(II) in a square planar geometry with the trichlorostannyl ligands taking the 
axial positions to overall result in a distorted octahedral complex. Notably, the iron-isonitrile unit 
has by enlarge a linear geometry (169°) with Fe-C and isonirile C-N bond lengths averaging 1.86 
Å and 1.14 Å, respectively (Table 16), indicating that no or little back bonding from the metal to 
the ligand takes place. Other interatomic data of the compound 119d includes the average Fe-Sn 
bond length of 2.466 Å.21 
 
Table 16: Selected bond lengths [Ǻ] and angles [°] of 119d. 
 
 
 
 
 
 
 
 
 
 
Bond lengths [A°] Bond angles [°]
Fe-Sn1 2.468 Sn1-Fe-Sn2 177.7
Fe-Sn2 2.464 C1-Fe-C20 89.2
Fe-C1 1.87 C1-Fe-C40 91.0
Fe-C20 1.85 C20-Fe-C21 93.3
Fe-C21 1.91 C21-Fe-C40 86.8
Fe-C40 1.82 C1-N1-C2 176
N1-C1 1.17 C15-N2-C20 164
N2-C20 1.15 C21-N3-C22 175
N3-C21 1.10 C35-N4-C40 162
N4-C40 1.18
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The chloride ligand in complex 118b can also be easily displaced by other ligands such as 
CO, PPh3 and OTf to obtain 119 as shown in scheme 44. Complexes 119b and 119c were 
isolated as their tetraphenylborate salts.  
 
 
 
 
 
 
 
 
Scheme 44: Synthesis of Iron Bis(isonitrile) complexes 119a-d. 
 
3.2 Transfer Hydrogenation of Aromatic Ketones  
 
Complexes 118(a-e) – 119(a-c) were tested as catalyst precursors for transfer hydrogenation 
of acetophenone to 1-phenylethanol in basic isopropanol and the results are summarized in 
Table 17. Complex 118b was found to be an active catalyst at room temperature (Table 17, 
entries 2 vs 4) and showed good activity with 90% conversion and 64% ee. Lowering the 
loading of complex 118b led to the decrease in the extent of conversion (Table 17, entry 3).  
Under hydrogenation using hydrogen at 50 bar, complex 118b showed moderate conversion 
and selectivity (Table 17, entry 5). On the basis of this result it was concluded that complex 
118b works better under transfer hydrogenation conditions. As revealed by the data 
presented in Table 17, the exchange of one or both chloride ligands with triflate (Table 17, 
entry 9), PPh3 (Table 17, entry 10) and CO (Table 17, entry 11) didn’t show appreciable 
results. 
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Table 17: Transfer Hydrogenation of Acetophenone Catalyzed by complexes 118 and 119 
O OH
entry complex time (h) conv %a ee %b
tBuOK, iPrOH
0.1 M
22 - 24 °C
S:B:C = 20:10:1
2 118b 8 90 64
3
119a9
119b10
119c
8 71 40
mol %
5
5
11
118b 2
8 118e 24 24 17 5
5 41 60
24 22 - 5
523 17 -
4 118bc 523 41 36
5 118bd 56 59 52
a Determined by GC using decane internal standard. b Determined by HPLC.
c Temperature 45 °C. d Under 50 bar H2 pressure.
1 118a 23 17 - 5
6 118c 58 71 54
118d7 24 56 10
(S)
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 The substitution pattern in the isonitrile ligands appears to play an important role to render 118 
an efficient catalyst in transfer hydrogenations. While the iso-propyl derivative 118c still showed 
appreciable activity and selectivity (Table 17, entry 6), the benzyl complex 118a and derivatives 
118d and 118e (Table 17, entry 7, 8) being substituted at the β-position of the isonitrile were by 
enlarge inactive. It was assumed that the presence of additonal chiral centre might lead to an 
increase in the enantioselectivity due to steric reasons, but observed decrease in selectivity and 
conversion may be attributed to blocking the access of substrate to the iron center. Since we 
assume (vide infra) that both, iron and the isonitrile moiety play an integral role in the hydride 
transfer to the ketone, small conformational changes in the iron-bis(isonitrile) complexes might 
sufficiently disturb the required arrangement of these two moieties to give catalytic turnover. The 
use of a strong base such as tBuOK was very essential for the catalysis, as no reaction was 
observed without the base. The optimal ratio of the catalyst to the base was 1: 10. 
Complex 118b was also extensively studied with a variety of substrates. Replacement of 
methyl group of acetophenone with bulky groups (Table 18, entry 2, 3, 4) brought down the 
conversion as well as the enantioslectivity. This finding demonstrated that the rate of 
reduction and enantioselectivities decreased with the more hindered aromatic ketones. 
Hydrogenation of the ketone with 1-phenylmethyl group (Table 18, entry 5) proceeded with 
reduced conversion and ee.  
The acetophenone with electron donating group such as p- and o-OMe acetophenone showed 
lower reactivity with moderate selectivity (Table 18, entry 6, 8), whereas m-OMe 
acetophenone was found to be reduced very fast with moderate selectivity (Table 18, entry 
7). Aromatic ketones with electron withdrawing group such as p- and m-Cl acetophenone 
showed excellent conversion with moderate selectivity (Table 18, entry 3, 4). In contrast,     
o-Br substituted acetophenone showed moderate activity as well as selectivity (Table 18, 
entry 5). This result is opposite to the results reported by Morris and co-workers,16 in which 
o-Cl substitution has no significant influence on the reactivities of the substrates. The 
acetonaphthone isomers (Table 18, entry 12, 13) and cyclic ketones (Table 18, entry 14, 15) 
were also reduced efficiently with lower selectivity.  
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Table 18: Transfer Hydrogenation of Aromatic Ketones catalyzed by complex 118b 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
R
O
R
OH
entry substrate time (h) conv %a ee %b
complex 118b, tBuOK,
iPrOH. 0.5 M
22 - 24 °C
S:B:C = 20:10:1
1c Ph-CO-Me 8 90 64
2 Ph-CO-Et 6 73 64
3 Ph-CO-iPr 3 36 36
4c Ph-CO-(cyclo-C6H11) 5 55 18
5 PhCH2-CO-Me 1 99 34
6 (4'-Cl-C6H4)-CO-Me 12 94 60
7 (3'-Cl-C6H4)-CO-Me 1 >99 67
8 (2'-Br-C6H4)-CO-Me 24 60 67
9 (4'-OMe-C6H4)-CO-Me 6 50 58
10 (3'-OMe-C6H4)-CO-Me 1 93 54
11 (2'-OMe-C6H4)-CO-Me 3 56 52
12c 2-aceto-naphthone 1 84 64
13 1-aceto-naphthone 1 48 41
14 3 62 46
15c 24 89 33
O
a Determined by GC using decane internal standard. b Determined by HPLC.
c 0.1 M concentration of substrate.d Absolute configuration was determined by comparison of the sign
of rotation with literature value.22, 23
O
(S)d
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3.3 Transfer Hydrogenation of Heteroaromatic and Pyridyl Ketones  
 
Table 19: Transfer Hydrogenation of Heteroaromatic Ketones catalyzed by 118b 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Furthermore, Iron complex 118b was also tested with some more variety of substrates such 
as heteroaromatic ketones. It also showed appreciable results, thereby, confirming its ability 
to reduce versatile substrates. 
Turning to heteroaromatic methylketones (Table 19), we observed high turnover for the carbonyl 
reduction, allowing reaction times as little as one hour to achieve complete conversion. 
Enantioselectivities remained moderate, however, a reversal of the absolute stereochemistry in 
the products with respect to the aromatic ketones was observed with the exception of 2-
acetylthiophene (Table 19, entry 2) and 4-acetylpyridine (Table 19, entry 4). Thus it is very 
2 1 70 53 (S)
6 85 413
1 99 55 (S)
4c
5
entry hetero time (h) conv %a ee %b
Het
O
Het
OHcomplex 118b,
tBuOK, iPrOH
0.05 M
22 - 24 °C
S:B:C = 20:10:1
1 95 61
2-acetylthiophene
2-acetylpyridine
3-acetylpyridine
4-acetylpyridine
3 >99 301 2-acetylfuran
a Determined by GC using decane internal standard. b Determined by HPLC.
c 0.1 M concentration of substrate. d Absolute conf iguration was determined by
comparison of the sign of rotation with literature value.24
(R)d
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much clear from above results that heteroaromatic ketones react faster than simple aromatic 
ketones because of extra possible coordination provided by heteroatom. Keeping this conclusion 
in mind, several pyridyl ketones with rigid backbone were synthesized and examined in complex 
118b catalyzed transfer hydrogenation. Chiral Pyridyl alcohols are very useful intermediates in 
the synthesis of ligands for asymmetric catalysis.25Till date only kinetic resolution of racemic 
pyridyl alcohols were reported by Pfaltz and co-workers,26 but there is no report on 
hydrogenation of pyridyl ketones to chiral pyridyl alcohols. Here, we have described the transfer 
hydrogenation of pyridyl ketones with excellent conversions and enantioselectivities. 
Pyridine with six membered fused ring was reduced with 80% yield and 91% ee (Table 20, entry 
1). In contrast, α-tetralone (Table 18, entry 14), bearing no nitrogen in aromatic ring showed 
diminshed reactivity and selectivity. This comparision illustrates the importance of presence of a 
heteroaromatic atom, which can represent an additional coordination point for the metal, giving 
rise to a better enanti-discrimination. Increasing the size of aliphatic cyclic ring fused to pyridine 
ring also showed excellent conversion and enantioselectivity (Table 20, entry 2). It was 
interesting to note that a substituent in 2-position is detrimental to the enantioselectivity (entries 
2-4), which might be an indication that the pyridine nitrogen is in proximity or even interacting 
with the active centre of the catalyst.When a six-membered ring is fused to the pyridine ring with 
phenyl substitution at α position, the enantioselectivtiy is higher than that with a five membered 
ring analogue (Table 20, entry 2, 4). Cl group α to the pyridine N-atom and six-membered ring 
was found to be hydrogenated with excellent yield and enenatioslectivity (Table 20, entry 3). 
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Table 20: Transfer Hydrogenation of Pyridyl Ketones Catalyzed by 118b 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N
O
24 80 911c, e
5c N
O
24 83 83
2d, e
N
N
O
Cl
N
O
Ph
Ph
3d
4d, e
3 7298
O
6 89 52
15 93 84
a Determined by GC using decane as internal standard. b Determined by chiral HPLC.
c 0.2 M concentration of substrate. d 0.05 M concentration of the substrate. e Isolated
yield. f Absolute configuration was determined by comparison of the sign of rotation
with literature value.25, 26
entry substrate time (h) conv %a ee %b
complex 118b, tBuOK,
iPrOH
22 - 24 °C
S:B:C = 20:10:1
N
O
n
R N
OH
n
R
n = 1,2,3
R = Ph, Cl(R)f
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3.4 Proposed Mechanism 
 
Infra red spectroscopy (IR) has been used to get a better understanding of the reaction 
mechanism. The IR spectrum of a solution of iron bis(isonitrile) complex 118b (6 mg, 0.007 
mmol) in isopropanol (1mL) showed a strong broad absorption of the isonitrile NC strech at 
higher frequency (2177 cm-1, B, Figure 24) than that of free bis(isonitrile) ligand 72b (2140 cm-1, 
A, Figure 24). The high value of υ (NC) is attributed to a strong σ- bonding interaction between 
the isonitrile carbon and the charged metal centre. This σ- bonding interaction becomes stronger 
in the presence of isopropanol. The solution of 118b in iPrOH was then treated with 10 
equivalents of tBuOK, resulting in the complete disappearance of the isonitrile band within 10 
minutes and the appearance of a new band at 1638 cm-1 (C, Figure 24).The presence of this 
broad intense absorption at very low energy is the evidence for the reduction of isonitrile groups 
in the iron complex 118b to corresponding imine N=C. The latter is assigned to the presence of a 
C=N double bond, indicating the reduction of isonitrile to the corresponding imine. In contrast, 
we could find no indication for a Fe-H band, which would have been expected around 1900 cm-1. 
Moreover, in NMR studies no signals at negative ppm (δH = -8 to -12 ppm),27 typical for such 
species, were observed. 
Therefore, we propose that the reaction proceeds by a outer sphere hydride transfer mechanism 
as shown in Figure 25,28 being different from the reported mechanisms for transfer 
hydrogenations with ruthenium involving achiral isonitrile ligands.29 We speculate that the 
ketone binds via its carbonyl group or alternatively through the respective heteroatom in the case 
of heteroaromatic substrates to the iron centre of the catalyst. Hydride transfer then occurs from 
the reduced isonitrile group.  
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Figure 24 IR spectrums in iPrOH (A) Free Ligand 72b, (B) Iron complex 118b, (C) Iron 
complex 118b in the presence of 10 equiv. tBuOK  
 
This mechanism is different from the reported mechanism. The mechanism consists of 
following steps: (a) iron bis(isonitrile) 118b was thought to undergo reduction of NC (Figure 
25) to imine by basic isopropanol (confirmed by IR), (b) coordination of ketone to iron 
centre, (c) hydride transfer from imine carbon via five-membered transition state to carbonyl 
group, (d) formation of alcohol by protonation by isopropanol, (e) hydride elimination from 
isopropoxide generated acetone, (f) regeneration of  the active iron species. 
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Figure 25: The proposed mechanism for Transfer Hydrogenation catalyzed by 118b 
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4. Conclusion 
 
In conclusion, we could develop a new type of iron catalyst (118) being effective in asymmetric 
transfer hydrogenations of ketones. The noteworthy feature of the iron complexes employed in 
our study are coordinating isonitrile groups that might serve as acceptors for hydrogen that is 
subsequently delivered to the ketone being activated by the iron centre. In addition, this is the 
first report that demonstrates the ability of isonitriles to be able to serve as chiral ligands in 
asymmetric catalyses.  
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E. Cu(I), Rh(I) and Ir(I)-bis(isonitrile) complexes 
 
1. Cyclopropanation 
 
Optically active cyclopropanes play an important role as intermediates in the synthesis of 
insecticides and drugs.1 In this perspective, metal catalyzed cyclopropanation is one of the 
most important methods for the synthesis of cyclopropane derivatives and has been widely 
applied in organic synthesis. Chiral ligands such as semicorrine,2 bisoxazolines,3 bipyridines4 
and Schiff’s bases5 are the most efficient ligands for copper-catalyzed alkene 
cyclopropanation with diazoacetate. Several rhodium catalysts6 were also reported to promote 
the cyclopropanation of styrene with aryldiazoacetates, in which both good 
diastereoselectivity and enantioselectivity are achieved. However, non-rhodium catalysts 
showed poor enantioselection in this reaction.6a 
 
1.1 Cu(I)-bis(isonitrile) complexes catalyzed cyclopropanation 
 
Being a unique ligand for a broad variety of transition metal complexes, we investigated 
Cu(I)-bis(isonitrile) complexes in the asymmetric alkene cyclopropanation reaction using 
ethyl phenydiazoacetate. Because of its susceptibility to oxidation, the catalyst was freshly 
made in situ. We chose to optimize the conditions for cyclopropanation using N-Boc pyrrole 
as a substrate. Thus, in the presence of 5 mol% CuPF6/BINC 72b N-Boc pyrrole could react 
with ethyl phenyldiazoacetate to afford the racemic cyclopropanation product in moderate 
yields and high diastereoselectivity. The results of our investigations are given in Table 21. 
Optimization studies revealed that the yield was strongly influenced by reaction conditions 
(Table 21). Under the screened conditions, ethylacetate gave the best result with a maximum 
57% yield of cyclopropanated product at 40 °C (Table 21, entries 1–9). Changing the solvent 
to toluene gave no cyclopropanation product (Table 21, entry 6), whereas dichloromethane 
and 1,2-dichloroethane gave lower yields (49-42% yield) (Table 21, entry 4, 5). Employing 
higher catalyst loadings (Table 21, entry 7, 8) did not improve the yield. The additional rigid 
BINC 72f did not prove to be beneficial in this reaction (Table 21, entry 10). More promising 
results in terms of yield were obtained using styrene (Table 21, entry 11, 12). Excellent 
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diastereoselctivity as well as yield were obtained using 10 mol% of BINC 72b/Cu(I). Again, 
it was noted that no enantioselectivity was observed in this reaction. The relative 
configuration of the major diastereomer was determined by NOESY NMR. The required 
ethylphenyldiazoacetate was prepared in a standard manner from p-toluolsulfonyl azide and 
ethyl phenylacetate in acetonitrile at 0 °C.7 
 
Table 21: BINC 72b,f catalyzed cyclopropanation of alkenes 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N
Boc
Ph
O
N2
O
N
Boc
Ligand/CuPF6
EtOAc, 9-10 h
de = >99 %
ee = 0%
H
H
Ph
CO2Et
entry alkene temp.(°C) solvent yield (%)
1a 72b
ligand
40 EtOAc 57
2a 72b 40 Hexanes/EtOAc (1/1) 32
3a 72b 40 CH3CN 24
4a 72b 40 CH2Cl2 49
7b 72b 40 EtOAc 37
8c 72b 40 EtOAc 37
5a 72b 80 ClCH2CH2Cl 42
6a 72b 110 toluene -
9a 72b rt EtOAc 18
10a 72f 40 EtOAc 21
R1
R2
R1 CO2Et
Ph
R2
product
11a 72b 40 EtOAc 60
12b 72b 40 EtOAc 87
Ph CO2Et
Ph
a 5 mol% ligand/Cu(I). b 10 mol% ligand/Cu(I). c 20 mol% ligand/Cu(I).
P
OPh
O O
NC CN
O
NC
P
O
Ph O
CN
72b 72f
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2. Imine hydrogenation 
 
Enantioselective hydrogenation of olefins and ketones were studied widely in contrast to 
enantioselective hydrogenation of prochiral imines to corresponding chiral amines although 
the reaction has considerable significance. Chiral aromatic amines are particularly sought 
after due to applications in the pharmaceutical, agrochemical and fine chemical industries. In 
this respect, metal-catalyzed asymmetric reductions of imines have attracted much interest in 
the last decade and have been the subject of several studies.8 Till now, a range of Rh, Ir and 
Ru complexes have been investigated in detail.9 
 
2.1 Rh(I) and Ir(I)-bis(isonitrile) complexes catalyzed imine hydrogenation 
 
We have synthesized cationic rhodium (I) and iridium (I) complexes with bis(isonitrile) 
ligand 72b and studied their catalytic activity in asymmetric imine hydrogenation. Rhodium-
bis(isonitrile) complexe of the type [Rh(tBu-BINC)(COD)]BF4 (120) was prepared according 
to scheme 45. Reaction of [Rh(COD)2]BF4 with one equivalent of bis(isonitrile) 72b under an 
inert atmosphere formed the cationic complex [Rh(tBu-BINC)(COD)]BF4 (120) in 
quantitative yields.  
 
 
 
 
 
 
Scheme 45: Preparation of [Rh(tBu-BINC)(COD)]BF4 (120) 
Similarly, [Ir(tBu-BINC)(COD)]BArF (121) was synthesized in excellent chemical yields by 
treating the dicholoromethane solution of tBu-BINC 67b and [Ir(COD)Cl]2 with Na(BArF) 
(122)  at room temperature. 
Rh
P
OO
O
NBut N Bu
t
Ph
C C
BF4
P
OPh
O O
tBu NC
tBuCN
[Rh(COD)2]BF4
CH2Cl2, rt, 4h
80%
72b
120
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Scheme 46: Preparation of [Ir(tBu-BINC)(COD)]BArF (121) 
 
The new rhodium and iridium complexes 120, 121 were tested in the asymmetric 
hydrogenation of a range of aromatic imines. Under the given reaction conditions, the 
cationic rhodium and iridium complexes 120 and 121 afforded N-arylamines in high yields, 
but no enantioselectivity was seen in this class of compounds. Table 22 shows that 50 bar of 
hydrogen pressure is optimum in the hydrogenation of imines, using cationic rhodium and 
iridium complexes 120 and 121 as the catalyst precursors. In contrast to rhodium complex 
120, the best results were obtained with iridium complex 121. Decreasing the catalyst loading 
of iridium complexes 121 to 1 mol% resulted in significant decrease in imine formation from 
99 to 81% in 14 h (Table 22, entries 3).  
 
Table 22: Hydrogenation of imines catalyzed with the iridium and rhodium complexes  
 
 
 
 
 
 
 
 
 
P
OPh
O O
tBu NC
tBuCN
[Ir(COD)Cl]2
CH2Cl2, rt, 30 min
quant. Ir
P
OO
O
NBut N Bu
t
Ph
C C
BArF
Na(BArF)
72b
121
122
entry complex mol % time (h) conv.% ee %
1 120 1 24 >99 -
2 121 5 1 >99 -
3 121 1 14 81 -
4 121 5 3 >99 -
N
Ar
NH
Ar
Ar
Bn
Ph
Ph
(p-OMe)Ph
Complex, MeOH,
H2 ( 50 bar), rt *
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3. Conclusion 
We have shown that bis(isonitrile) ligands form very stable complexes with Cu(1), Rh(1) and 
Ir(1). Cu-BINC complex catalyzed cyclopropanation reactions with excellent reactivity, 
whereas cationic rhodium-BINC complex and iridium-BINC complex 120 and 121 formed 
efficient imine hydrogenation catalysts displaying high conversions at 50 bar hydrogen 
pressure. The catalyst precursors are readily prepared, easily handled and air-stable.  
Bis(isonitrile) complexes are capable to perform the above mentioned reaction with moderate 
reactivites. Nevertheless, the obtained results are not capable of competing with the best 
values in literature. Therefore, no further exploration regarding these transformation were 
undertaken 
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F. Summary 
 
Synthesis of Chiral Novel Bis(isonitrile) Ligands 
 
This thesis describes the development and application of new chiral bis(isonitrile) ligands 
(BINC) in catalysis. These BINC ligands are capable of forming very stable complexes with 
various transition metals such Pd, Fe, Cu, Rh and Ir.  
Specifically, the syntheses of a wide variety of sterically and electronically different 
bis(isonitrile) ligands 72 can be prepared by structural variation of the oxazolines 71 and 
phosphorus chloride (Scheme 47). Preparation of the requisite bis(isonitrile) ligands 72a-e 
was achieved in moderate yields via lithiation of 2-oxazolines (71a-e) following the 
procedure of Meyers and Novachek and subsequent treatment with phenylphosphonic 
dichloride at low temperature (Scheme 47).  
 
 
 
 
 
 
Scheme 47: Synthesis of bis(isonitrile) ligands 72a-e 
 
Efficient aerobic Wacker oxidation of styrenes using novel palladium 
bis(isonitrile) catalysts 
 
Chiral pseudo C2-symmetrical palladium (II) bis(isonitrile) complexes were found to catalyze 
the Wacker oxidation of aliphatic and especially styrenes in the absence of further cocatalysts 
gives rise to methyl ketones in a highly chemoselective manner (Scheme 48). The palladium 
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bis(isonitrile) catalyst was characterized by NMR spectroscopy and X-ray structure analysis, 
revealing a dissymmetric coordination of palladium by the two isonitrile moieties. 
 
 
 
 
 
 
 
Scheme 48: Wacker oxidation of aliphatic and aromatic alkenes using bis(isonitrile) 
palladium complexes. 
 
Asymmetric Transfer Hydrogenation of Aromatic and Heteroaromatic 
ketones using Chiral Novel bis(isonirile) iron complexes 
 
We have also achieved the first version of iron complex of chiral bis(isonitrile) ligand (118b), 
catalyzing asymmetric transfer hydrogenation of aromatic, heteroaromatic  and pyridyl 
ketones under mild conditions. 
 
 
 
 
 
 
 
 
Figure 26: Iron (tBu-BINC) catalyst 
 
Complex 118b was found to be an active catalyst at room temperature for transfer 
hydrogenation of substituted acetophenones, cyclic ketones, heteroaromatic and pyridyl 
ketones to corresponding alcohols in basic isopropanol. Excellent conversion with 
moderate enantioselectivity was observed in substituted acetophenones and 
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heteroaromatic ketones (Equation 1) using iron bis(isonitrile) complex 118b. In contrast, 
several pyridyl ketones with rigid backbones were reduced with excellent conversions and 
enantioselectivities (Equation 2) to corresponding chiral Pyridyl alcohols.  
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G. Experimental  
 
General 
 
1H NMR-Spectra were recorded on Bruker Avance 300, Bruker Avance 400, Bruker Avance 
600, Varian Inova 600, Bruker DRX-400 with a H/C/P/F QNP gradient probe and Bruker 
Avance 500 with a dual carbon/proton CPDUL cryoprobe. The chemical shift δ is given in 
[ppm], calibration was set on chloroform-d1 (7.26 ppm) or tetramethylsilane (0.00 ppm) as 
internal standard. The spectra were evaluated in 1st order and the coupling constants are 
given in Hertz [Hz]. The following abbreviations for the spin multiplicity were used: s = 
singlet, d = doublet, t = triplet, q = quartet, qt = quintet, m = multiplet, dt = doublet of a 
triplet, dd = double doublet, ddd = doublet of a double doublet, sept = septet. The used 
deuterated solvents are given separately.  
 
13C NMR-Spectra were recorded on Bruker Avance 300, Bruker Avance 400, Bruker 
Avance 600, Varian Inova, Bruker DRX-400 with a H/C/P/F QNP gradient probe and Bruker 
Avance 500 with a dual carbon/proton CPDUL cryoprobe. The chemical shift δ is given in 
[ppm], calibration was set on chloroform-d1 (77.16 ppm), or tetramethylsilane (0.00 ppm) as 
internal standard.  
 
Melting points were measured on a Büchi SMP 20 in a silicon oil bath. The melting points 
are uncorrected. 
 
Infrared-Spectra were recorded on a Bio-Rad Excalibur FTS 3000 spectrometer, equipped 
with a Specac Golden Gate Diamond Single Reflection ATR-System. The wave numbers are 
given in [cm-1]. 
 
Masspectrometry was performed on Varian MAT 311A, Finnigan MAT 95, Thermoquest 
Finnigan TSQ 7000, Nermag quadrupoles, VG ZAB high-resolution double-focusing and VG 
Autospec-Q tandem hybrid with EBEqQ configuration. The percentage set in brackets gives 
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the peak intensity related to the basic peak (I = 100%). High resolution mass spectrometry 
(HRMS): The molecular formula was proven by the calculated precise mass. 
Elemental analysis was prepared by the micro analytic section of the University of 
Regensburg using a Vario EL III or Mikro-Rapid CHN (Heroes). 
 
Optical rotation was measured at rt on a 241 MC Perkin-Elmer polarimeter at a wavelength 
of 589 nm (Na-D) in a 1 dm or 0.1 dm cell. The concentration is given in [g/100 ml]. 
 
X-ray analysis was performed by the crystallography laboratory of the University of 
Regensburg (STOE-IPDS, Stoe & Cie GmbH).  
 
Chiral HPLC was performed in the analytic department of the University of Regensburg or 
on a Kontron Instruments 325 System (HPLC 335 UV detector, λ = 254 nm, Chiracel 
OD/OD-H, OJ and AS respectively served as chiral stationary phase. 
 
Gaschromatography (GC) was measured in the analytic department of the University of 
Regensburg or on Fisons Instruments GC 8000 series (Data Jet Integrator, CP-chiralsil-DEX-
CP column). 
 
Thin layer chromatography (TLC) was prepared on TLC-aluminium sheets (Merck, silica 
gel 60 F254, 0.2 mm). Detection in UV-light λ = 254 nm, staining with I2, Mostain, 
molybdatophosphoric-acid (5% in ethanol), KMnO4 solution or vanillin-sulfuric acid. GC 
conversions for the reactions were determined relative to decane as an internal standard 
 
Column chromatography was performed in glass columns (G2 or G3). As a stationary 
phase silica gel Merck-Geduran 60 (0.063-0.200 mm) or flash silica gel Merck 60 (0.040-
0.063 mm) was used. 
 
Solvents: Absolute solvents were prepared according to usual lab procedures or taken from 
the MB-SPS solvent purification system. Ethylacetate, hexanes (40-60 °C) and  
dichloromethane were purified by distillation before use. Further solvents and reagents were 
of p.a. quality. THF, diethyl ether and toluene were distilled over sodium/benzophenone. 
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Isopropanol was dried over sodium and DMA was dried over vacuum activated 4 Ǻ 
molecular sieves.   
Reactions with oxygen- and moisture sensitive reactants were performed in oven dried and in 
vacuo heated reaction flasks under a pre-dried inert gas (nitrogen or argon) atmosphere. For 
cooling to temperatures < -40 °C a cryostat Haake EK 90 or dry ice/iso-propanol mixture was 
used. 
 
Synthesis of oxazolines  
 
                                                                                                                                      
  
  
 
(S)-Benzyl-2-oxazoline (71a): 
(S)-Phenylalinol (3 g, 19.8 mmol), and DMF-DMA (2.77 mL, 1.05equiv) and Amberlite IR-
120 resin (150 mg) in benzene ( 50 mL) were refluxed for 16 h in a flask equipped with a 
liquid/solid extraction apparatus containing 15 g of 4Ǻ molecular sieves. The reaction 
mixture was filtered of resin, washed with 10% KHCO3 (30 mL) and brine and dried. The 
solution was concentrated and subjected to Kugelrohr distillation 55°C to obtain 1.78 g (56%) 
of the compound 71a as a clear liquid. 
IR (neat): υ 3062, 3029, 1629, 1091 cm-1. 1H NMR (CDCl3, 300 MHz): δ 2.68 (dd, J = 8.1, 
13.8 Hz, 1H), 3.09 (dd, J = 5.7, 13.7 Hz, 1H), 3.93 (t, J = 7.7, 1H), 4.16(t, J = 8.8 Hz, 1H), 
4.34-4.45 (m, 1H), 6.82 (d, J = 1.9 Hz ,1H), 7.20-7.34 ( m, 5H). 13C NMR (CDCl3, 75 MHz): 
δ 41.57, 66.46, 70.43, 126.49, 128.49, 129.13, 137.69, 154.73.   
 
 
 
                                 
  
(S)-tert-butyl-2-oxazoline (71b): 
With a water bath to moderate the exotherm, (S)-tert-leucinol (10.2 g, 86.8 mmol), and DMF-
DMA (13.8 mL, 1.2 equiv) were combined, neat. After the mixture was stirred with for 4 h, 
N
O
N
O
Ph
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the volatiles were removed by rotory evaporation and the mixture was twice azeotropically 
concentrated with 30 ml of hexane. TsOH (40 mg) was added to the resultant mixture, and 
the mixture was diluted with hexanes (150 mL), fitted with a liquid/solid extraction apparatus 
containing 30 g of 4Ǻ molecular sieves and refluxed for 48 h. The solution was washed with 
10% KHCO3 (30 mL) and brine and dried. The hexanes were removed by distillation at 
atmospheric pressure. The mixture was then distilled at reduced pressure 74-75 °C to obtain 5 
g (50%) of the compound 71b as a clear liquid. 
IR (neat): υ 1635, 1395, 1366, 1102 cm-1. 1H NMR (CDCl3, 300 MHz): δ 0.811 (s, 9H), 3.73--
3.79 (m, 1H), 3.90 (t, J= 8.5 Hz, 1H), 4.04 (dd, J = 8.9, 10.6 Hz, 1H), 6.724 (d, J = 1.94 Hz, 
1H). 13C NMR (CDCl3, 75 MHz): δ 25.76 (CH3 t-Bu), 33.26 (CH3 t-Bu), 67.32 (CH t-Bu), 74.94 
(Coxa), 154.13(C=Noxa).  
                                                                                                                                                                              
 
  
 
 
(S)–iso-propyl-2-oxazoline (71c): 
With a water bath to moderate the exotherm, S-valinol (4 g, 38.8 mmol), and DMF-DMA 
(6.19 mL, 46.60 mmol) were combined neat. After the mixture was stirred with for 4 h, the 
volatiles were removed by rotory evaporation and the mixture was twice azeotropically 
concentrated with 15 mL of hexane. TsOH (16.8 mg) was added to the resultant mixture, and 
the mixture was diluted with hexanes (150 mL), fitted with a liquid/solid extraction apparatus 
containing 14.6 g of 4Ǻ molecular sieves and refluxed for 48 h. The solution was washed 
with 10% KHCO3 (15 mL) and brine and dried. The hexanes were removed by distillation at 
atmospheric pressure. The mixture was then distilled at reduced pressure 69-70 °C to obtain 3 
g (40%) of the compound 71a as a clear liquid. 
IR (neat): υ 1632, 1386, 1368, 1094 cm-1. 1H NMR (CDCl3, 300 MHz): δ 0.79, 0.87 (d, J = 
2.2, 6.8 Hz, 3H), 1.56-1.70 (m, 1H), 3.72-3.86 (m, 2H), 4.03-4.15 (m, 1H), 6.71 (s, 1H). 13C 
NMR (CDCl3, 75 MHz): δ 18.23 (CH3 iPr), 18.61 (CH3 iPr), 32.42 (CHiPr), 68.82(Coxa), 71.32 
(Coxa), 154.13 (C=Noxa).  
N
O
 
Experimental 
101 
 
  
                                                                                                                           
 
 
(4R,5S)-4-methyl-5-phenyl-2-oxazoline (71d): 
A solution of L-(-) norephedrine (1 g, 6.6 mmol), triethyl orthoformate (1.1 g, 7.3 mmol), and 
trifluoroacetic acid (17 mol %) in 1,2-dichloroethane (20 mL) was heated at reflux for 7 h 
under N2. After cooling, the reaction mixture was poured, with vigorous stirring, into ice cold 
20% KHCO3 (1.5 mL/mmol), and the organic layer was separated. The combined organic 
layer was washed with saturated brine, dried over anhydrous Na2SO4, filtered, and evaporated 
under reduced pressure to leave a light yellowish solid (639 mg, 60%).  
IR (neat): υ 1632 cm-1. 1H NMR (CDCl3, 300 MHz): δ = 0.75 (d, J = 6.8 Hz, 3H), 4.34 – 4.47 
(m, 1H), 5.52 (d, J = 10.1 Hz, 1H), 6.97 (d, J = 1.9 Hz, 1H), 7.17 – 7.36 (m, 5H). 13C NMR 
(75 MHz): δ = 16.70, 63.01, 81.72, 125.1, 126.9, 127.3, 135.4, 152.9. Mass (CI- MS), m/z 
(rel. intensity): [M+H+] 162, [MNH4+] 179. 
      
 
                                                                                                                    
 
 
(S)-benzyl-2-(dibenzylamino)-3-methylbutanoate (76): 
A solution of benzyl bromide (2.62 gm, 15.24 mmol) in ethanol (4 mL) was slowly added to 
solution of S-valine (0.5 gm, 3.81 mmol) and K2CO3 (2.1 gm, 15.24 mmol) in a 5:1 mixture 
of ethanol-water (22 mL). The reaction mixture was heated under reflux for 14 h. The solvent 
was removed under reduced pressure and water was added to the residue. The resulting slurry 
was extracted with ethyl acetate. The combined organic layers were dried over Na2SO4 and 
evaporated under reduced pressure. The resulting crude mixture was purified by column 
chromatography to get colorless oily product (1.2 gm, 73%). 
1H NMR (CDCl3, 300 MHz): δ = 0.80 (d, J = 6.6 Hz, 3H), 1.05 (d, J = 6.8 Hz, 3H), 2.14- 
2.30 (m, 1H), 2.95 (d, J = 10.97 Hz, 1H), 3.32 (d, J = 14 Hz, 2H), 4.0 (d, J = 14  
 
OBn
N(Bn)2
O
N
OPh
 
Experimental 
102 
 
Hz, 2H), 5.26 (quart. J =12.3, 42 Hz, 2H), 7.2- 7.5(m, 15 H). 13C NMR (75 MHz): δ = 19.58, 
19.99, 27.31, 54.64, 65.74, 68.15, 126.9, 128.3, 129.4, 128.6, 128.7, 128.8, 136.2, 139.5, 
171.9. 
          
                                                                                                              
 
 
 
(S)-2-(dibenzylamino)-3-methylbutan-1-ol (77): 
A solution of benzyl protected amino acid (4.8 gm, 12.39 mmol) in dry THF (25 mL) was 
slowly added to suspension of LiAlH4 (0.94 gm, 24.77 mmol) in a dry THF (25 mL) at 0 °C. 
The reaction mixture was warmed to room temperature and quenched with NH4Cl at 0 °C. 
The resulting slurry was extracted with ethyl acetate. The combined organic layers were dried 
over Na2SO4 and evaporated under reduced pressure. The resulting crude mixture was 
purified by column chromatography to get colorless oily product in quantitative yield. 
1H NMR (CDCl3, 300 MHz): δ = 0.90 (d, J = 6.6 Hz, 3H), 1.15 (d, J = 6.8 Hz, 3H), 1.99- 
2.16 (m, 2H), 2.49- 2.81 (m, 1H), 3.02 (bs, 1H), 3.45 (t, 1H), 3.52-3.64 (m, 1H), 3.67(d, J = 
13.4 Hz, 1H), 3.89 (d, J = 13.2 Hz, 1H), 7.22-7.36 (m, 10H). 13C NMR (75 MHz): δ = 21.16, 
22.78, 27.64, 54.24, 59.26, 64.69, 127.2, 128.5, 129.2, 139.7. 
         
                                                                                                                 
 
 
 
(S)-2-(dibenzylamino)-3-methylbutanal (78): 
A  solution of dichloromethane ( 21 mL) and oxalyl chloride (0.8 mL, 9.2 mmol) was placed 
in a 100mL three neck flask equipped with two dropping funnels containing DMSO (1.6 mL, 
22.5 mmol) dissolved in dichloromethane (5 mL) and the alcohol (2.9 gm, 10.2 mmol) 
dissolved in dichloromethane (10 mL) respectively. The DMSO was added to the stirred 
oxalyl chloride solution at -78 °C. The reaction mixture was stirred for 4-5 minutes and the 
alcohol was added within 5-10 min; stirring was continued for next 30 minutes Triethylamine 
(7.1 mL, 51.2 mmol) was addedand the reaction mixture was allowed to warm to room 
temperature. Water was added and the aqueous layer was extracted with dichloromethane. 
OH
N(Bn)2
H
N(Bn)2
O
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The organic layers were combined, washed with saturated NaCl and dried over sodium 
sulfate and concentrated under reduced pressure. The crude aldehyde was used without any 
purification. 
          
                                                                                                               
 
 
 
(2R,3S)-3-(dibenzylamino)-4-methylpentan-2-ol (79): 
The solution of aldehyde (100 mg, 0.36 mmol) in ether (0.5 mL) was added dropwise under 
nitrogen to a solution of methymagnesium iodide (0.6 mmol) in ether (2 mL). After one hour 
stirring the reaction mixture was quenched with saturated NH4Cl solution and the aqueous 
phase was extracted with ether. The combined organic layers were washed with brine 
solution and dried over Na2SO4. The crude mixture was purified by column chromatography 
(80 mg, 76%). 
1H NMR (CDCl3, 600 MHz): δ = 0.96 (d, J = 6.6 Hz, 3H), 1.21 (d, J = 6.6 Hz, 3H), 1.23 (d, J 
= 6.6 Hz, 3H), 2.13 – 2,19(m, 1H), 2.50 (dd, J = 4.9, 9 Hz, 1H), 2.81 (bs, 1H), 3.76 (d, J = 
13.6 Hz, 2H), 3.80 – 3,86 (m, 1H), 3.89 (d, J = 13.6 Hz, 2H), 7.23 – 7.28 (m, 2H), 7.29 – 7.35 
(m, 8H). 13C NMR (75 MHz): δ = 19.53, 20.88, 23.33, 18.34, 56.59, 66.05, 67.40, 127.25, 
128.48, 129.19, 139.96. 
 
 
                                                                                                                            
 
(2R,3S)-3-amino-4-methylpentan-2-ol (81): 
To a solution of the dibenzylamino alcohol (50 mg, 0.168 mmol) in 2 mL of dry MeOH was 
added 9 mg of 20% Pd(OH)2-C in one portion. The mixture was stirred under 1 atmosphere 
of hydrogen, and the reaction was monitored by TLC. After completion of the reaction, the 
catalyst was removed by filtration through celite and washed with 5 mL of MeOH. The 
solvent was removed under reduced pressure to afford the pure product (15 mg, 78%). 
1H NMR (CDCl3, 300 MHz): δ = 0.89 (d, J = 6.6 Hz, 3H), 0.98 (d, J = 6.6 Hz, 3H), 1.05 (d, J 
= 6.6 Hz, 3H), 1.44 – 1.55 (m, 1H), 1.74 (bs, 3H), 2.37 (dd, J = 4.7, 8.5 Hz, 1H), 3-79 – 3.90 
OH
N(Bn)2
OH
NH2
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(m, 1H). 13C NMR (75 MHz): δ = 16.43, 19.63, 19.68, 31.60, 61.91, 67.28. Mass (EI- MS), 
m/z (rel. intensity): [M-C2H5O]+ 72.2, [M-C3H7]+ 74.1. 
 
N
O
 
 
(4S,5R)-4-isopropyl-5-methyl-2-oxazoline (71e): 
With a water bath to moderate the exotherm, amino alcohol (4 g, 34.2 mmol), and DMF-
DMA (5.4 mL, 41.02 mmol) were combined neat. After the mixture was stirred with for 4 h, 
the volatiles were removed by rotory evaporation and the mixture was twice azeotropically 
concentrated with 15 mL of hexane. TsOH (16.8 mg) was added to the resultant mixture, and 
the mixture was diluted with hexanes (150 mL), fitted with a liquid/solid extraction apparatus 
containing 14.6 g of 4Ǻ molecular sieves and refluxed for 48 h. The solution was washed 
with 10% KHCO3 (15 mL) and brine and dried. The hexanes were removed by distillation at 
atmospheric pressure. The mixture was then distilled at reduced pressure to obtain 1.7 g (39 
%) of the compound as a clear liquid. 
IR (neat): 1626 cm-1. 1H NMR (CDCl3, 300 MHz): δ 0.967 (d, J = 6.6 Hz, 3H), 1.05 (d, J = 
6.6 Hz, 3H), 1.22 (d, J = 6.6 Hz, 3H), 1.73 – 1.90 (m, 1H), 3.54 – 3.63 (m, 1H), 4.61 – 4.74 
(m, 1H), 6.789 (d, J = 2.2 Hz, 1H). 13C NMR (CDCl3, 75 MHz): δ 14.44, 20.16, 21.54, 27.77, 
73.44, 77.79, 154.04. Mass (EI- MS), m/z (rel. intensity): [M+H+] 128.1, [MNH4+] 145. 
 
                                                                                                                  
 
 
 
(3aR,8aS)-8,8a-dihydro-3aH-indeno[1,2]oxazole (71f): 
A solution of (1R,2S)-2-amino-2,3-dihydro-1H-inden-1-ol (500 mg, 3.35 mmol), triethyl 
orthoformate (548 mg, 3.7 mmol), and trifluoroacetic acid (17 mol %) in 1,2-dichloroethane 
(9 mL) was heated at reflux for 7 h under N2. After cooling, the reaction mixture was poured, 
with vigorous stirring, into ice cold 20% KHCO3 (1.5 mL/mmol), and the organic layer was 
separated. The combined organic layer was washed with saturated brine, dried over 
N
O
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anhydrous Na2SO4, filtered, and evaporated under reduced pressure to leave a light yellowish 
solid (501 mg, 94%).  
IR (neat): υ 3037, 2972, 1646, 1614, 1477, 1256 cm-1. 1H NMR (CDCl3, 300 MHz): δ = 3.25 
(dd, J = 17.99, 1.64 Hz, 1H), 3.46 (dd, J = 17.99, 6.9 Hz, 1H), 5.27 (ddd, J = 7.9, 6.9, 1.6 Hz, 
1H), 5.54 (dd, J = 7.9, 1.8 Hz), 6.8 (d, J = 1.8 Hz), 7.25 - 7.29 (m, 3H), 7.46 – 7.50 (m, 1H). 
13C NMR (75.5 MHz): δ = 39.62, 75.63, 81.96, 125.27, 125.36, 127.51, 128.57, 139.46, 
141.62, 154.74. MS (CI-MS), m/z (rel. intensity): [M+H+] 160.1, [MNH4+] 177.1. 
 
Synthesis of BINC Ligands: 
                                                                                                           
  
   
 
 
Bis((S)-2-isocyano-3-methylbutyl) phenylphosphonate (iPr-BINC, 72c):   
To a solution of diisopropylamine (0.2 mL, 1.42 mmol) in 4 mL of THF was added under 
nitrogen atmosphere at 0 °C n-butyl lithium (15 % in hexane, 0.5 mL, 1.15 mmol). After 
stirring for 15 min the solution was cooled down to –78 °C and i-Propyl-2-oxazoline (71c, 
100 mg, 0.885 mmol) dissolved in 4 mL THF was added. After stirring for 30 min, 
phenylphosphonic dichloride (0.07 mL, 0.53 mmol) was added followed by immediate 
removal of the cooling bath, and the solution was allowed to stir at room temperature for 2 
hours. Aqueous NH4Cl solution was added followed by work up of the mixture with ethyl 
acetate and brine. The organic layer was dried over Na2SO4 and concentrated under vacuum. 
Yellowish viscous liquid was obtained after purification on silica (113 mg, 61%). 
(hexanes/ethyl acetate 2:3, Rf = 0.52). [α]20D  + 36 ( c = 1.0, CHCl3 ). IR (neat): υ 2969, 2141, 
1595, 1475, 1442, 1253 cm-1. 1H NMR (CDCl3, 300 MHz): δ 7.80-7.90 (m, 2H), 7.58 - 7.66 
(m, 1H), 7.48-7.55 (m, 2H), 4.03-4.28 (m, 4H), 3.63-3.76 (m, 2H), 1.88-2.03 (m, 2H), 1.03 
(d, 6H), 1.01 (d, 6H). 13C NMR (CDCl3, 75 MHz): δ 158.3 (CN), 133.37 (d, J = 2.8 Hz), 
131.88 (d, J = 10.5 Hz), 128.85(d, J = 15.4 Hz), 126.05 (d, J = 190.9 Hz ), 65.49 (rel. intens. 
2), 60.80 (rel. intens. 2), 28.83, 28.78, 19.40, 19.34, 17.09, 16.97. 31P NMR (CDCl3, 121.5 
MHz): δ 20.78 (s).  MS (EI-MS), m/z (rel. intensity): [M+H+] 349, [MNH4+] 366. HRMS: 
calcd. for C18H25O3N2P [M.+ ]: 348.160, found: 348.1603. 
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Bis((S)-2-isocyano-3,3-dimethylbutyl) phenylphosphonate (tBu-BINC, 72b): 
To a solution of diisopropylamine (0.09 mL, 0.630 mmol) in 2 mL of THF was added under 
nitrogen atmosphere at 0 °C n-butyl lithium (15 % in hexane, 0.22 mL, 0.512 mmol). After 
stirring for 15 min the solution was cooled down to –78 °C and t-Butyl-2-oxazoline (71b, 50 
mg, 0.394 mmol) dissolved in 2 mL THF was added. After stirring for 30 min, 
phenylphosphonic dichloride (0.03 mL, 0.236 mmol) was added followed by immediate 
removal of the cooling bath, and the solution was allowed to stir at room temperature for 2 
hours. Aqueous NH4Cl solution was added followed by work up of the mixture with ethyl 
acetate and brine. The organic layer was dried over Na2SO4 and concentrated under vacuum. 
White colored solid was obtained after purification on silica (52 mg, 59 %). 
m.p 67 °C, (hexanes/ethyl acetate 2:3, Rf = 0.56). [α]20D  + 83 (c = 1.0, CHCl3 ). IR (KBr): υ 
2964, 2140, 1594, 1475, 1442, 1394, 1370, 1346, 1246, 926 cm-1. 1H NMR (CDCl3, 300 
MHz): δ 7.87 (dd, 2H, J = 7 Hz, 13.8 Hz), 7.61(t, 1H, J = 7.5 Hz), 7.45-7.54 (m, 2H), 4.28- 
4.36 (m, 1H), 4.16- 4.27 (m, 2H), 4.01 (q, 1H, J = 9.2 Hz ), 3.68 (dd, 1H, J= 3.1, 9.1 Hz), 
3.54 (dd, 1H, J= 3.8, 8.9 Hz), 1.03 (s, 18 H). 13C NMR (CDCl3, 75 MHz): δ 158.37 (CN), 
133.45 (d, CAr-p, J = 3.05 Hz)), 132.06 (d, CAr-o, J = 10.3 Hz), 128.96 (d, CAr-m, J = 15.5 Hz), 
126.4 (d, C ipso, J = 191 Hz), 65.07 (CHt-Bu), 64.77 (CHCH2), 33.56 (C t-Bu), 33.50 (C t-Bu), 
26.37(CH3 t-Bu). 31P NMR (CDCl3, 121.5 MHz): δ 20.96 (s). MS (EI-MS), m/z (rel. intensity): 
[M+H+] 377, [MNH4+] 394. HRMS: calcd. for C20H29O3N2P [M.+ ]: 376.190, found: 376.191. 
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Bis((S)-2-isocyano-3-phenylpropyl) phenylphosphonate (Bn-BINC, 72a): 
 To a solution of Benzyl-2-oxazoline (71a, 500 mg, 3.11 mmol) in 40 mL of THF was added 
under nitrogen atmosphere –78 °C n-butyl lithium (15 % in hexane, 1.7 mL, 4.04 mmol) for 
10 minutes. After stirring for 30 min, phenylphosphonic dichloride (0.3 mL, 1.9 mmol) was 
added followed by immediate removal of the cooling bath, and the solution was allowed to 
stir at room temperature for 2 hours. Aqueous NH4Cl solution was, followed by work up of 
the mixture with ethyl acetate. Yellowish viscous liquid was obtained after purification on 
silica (276 mg, 33 %). 
(hexanes: ethyl acetate = 2:3, Rf = 0.47). [α]20D : + 3.4 ( c = 1.5, CHCl3 ). IR (KBr): υ 2140, 
1593, 1495, 1253, 961, 746 cm-1. 1H NMR (CDCl3, 300 MHz): δ 7.83-7.91 (m, 2H), 7.61-
7.66 (m, 1H), 7.49-7.56 (m, 2H), 7.17-7.36(m, 10H), 4.11-4.28 (m, 3H), 3.97-4.06 (m, 3H), 
2.97 (t, 4H). 13C NMR (CDCl3, 75 MHz): δ 159.01(CN), 134.82, 133.60 (d, J = 3.05 Hz), 
132.06 (d, J = 10 Hz), 129.38, 129.04(d, J = 15 Hz), 129.02, 127.76, 126.06(d, J = 191 Hz), 
65.80, 56.09, 37.64. 31P NMR (CDCl3, 121.5 MHz): δ 20.77 (s). MS (ES-MS), m/z (rel. 
intensity): [M+H+] 445, [MH++H2O] 463. HRMS: calcd. for C26H26O3N2P [MH+]: 445.168, 
found: 445.167. 
 
 
                                                                                                               
 
 
Bis((1S,2R)-2-isocyano-1-phenylpropyl) phenylphosphonate (72d): 
To a solution of HMDS (0.112 mL, 0.525 mmol) in 2 mL of THF was added under nitrogen 
atmosphere at 0 °C n-butyl lithium (1.6 M, 0.25 mL, 0.404 mmol). After stirring for 15 min 
the solution was cooled down to –10 °C and oxazoline (71d, 50 mg, 
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0.311 mmol) dissolved in 2 mL THF was added. After stirring for 30 min, phenylphosphonic 
dichloride (0.026 mL, 0.187 mmol) was added followed by immediate removal of the cooling 
bath, and the solution was allowed to stir at room temperature for 2 hours. Aqueous NH4Cl 
solution was added followed by work up of the mixture with ethyl acetate and brine. The 
organic layer was dried over Na2SO4 and concentrated under vacuum. Colorless oil was 
obtained after purification on silica (64 mg, 77%). 
IR (neat): υ 2137 cm-1. 1H NMR (CDCl3, 600 MHz): δ = 1.02 (d, J = 6.6 Hz, 3H), 1.29 (d, J = 
6.8 Hz, 3H), 3.71 – 3.78 (m, 1H), 4.08 – 4.14 (m, 1H), 5.06 (dd, J = 4.6, 9.2 Hz, 1H), 
5.57(dd, J = 5, 9.2 Hz, 1H), 7.35 (d, J = 7.3Hz, 2H), 7.17 (t, 2H), 7.25 – 7.25 (m, 1H), 7.32 – 
7.37 (m, 2H), 7.45 – 7.51 (m, 4H), 7.52 – 7.55(m, 2H), 7.62 – 7.68 (m, 2H). 13C NMR (151 
MHz): δ = 17.01, 17.70, 54.71, 55.02, 78.42, 78.68, 127.05, 127.35, 128.36, 128.37, 129.23, 
131.51, 132.84, 133.93, 134.94, 158.1, 158.3. Mass (LSI- MS), m/z (rel. intensity): [M+H+] 
445. HRMS: calcd. for C26H26O3N2P [MH+ ]: 445.2, found: 445.168. 
 
 
 
 
 
Bis((2R,3S)-3-isocyano-4-methylpentan-2-yl) phenylphosphonate (72e): 
To a solution of diisopropylamine (94 µL, 0.665 mmol) in 2 mL of THF was added under 
nitrogen atmosphere at 0 °C n-butyl lithium (1.6 M, 0.3 mL, 0.512 mmol). After stirring for 
15 min the solution was cooled down to –10 °C and oxazoline (71e, 50 mg, 0.394 mmol) 
dissolved in 2 mL THF was added. After stirring for 30 min, phenylphosphonic dichloride 
(0.033 mL, 0.236 mmol) was added followed by immediate removal of the cooling bath, and 
the solution was allowed to stir at room temperature for 2 hours. Aqueous NH4Cl solution 
was added followed by work up of the mixture with ethyl acetate and brine. The organic layer 
was dried over Na2SO4 and concentrated under vacuum. Colorless oil was obtained after 
purification on silica (70 mg, 70 %). 
IR (neat): υ 2969, 2139, 1440, 1392, 1250, 986 cm-1. 1H NMR (CDCl3, 400 MHz): δ 0.914 
(dd, J = 6.6, 9.2 Hz, 6H), 0.995 (d, J = 6.8 Hz, 3H), 1.11 (d, J = 6.6 Hz, 3H), 1.316 (d, J = 6.3 
Hz, 3H), 1.538 (d, J = 6.2 Hz, 3H), 1.74 – 1.85 (m, 1H), 1.86 – 1.97(m, 1H), 3.375 (t, J = 6 
Hz, 1H), 3.67 (t, J = 6.2 Hz, 1H), 4.50 – 4.70 (m, 2H), 7.45 – 7.53 (m, 2H), 7.56 – 7.63 (m, 
1H), 7.76 – 7.85 (m, 2H). 13C NMR (CDCl3, 100 MHz): δ 158.54, 133.06 (d, J = 3 Hz), 
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131,64 (d, J = 10 Hz), 128.7 (d, J = 15.4 Hz), 127.7 (d, J = 190.5 Hz), 71.44, 66.25, 29.63, 
28.94, 28.60, 19.31, 18.18, 17.53, 16.76. Mass (EI- MS), m/z (rel. intensity): [M - H]+ 375.2. 
HRMS: calcd. for C20H29O3N2P [MH+ ]: 376.191, found: 376.1905. 
                                                                                                                                 
 
 
 
 
 
Bis((1R,2S)-1-isocyano-2,3-dihydro-1H-inden-2-yl) phenylphosphonate (72f): 
To a solution of oxazoline (71f, 100 mg, 0.628 mmol) in 8 mL of THF was added under N2 
atmosphere -78 °C n-BuLi (15% in hexane, 0.691 mmol) dropwise. After stirring for 30 min, 
phenylphosphonic dichloride (0.053 mL, 0.377 mmol) was added followed by immediate 
removal of the cooling bath, and the solution was allowed to stirred at room temperature for 1 
h. Aqueous NH4Cl solution was added, followed by work up of mixture with ethyl acetate. 
Desired product is unstable on silica column. 
IR (neat): υ 3049, 2361, 2144, 1728, 1682, 1439, 1248 cm-1. 1H NMR (CDCl3, 600 MHz): δ 
= 3.12 (dd, J = 16.12, 6.13 Hz, 1H), 3.2 (dd, J = 16.12, 5.7 Hz, 1H), 3.35 (dd, J = 16.37, 5.9 
Hz, 1H), 3.42 (dd, J = 16.37, 5.3, 1H), 5.09 (d, J = 5.5 Hz, 1H), 5.12 (d, J = 5.5 Hz, 1H), 5.18 
(dddd, J = 7.7, 6.13, 5.7, 5.5 Hz), 5.32 (dddd, J = 8.0, 5.95, 5.3, 5.5 Hz), 7.19 (d, J = 6.5 Hz, 
1H), 7.26 - 7.37 (m, 5H), 7.42 – 7.45 (m, 2H), 7.48 – 7.52 (m, 2H), 7.58 – 7.63 (m, 1H), 7.90 
– 7.96 (m, 2H). 13C NMR (150.9 MHz): δ = 36.97, 37.62, 59.77, 59.89, 75.26, 75.56, 124.53, 
124.69, 125.30, 125.42, 127.98, 128.08, 128.69, 128.79, 129.91, 130.01, 132.09, 132.16, 
133.29, 135.79, 138.43, 138.64, 159.82, 159.87. 31P NMR (121.5 MHz): δ = 20.59. MS (CI-
MS), m/z (rel. intensity): [MH+] 441.2, [MNH4+] 458.2. 
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Bis((S)-2-isocyano-3-methylbutyl) admantylphosphonate (72g): 
To a solution of diisopropylamine (0. 1 mL, 0.747 mmol) in 2 mL of THF was added under 
nitrogen atmosphere at 0 °C n-butyl lithium (15 % in hexane, 0.32 mL, 0.575 mmol). After 
stirring for 15 minutes the solution was cooled down to –78 °C and i-Propyl-2-oxazoline 
(71c, 50 mg, 0.442 mmol) dissolved in 2 mL THF was added. After stirring for 30 min, 
admantylphosphonic dichloride (74, 67 mg, 0.265 mmol) was added followed by immediate 
removal of the cooling bath, and the solution was allowed to stir at room temperature for 2 
hours. Aqueous NH4Cl solution was added followed by work up of the mixture with ethyl 
acetate and brine. The organic layer was dried over Na2SO4 and concentrated under vacuum. 
Colorless viscous liquid was obtained after purification on silica (43 mg, 40 %). 
(hexanes/ethyl acetate 2:1, Rf = 0.43). 1H NMR (CDCl3, 300 MHz): δ 4.01-4.21 (m, 4H), 
3.61-3.71 (m, 2H), 1.85-2.1 (m, 8H), 1.63-1.82 (m, 9H), 1.0-1.10 (m, 12H). 13C NMR 
(CDCl3, 75 MHz): δ 158.08 (CN), 65.29, 61.17, 36.35, 35.26, 34.98, 28.99, 26.92, 19.45, 
17.22. 31P NMR (CDCl3, 121.5 MHz): δ 34.57 (s).  MS (CI-MS), m/z (rel. intensity): [M+H+] 
407, [MNH4+] 424.  
 
 
 
 
 
Admantylphosphonic dichloride (74):  
To a solid mixture of admantylbromide (500 mg, 2.33 mmol) and aluminum tribromide (900 
mg, 3.4 mmol) phosphorus trichloride (5 mL, 53.47 mmol) was added dropwise at room 
temperature. The mixture was refluxed for 5 h, then allowed gradually to cool down to room 
temperature. The mixture was filtered and washed with benzene. The addition of CCl4 gives a 
suspension, which is hydrolyzed by ice water. The organic layer is separated, dried over 
Na2SO4 and concentrated under vacuum to give yellow crystalline product (547 mg, 93%).  
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 IR (neat): υ 1265 (P-O) cm-1. 1H NMR (CDCl3, 300 MHz): δ 2.0-2.24 (m, 9H), 1.7 – 1.86 (m, 
7H). 13C NMR (CDCl3, 75 MHz): δ 48.86 (d, J = 88.2 Hz), 35.838 (d, J = 29 Hz), 34.96 (d, J 
= 4.4 Hz), 27.49 (d, J = 15.5 Hz). 31P NMR (CDCl3, 121.5 MHz): δ 65.78 (s).            
 
 
 
 
 
 
(R)-N,N'-(1,1'-binaphthyl-2,2'-diyl)diformamide (86): 
To a saturated solution of the (R)-diamine (20 mg, 0.070 mmol) in ether at 0°C was added 
dropwise acetic formic anhydride (4 equiv., 25 mg). After stirring for 1 h at 0 °C the mixture 
was cooled to -78 °C and the solvent was evaporated after 1 h. Product obtained was used for 
next step without purification. 
  
                                                                                                                 
                
 
 
 
(R)-2,2'-diisocyano-1,1'-binaphthyl (87): 
To a cooled solution of formamide (34 mg, 0.099 mmol) in dichlorormethane (0.8 mL) at 
0°C was added triethylamine (0.072 mL, 0.515 mmol) and diphosgene (0.017 mL, 0.138 
mmol). The reaction was warmed to room temperature and stirred overnight. The mixture 
was washed with NaHCO3 and water. The organic layer was dried over Na2SO4 and 
concentrated under vacuum. Yellowish solid was obtained after purification on silica (27 mg, 
89%). 
 [α]20D : - 79.6 ( c = 0.5, CHCl3 ).IR (neat): υ 3057, 2924, 2114, 1504, 815, 748 cm-1 1H NMR 
(CDCl3, 300 MHz): δ = 7.146 (d, J = 8.5 Hz, 2H), 7.41 (t, J = 7.5    2H), 7.59 (t, J = 7.9 Hz, 
2H), 7.66 (d, J =8.7 Hz, 2H), 7.99 (d, J = 8.3 Hz, 2H), 8.07 (d, J = 8.7 Hz, 2H). 13C NMR (75 
MHz): δ = 123.57, 124.09, 126.02, 127.90, 128.26, 128.56, 130.75, 130.86, 131.78, 133.08, 
167.14. MS (EI-MS), m/z (rel. intensity): [M+.] 304.1. HRMS: calcd. for C22H12N2 [M+.]: 
304.099, found 304.100. 
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(R)-2,2’-diamino-H8-1,1’-binaphthyl (BINAM, 84): 
25 mg (0.088 mmol) of (R)-diamine, 3 mg of 10 % Pd/C and 1 mL of methanol were placed 
into a autoclave and stirred under 50 bar H2 at 100 °C for 1 h. The reaction mixture was 
cooled to rt, the metal catalyst was filtered off and washed with dichloromethane. The 
combined filtrated were concentrated in vacuum to give 14 mg (70 %) of desired product, 
which was purified by silica chromatography. 
IR (neat): υ 3456, 3365, 2926, 1607, 1275, 1441, 1302, 1285, 829, 807 cm-1. 1H NMR 
(CDCl3, 300 MHz): δ = 1.63 – 1.77 (m, 8H), 2.13 – 2.34 (m, 4H), 2.72 (t, J = 6.3 Hz, 4H), 
3.24 (s, 4H), 6.62 (d, J = 8.1 Hz, 2H), 6.92 (d, J = 7.9 Hz, 2H). 13C NMR (75 MHz): δ = 
23.27, 23.47, 27.0, 29.39, 113.12, 122.0, 127.7, 129.3, 136.3, 141.6. MS (EI-MS), m/z (rel. 
intensity): [M+.] 294.1. 
 
                                                                                                            
 
 
 
 
(R)-N,N'-(H8-1,1'-binaphthyl-2,2'-diyl)diformamide (88): 
To a saturated solution of the diamine (68 mg, 0.233 mmol) in ether at 0°C was added 
dropwise acetic formic anhydride (4 equiv., 82 mg). After stirring for 1 h at 0 °C the mixture 
was cooled to -78 °C and the solvent was evaporated after 1 h. Product obtained was used for 
next step without purification. 
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(R)-2,2'-diisocyano-H8-1,1'-binaphthyl (89): 
To a cooled solution of formamide (80 mg, 0.229 mmol) in dichlorormethane (2 mL) at 0 °C 
was added triethylamine (0.166 mL, 1.2 mmol) and diphosgene (0.039 mL, 0.322 mmol). The 
reaction was warmed to room temperature and stirred overnight. The mixture was washed 
with NaHCO3 and water. The organic layer was dried over Na2SO4 and concentrated under 
vacuum. Yellowish solid was obtained after purification on silica (62 mg, 86%). 
[α]20D : + 83.3( c = 1, CHCl3 ). IR (neat): υ 2035, 2860, 2113, 1869, 1462, 833, 813 cm-1. IR 
(neat): υ cm-1. 1H NMR (CDCl3, 300 MHz): δ = 1.6 – 1.8 (m, 8H), 2.0 – 2.1 (m, 2H), 2.2 – 
2.4 (m, 2H), 2.7 – 2.9 (m, 2H), 7.12 (d, J = 8.2 Hz, 2H), 7.22 (d, J = 8.2 Hz, 2H). 13C NMR 
(75 MHz): δ = 22.28, 22.64, 27.26, 29.83, 123.03, 130.09, 133.73, 136.69, 139.87, 164.74. 
MS (EI-MS), m/z (rel. intensity): [M+.] 312.2. HRMS: calcd. for C22H20N2 [M+.]: 312.41, 
found 312.16..  
 
                                                                                                                     
 
 
 
 
3,3′-dibromo (R)-BINAM (90): 
To a stirred solution of (R)-5,5’,6,6’,7,7’,8,8’-octahydro- 1,1’- binaphthyl-2,2’-diamine (56 
mg, 0.192 mmol) in dry THF (1 mL)was added NBS (68 mg, 0.383 mmol) at 0 °C. The 
reaction mixture was stirred at 0 °C for 1 minute. The mixture was then quenched with 
saturated NaHCO3 and saturated Na2SO3 at 0 °C, and extracted with ethylacetate. The 
combines organic layers were washed with brine, dried over Na2SO4 and concentrated. The 
residue was purified by column chromatography (hexanes/ethyl acetate = 40:1) to afford 
desired product (79 mg, 92%). 
IR (neat): υ 3471, 3375, 2930, 2855, 2359, 2334, 1603, 1452, 907, 732 cm-1. 1H NMR 
(CDCl3, 300 MHz): δ = 1.60- 1.74 (m, 8H), 2.03 – 2.26 (m, 4H), 2.70 (t, J = 6.0 Hz, 4H), 
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3.72 (brs, 4H), 7.21 (s, 2H). 13C NMR (75 MHz): δ = 22.98, 23.16, 26.76, 29.06, 127.04, 
122.39, 129.04, 132.3, 135.7, 139.2. MS (EI-MS), m/z (rel. intensity): [MH+] 449.0 
     
                                                                                                              
 
 
 
 
(R)-3,3'-dibromo-1,1'-binaphthyl-2,2'-diamine (91): 
To a stirred solution of (R)-3,3’-Dibromo-5,5’,6,6’,7,7’,8,8’-octahydro-1,1’- binaphthyl-2,2’-
diamine (24 mg, 0.0533 mmol) in benzene (1 mL)was added DDQ (61 mg, 0.266 mmol) at 
room temperature, and the mixture was refluxed for 5 minutes. Upon consumption of starting 
material, the reaction mixture was directly purified by column chromatography to afford 
desired product (9.3 mg, 40% yield, >94% ee). 
[α] + 80.7 (c 0.5, CHCl3). IR (neat): υ 3472, 3371, 2956, 2925, 2854, 2365, 1730, 1596 cm-1. 
1H NMR (CDCl3, 300 MHz): δ = 4.14 (bs, 4H), 6.98 (d, J = 7.6 Hz, 2H), 7.19 – 7.31 (m, 4H), 
7.73 (d, J = 7.6 Hz, 2H), 8.17 (s, 2H). 13C NMR (75 MHz): δ = 112.66, 113.38, 123.43, 
123.84, 127.36, 127.36, 127.41, 128.65, 132.24, 132.46, 140.33. MS (EI-MS), m/z (rel. 
intensity): [MH+] 440.8. HPLC (Chiralpak AD-H, hexane/iPrOH 95/5, 0.5 ml/min, 254 nm). 
 
 
 
 
 
 
(R)-3,3'-diphenyl-1,1'-binaphthyl-2,2'-diamine (92): 
A mixture of (R)-3,3’-Dibromo-1,1’- binaphthyl-2,2’-diamine (20 mg, 0.045 mmol), 
Pd(OAc)2 (1 mg, 0.0045 mmol), PPh3 (5 mg, 0.018 mmol), Ba(OH)2. 8H2O (57 mg, 0.18 
mmol) and phenylboronic acid (35 mg, 0.14 mmol) in DME (0.5 mL) and H2O (45 µL) was 
refluxed for 20 h. After cooling to room temperature, the mixture was poured into water and 
extracted with ethylacetate. The combined organic layers were washed with brine, dried over 
Na2SO4 and concentrated. The residue was purified by column chromatography to afford 
white solid (11 mg, 57 %). 
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1H NMR (CDCl3, 300 MHz): δ =2.67 (bs, 4H), 7.12 – 7.18 (m, 2H), 7.20 – 7.30 (m, 4H), 
7.37 – 7.45 (m, 2H), 7.46 – 7.54 (m, 4H), 7.59 – 7.67 (m, 4H), 7.75 – 7.84 (m, 4H). 13C NMR 
(75 MHz): δ = 113, 122.7, 123.9, 126.8, 127.7, 128.2, 128.3, 128.9, 129.4, 129.8, 130.8, 133, 
139.3, 140.8. MS (EI-MS), m/z (rel. intensity): [M+.] 436.2.  
 
 
 
 
 
1,6-anhydro-2-deoxy-2-iodo-ß-D-glucopyranose (100): 
A mixture of glucal (340 mg, 2.33 mmol), bis-(tributylstannyl) oxide (0.95 mL, 1.86 mmol) 
and 3 Å molecular sieves (4 gm/ 100 mL) in acetonitrile (10 mL) was refluxed for 3 h. After 
cooling to room temperature iodine (355 mg, 2.8 mmol) was added and mixture was stirred at 
room temperature for 2 h. Solvent was evaporated after 2 h and crude product was purified by 
column chromatography to afford colorless oily product (210 mg, 78 %). 
1H NMR (D2O, 300 MHz): δ = 3.34 (s, 1H), 3.55 – 3.70 (m, 2H), 3.86 – 3.91 (m, 1H), 4.09 – 
4.13 (m, 1H), 4.16 (dd, J = 1, 7.4 Hz, 1H), 4.48 – 4.55 (m, 1H), 5.67 (s, 1H). 13C NMR (75 
MHz): δ = 28.8, 67.1, 73.9, 76.6, 77.9, 105.1. MS (ESI-MS), m/z (rel. intensity): [M + 
HCOO-] 316.9, [MCl-] 306.9. 
 
 
 
 
 
1,6-anhydro-2-deoxy-2-azido-ß-D-glucopyranose (101): 
A mixture of 1,6-anhydro-2-deoxy-2-iodo-ß-D-glucopyranose (210 mg, 0.77 mmol) and 
sodium azide (15q mg, 2.32 mmol) in DMF (1.4 mL) and H2O (0.2 mL) was stirred at 120 °C  
for 2 h. The mixture was concentrated under vacuum and the residue was dissolved in EtOH 
(0.62 mL) and H2O (0.07 mL) and treated with charcoal under reflux for 30 min. The mixture 
was filtered through Celite, concentrated and purify by column chromatography to furnish 
white solid (115 mg, 80 %). 
1H NMR (DMSO-d6, 300 MHz): δ = 3.02 (s, 1H), 3.42 (s, 1H), 3.5 – 3.6 (m, 2H), 3.93 (d, J = 
7 Hz, 1H), 4.43 (d, J = 4.9 Hz, 1H), 5.26 (d, J = 3.6 Hz, 1H), 5.35 – 5.43 (m, 2H). 13C NMR 
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(75 MHz): δ = 62, 64.8, 70.6, 41.4, 76.3, 99.7. MS (ESI-MS), m/z (rel. intensity): [M + 
HCOO-] 232.1, [MCl-] 222.1. 
 
 
 
 
 
1, 6-anhydro-2-azido-3,4-di-O-benzyl-2-deoxy-ß-D-glucopyranose (102): 
A solution of benzyl bromide (40 mg, 0.235 mmol) in DMF (1 mL) was slowly added to 
solution of azide (20 mg, 0.11 mmol) and NaH (60 % in petether, 10 mg, 0.235 mmol) in 
DMF (2 mL) at 0 °C. The reaction mixture was allowed to reach room temperature and the 
solvent was removed under vacuum. The resulting crude mixture was purified by column 
chromatography to afford desired product (33 mg, 83 %). 
1H NMR (CDCl3, 300 MHz): δ = 3.3 (s, 1H), 3.4 (s, 1H), 3.74 (dd, J = 6, 7 Hz, 1H), 4.03 (dd, 
J = 0.8, 7.4 Hz, 1H), 4.49 – 4.68 (m, 5H), 5.52 (s, 1H), 7.28 – 7.43 (m, 10H). 13C NMR (75 
MHz): δ = 59.9, 65.4, 71.4, 72.4, 74.4, 75.9, 76.2, 100.6, 127.8, 127.9, 128.0, 128.1, 128.6, 
137.3, 137.4. MS (ESI-MS), m/z (rel. intensity): [MNH4]+ 385.1. 
 
 
 
 
 
1, 6-anhydro-2-azido-3-O-benzyl-2-deoxy-ß-D-glucopyranose (103): 
To a solution of 1, 6-anhydro-2-azido-3,4-di-O-benzyl-2-deoxy-ß-D-glucopyranose (12 mg, 
0.033 mmol) in dichloromethane (0.6 mL) was added TiCl4 (4 µL) at room temperature. 
After 45 min, the solution was poured into ice water, and the organic layer was washed with 
NaHCO3, water, dried over Na2SO4 and concentrated. The crude mixture was purified by 
column chromatography to give 1,6-anhydro-2-azido-3-O-benzyl-2-deoxy-ß-D-
glucopyranose (7.2 mg, 82 %).  
1H NMR (CDCl3, 300 MHz): δ = 2.65 (d, J = 10.7 Hz, 1H), 3.52 (s, 1H), 3.61 (m, 1H), 3.67 
(d, J = 9.8 Hz, 1H), 3.783 (dd, J = 6, 7 Hz, 1H), 4.24 (dd, J = 0.5, 7 Hz, 1H), 4.54 (d, J = 5.5 
Hz, 1H), 4.62 (s, 1H), 4.63 (s, 1H), 5.45 (s, 1H), 7.29 – 7.41 (m, 5H).. 13C NMR (75 MHz): δ 
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= 59.61, 65.08, 68.82, 72.53, 76.29, 77.98, 100.08, 127.73, 128.2, 128.6, 137.1. MS (ESI-
MS), m/z (rel. intensity): [M + HCOO-] 322, [MCl-] 312. 
 
 
 
 
 
1, 6-diacetae-2-azido-3,4-di-O-benzyl-2-deoxy-ß-D-glucopyranose (104): 
The anhydro compound 103 (8mg, 0.022 mmol) was dissolved in 9:1 Ac2O-CF3CO2H (10 
mL) and the solution was stirred for 16 h at room temperature. Solvents were removed and 
residual traces of acid were removed with toluene. Purification by column chromatography 
gave the anomeric mixture of diacetate (9 mg, 90 %). 
1H NMR (CDCl3, 300 MHz): δ = 2.04 (s, 3H), 3.52 (s, 1H), 2.16 (s, 3H), 3.55 – 3.70 (m, 2H), 
3.90 – 4.04 (m, 2H), 4.277 (d, J = 3 Hz, 2H), 4.56 – 4.65 (m, 1H), 4.82 – 4.99 (m, 3H), 6.241 
(d, J = 3.5 Hz, 1H), 7.27 – 7.45 (m, 10H). 13C NMR (75 MHz): δ = 20.82, 20.98, 62.35, 
62.44, 62.74, 65.07, 71.31, 73.93, 75.15, 75.34, 75.73, 75.84, 76.83, 77.20, 80.57, 83.13, 
90.40, 92.72, 128.11, 128.27, 128.62, 128.66, 137.23, 137.45, 168.83, 170.59. MS (ESI-MS), 
m/z (rel. intensity): [MNH4]+ 487.1. 
 
 
 
 
 
6-acetae-2-azido-3,4-di-O-benzyl-2-deoxy-ß-D-glucopyranose (105): 
Benzylamine (0.2 mL, 1.83 mmol) was added at room temperature to a solution of anomeric 
acetate 104 (86 mg, 0.183 mmol) in THF (7mL). The mixture was stirred for 2 days at room 
temperature, by which time starting material was disappeared. The solution was neutralized 
with IR- 120 (H+) resin, filtered and concentrated. Column chromatography of the residue 
gave anomeric alcohol (56 mg, 72 %). 
1H NMR (CDCl3, 300 MHz): δ = 2.05 (s, 3H), 3.34 – 3.62 (m, 3H), 3.97 – 4.26 (m, 3H), 4.30 
– 4.40 (m, 1H), 4.55 – 4.65 (m, 1H), 4.80 – 4.96 (m, 3H), 5.26 – 5.31 (m, 1H), 7.25 – 7.43 
(m, 10H). 13C NMR (75 MHz): δ = 20.89, 62.85, 63.98, 67.43, 69.21, 73.22, 75.15, 75.67, 
75.74, 77.15, 77.95, 80.15, 83.09, 92.03, 96.18, 128.03, 128.10, 128,20, 128.60, 137.35, 
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137.48, 137.59, 137.63, 170.97. MS (ESI-MS), m/z (rel. intensity): [MH]+ 428.1, [MNH4]+ 
445.1. 
 
 
 
 
 
 
6-acetae-2-azido-3,4-di-O-benzyl-2-deoxy-ß-D-glucopyranose trichloroacetimidate 
(106): 
1,8-Diazabicyclo[5.4.0]undec-7-ene (4 µL, 0.025 mmol) was added at 0 °C to a stirred 
mixture of anomeric alcohol 105 (107 mg, 0.250 mmol), trichlroacetonitrile (50.2 µL, 0.501 
mmol), and activated powdered molecular sieves (4 Å, 30 mg ) in dry dichlromethane (7 
mL). This mixture was stirred for 3 h at 0 °C. The reaction mixture was directly poured onto 
column using silica gel equilibrated with 2 % triethyamine to furnish desired product (86 mg, 
60 %). 
1H NMR (CDCl3, 300 MHz): δ = 2.03 (s, 3H), 3.63 – 3.75 (m, 2H), 4.03 – 4.13 (m, 2H), 4.20 
– 4.37 (m, 2H), 4.62 (d, J = 10.7 Hz, 1H), 4.85 – 4.98 (m, 3H), 6.421 (d, J = 3.6 Hz, 1H), 
7.27 – 7.46 (m, 10H), 8.75 (s, 1H). 13C NMR (75 MHz): δ = 20.82, 62.23, 63.08, 71.76, 
75.39, 75.69, 77.28, 80.24, 90.81, 94.55, 128.15, 128.18, 128.27, 128.33, 128.61, 128.69, 
137.16, 137.45, 160.71, 170.54.  
 
 
 
 
 
 
1,6-anhydro-2-azido-3-O-benzyl-4-O-(6-acetate-3,4-di-O-benzyl-2-deoxy-2-azido-ß-D-
glucopyranosyl)-2-deoxy- ß-D-glucopyranose (95): 
A mixture of the imidate (106, 20 mg, 0.035 mmol), the alcohol (103, 14 mg, 0.049 mmol) 
and activated powdered 4 Å molecular sieves (20 mg) in dry toluene (0.3 mL) was stirred at 
room temperature and then cooled to – 78 °C. BF3.Et2O (0.5 µL, 10 mol %) was added to the 
mixture which was then stirred for 3 h. The mixture was diluted with dichloromethane and 
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washed with water, dried and concentrated. The residue was purified by column 
chromatography to give disaccharide (19 mg, 80 %). 
1H NMR (CDCl3, 300 MHz): δ = 1.96 (s, 3H), 3.24  (s, 1H), 3.30 – 3.45 (m, 2H), 3.46 – 3.59 
(m, 2H), 3.7 – 3.83 (m, 2H), 3.86 (t, 1H), 4.04 – 4.2 (m, 3H), 4.27 – 4.39 (m, 2H), 4.55 – 4.73 
(m, 4H), 4.80 – 4.95 (m, 3H), 5.52 (d, 1H), 7.22 – 7.4 (m, 15H).  MS (ESI-MS), m/z (rel. 
intensity): [MH+] 687.2, [MNH4]+ 704.2. 
 
 
 
 
 
 
[PdCl2(tBuBINC)] (105b):  
A mixture of tBu diisonitrile ligand (72b, 50 mg, 0.133 mmol) and PdCl2(PhCN) 2 (50 mg, 
0.131 mmol) in dichloromethane (2mL) was stirred at room temperature for 16 h. The 
mixture was filtered through a small pad of celite and washed with dichloromethane. The 
filtrate was concentrated to a volume of approx. 0.5 ml. The crude product was precipitated 
by addition of 1 ml of hexane and solvent was decanted after stirring for 10 minutes. This 
procedure was repeated thrice. The resulting solid was washed with diethyl ether (3 x 1 ml) to 
give 105b (67 mg, 91% yield) as an off white solid. Crystals suitable for X-ray-
crystaollography were obtained from benzene at room temperature. IR (neat) υ (CN) 2237; 
(P=O) 1250, (Pd-Cl) 343, 321 cm-1. 1H NMR (CDCl3, 300 MHz): δ 1.05 (s, 9H), 1.12 (s, 9H), 
3.93 (dd, 1H, J = 10.3 Hz, 3.19 Hz), 3.98 (ddd, 1H, J = 10.5 Hz, 11.08 Hz, 7.6 Hz), 4.16 (dd, 
1H, J = 7.6 Hz, 4.2 Hz), 4.18 (ddd, 1H, J = 3.6 Hz, 10.9 Hz, 3.2 Hz), 4.29 (ddd, 1H, J = 7.6 
Hz, 11.08 Hz, 4,2 Hz), 4.49 (ddd, 1H, J = 8.4 Hz, 10.9 Hz, 10.3 Hz), 7.55-7.64 (m, 2H), 7.65- 
7.74 (m, 1H), 7.77 -7.88 (m, 2H). 13C NMR (CDCl3, 150 MHz): δ 26.29, 33.95, 62.94, 64.20, 
67.95, 68.72, 119.67 (CN), 120.94 (CN), 125.23, 129.26, 131.81, 133.9. 31P NMR (CDCl3, 
121.5 MHz): δ 21.05 (s). Anal. Calc. for C20H29Cl2N2O3PPd : C, 43.38; H, 5.28; N, 5.06. 
Found: C, 42.88; H, 5.50; N, 4.83. 
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[PdCl2(iPrBINC)] (105c):  
A mixture of iPr diisonitrile ligand (72c, 50 mg, 0.144 mmol) and PdCl2(PhCN) 2 (55 mg, 
0.144 mmol) in dichloromethane (2mL) was stirred at room temperature for 16 h. The 
mixture was filtered through a small pad of celite and washed with dichloromethane. The 
filtrate was concentrated to a volume of approx. 0.5 ml. The crude product was precipitated 
by addition of 1 ml of hexane and solvent was decanted after stirring for 10 minutes. This 
procedure was repeated thrice. The resulting solid was washed with diethyl ether (3 x 1 ml) to 
give [PdCl2(iPrBINC)] (68 mg, 90% yield) as a off white solid. 
IR (neat) υ (CN) 2237; (P=O) 1245 cm-1. 1H NMR (CDCl3, 300 MHz): δ 0.87-1.148 (m, 
12H), 2.03-2.31 (m, 2H), 3.95- 4.69 (m, 6H), 7.51-7.70 (m, 3H), 7.80- 7.80-8.12 (m, 2H). 13C 
NMR (CDCl3, 150 MHz): δ 18.60, 18.91, 19.32, 19.41, 29.39, 29.47, 64.48, 65.29, 65.42, 
65.61, 125.71(J = 188.7 Hz), 129.38 (J = 15.6 Hz), 131.99 (J = 10.6 Hz). 31P NMR (CDCl3, 
121.5 MHz): δ 20.93 (s). Anal. Calc. for C18H25Cl2N2O3PPd: C, 41.12; H, 4.19; N, 5.33. 
Found: C, 40.10; H, 5.02; N, 5.02. 
 
Representative procedure for the Wacker oxidation of alkenes: 
In a flame dried 10 ml schleck tube equipped with a sidearm and stir bar, a mixture of 
[PdCl2(DiNC)] (105, 14 mg, 5 mol %) and 4 ml of  a 6:1 (v/v) solution of DMA:H2O mixture 
were heated at 70 °C for 10 minutes to assure complete solubility of the catalyst. The tube 
was allowed to cool to room temperature and connected with a condenser and a one way joint 
with a balloon of O2. The tube was evacuated (50 mbar) and refilled with O2 three times. The 
reaction mixture was stirred vigorously for 10 minutes upon which the alkene (0.5 mmol) 
was added. For the indicated reaction time the mixture was then heated at 70 °C. After 
cooling to room temperature, the reaction mixture was analyzed by GC using decane as 
internal standard. For product isolation the reaction mixture diethylether was added and 
washed twice with 1N HCl. The aqueous layers were combined and extracted thrice with 
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diethylether. The organic layers were combined and washed with brine, dried over Na2SO4 
and filtered. The product was purified by flash silica chromatography. 
 
 
 
 
 
2, 2, 6-trimethyl-6-(2-oxopropyl)-cyclohexanone (Table 12, entry 4): 
1H NMR (CDCl3, 300 MHz): δ 2.76(dd, 2H, J= 18Hz, 279 Hz), 2.02 (s, 3H), 1.72-1.95 (m, 
3H), 1.43-1.65 (m, 3H), 1.14 (s, 3H), 1.09 (s, 3H), 1.07 (s, 3H). 13C NMR (CDCl3, 75.5 
MHz): δ 220.6, 206.9, 55.6, 44.9, 44.32, 38.9, 36.9, 30.1, 27.87, 27.7, 26.9, 18.2. 
 
 
 
 
10-hydroxy-2-undecanone (Table 12, entry 3): 
1H NMR (CDCl3, 300 MHz): δ 3.62 (t, 2H, J= 6.6Hz), 2.41(t, 2H, J= 7.4Hz), 2.12 (s, 3H), 
1.47-1.65 (m, 5H), 1.21-1.42 (m, 10 H). 13C NMR (CDCl3, 75.5 MHz): δ 209.6, 63.2, 43.9, 
32.9, 30.0, 29.54, 29.49, 29.46, 29.28, 25.9, 23.9. 
 
Suzuki couplings: 
An oven dried Schlenk tube was evacuated and backfilled with nitrogen and charged with 
[PdCl2(DiNC)] (105, 5 mol %), the boronic acid (1.5 equiv.), aryl halide (1 equiv.) and 
K3PO4 (2 equiv.). The flask was evacuated and backfilled with nitrogen and DMA (2ml/ 
0.25mmol of aryl halide).The reaction mixture was stirred at 120 °C for 16 h. The reaction 
mixture was diluted with ether and washed with 1M NaOH and the aqueous layer was 
extracted with ether. The combined organic layers were washed with brine, dried over 
sodium sulfate, filtered and concentrated in vacuum. The crude material was purified by flash 
chromatography on silica gel. 
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4-nitrobiphenyl (Table 10, entry 1): 
1H NMR (CDCl3, 300 MHz): δ 8.31 (d, 2H, J = 9 Hz), 7.74 (d, 2H, J = 9 Hz), 7.63 (dd, 2H, J 
= 2 Hz, 6 Hz), 7.42- 7.53 (m, 3H). 13C NMR (CDCl3, 75 MHz): δ 147.8, 147.2, 138.9, 129.3, 
120.1, 127.9, 127.6, 124.3. 
 
 
 
 
4-cyanobiphenyl (Table 10, entry 2): 
1H NMR (CDCl3, 300 MHz): δ 7.67- 7.75 (m, 4H), 7.57- 7-61 (m, 2H), 7.40- 7.52 (m, 3H). 
13C NMR (CDCl3, 75 MHz): δ 145.8, 139.3, 132.7, 129.3, 128.8, 127.9, 127.4, 119.1, 111. 
 
 
 
 
biphenyl-4-carbaldehyde (Table 10, entry 3): 
1H NMR (CDCl3, 300 MHz): δ 10.06 (s, 1H), 7.96 (d, 2H, J = 8.5 Hz), 7.76 (d, 2H, J = 8.24), 
7.64 (dd, 2H, J = 1.6 Hz, 7 Hz), 7.39-7.52 (m, 3H). 13C NMR (CDCl3, 75 MHz): δ 192.1, 
147.3, 139.8, 135.3, 130.4, 129.2, 128.6, 127.8, 127.5. 
 
 
 
 
4-methoxybiphenyl (Table 10, entry 4): 
1H NMR (CDCl3, 300 MHz): δ 7.53- 7.59 (m, 4H), 7.42- 7.49 (m, 2H), 7.30- 7.35 (m, 1H), 
7.0 (d, 2H, J = 9 Hz), 3.87 (s, 3H). 13C NMR (CDCl3, 75 MHz): δ 159.3, 140.9, 133.9, 128.9, 
128.3, 126.9, 126.8, 114.4, 55.5. 
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1-(biphenyl-4-yl)ethanone (Table 10, entry 5): 
1H NMR (CDCl3, 300 MHz): δ 8.04 (d, 2H, J = 8.5 Hz), 7.62- 7.71 (m, 4H), 7.37- 7.51 (m, 
3H), 2.65 (s, 3H). 13C NMR (CDCl3, 75 MHz): δ 197.9, 145.9, 140.1, 136, 129.14, 129.10, 
128.4, 127.46, 127.41, 26.9. 
 
Typical procedure for synthesis of Bis(isonitrile) iron complexes 118a-e: 
To FeCl2.4H2O (1 equiv.) in dry MeOH was added a solution of bis(isonitrile) ligand ( 72, 2 
equiv.) dissolved in minimum amount of dichloromethane. The reddish solution was obtained 
which was stirred for 12 h at room temperature after which no bis(isonitrile) was seen by 
TLC. The solvent was removed under pressure and residue was washed with hexane thrice. 
Yellowish orange colored solid was obtained after drying under vacuum. 
 
 
 
 
 
 
 
Complex 118a:  
Yield: 52 %. IR (KBr): υ 3446, 2163, 1496, 1455, 1244, 1131, 1012, 958 cm-1. 1H NMR 
(CD2Cl2, 400 MHz): δ 2.73.5 – 1.5 (m, 4H), 3.7 – 4.7 (m, 6H), 7.70 – 8.0 (m, 2H), 7.1 – 7.68 
(m, 13H). 31P NMR (CD2Cl2, 162 MHz): δ 19.56, 19.69, 19.78, 19.86, 20.12, 20.30. MS 
(LSI-MS), m/z (rel. intensity): [M-Cl]+ 978.8.  
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Complex 118b:  
Yield: 56 %. IR (KBr): υ 2963, 2165, 1473, 1439, 1247, 1131, 1020, 988 cm-1. 1H NMR 
(CD2Cl2, 400 MHz): δ 0.5 – 1.4 (m, 18H), 3.3 – 4.9(m, 6H), 7.4 – 7.70 (m, 3H), 7.72 – 7.9 
(m, 1H), 7.92 – 8.19 (m, 1H). 31P NMR (CD2Cl2, 162 MHz): δ 20.19 (bs). MS (LSI-MS), m/z 
(rel. intensity): [M-Cl]+ 843.2. HRMS: calcd. for C40H58O6N4P2FeCl [M-Cl]+: 843.2, found: 
843.287. 
 
 
 
 
 
 
 
Complex 118c:  
Yield: 58 %. IR (KBr): υ 2967, 2161, 1466, 1439, 1243, 1131, 1024, 988 cm-1. 1H NMR 
(CD2Cl2, 300 MHz): δ 0.6 – 1.5 (m, 12H), 1.7 – 2.5 (m, 2H), 3.4 – 4.8 (m, 6H), 7.2 – 8.15 (m, 
5H). 31P NMR (CD2Cl2, 121 MHz): δ 19.93 (s). MS (LSI-MS), m/z (rel. intensity): [M-Cl]+ 
787.2.  
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Complex 118d: 
Yield: 62 %. IR (KBr): υ 3525, 2936, 2162, 1454, 1252, 1130, 992 cm-1. 31P NMR (CD2Cl2, 
243 MHz): δ 17.17, 17.31, 17.61, 17.76, 17.80, 18.07. MS (LSI-MS), m/z (rel. intensity): [M-
Cl]+ 978.8.   
 
 
 
 
 
 
 
Complex 118e: 
Yield: 54 %. IR (KBr): υ 2967, 2167, 1439, 1248, 1131, 990 cm-1. 31P NMR (CD2Cl2, 243 
MHz): δ 16.04, 16.57, 17.17, 17.34, 17.66. MS (LSI-MS), m/z (rel. intensity): [M-Cl]+ 843.3.  
 
 
 
 
 
 
 
Complex 119a: 
Trifluoromethanesulfonic acid (HOTf, 9 μL) was added to the stirring solution of complex 
118b (25 mg, 0.03 mmol) in degassed benzene (2 mL). The reaction mixture darkens 
immediately to give a reddish precipitate. After 10 min of gentle stirring, the benzene was 
removed via syringe and the precipitate was washed with copious amounts of dry ether, 
followed by drying under vacuum to isolate Fe(tBu-BINC)2(OTf)2. Yield: 19 mg, 63 %. IR 
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(KBr): υ 3435, 2973, 2224, 1221, 1134, 1022 cm-1. MS (LSI-MS), m/z (rel. intensity): [M-
OTf+Cl+H]+ 957.3.  
 
 
 
 
 
 
 
Complex 119b: 
Triphenylphosphine (16.4 mg, 0.063 mmol) was added to the solution of complex 118b (50 
mg, 0.06 mmol) in methanol (19 mL). After stirring the reaction mixture for 12 h, NaBPh4 
(19.5 mg, 0.06 mmol) was added and stirring was continued for next 4 h. The solvent was 
removed under pressure and residue was washed with hexane thrice. Yellowish colored solid 
was obtained after drying under vacuum.  
Yield: 43 mg, 53 %. IR (KBr): υ 3056, 2966, 2166, 1479, 1250, 1131, 990 cm-1. MS (ES-
MS), m/z (rel. intensity): [M+] 1105.3.  
 
 
 
 
 
 
 
Complex 119c: 
Under nitrogen complex 118b (50 mg, 0.06 mmol) was dissolved in methanol (25 mL). 
Resulting reaction solution was perched with CO gas (1 atm) and stirred for 12 h under 1 atm 
of CO. Solvent was evaporated under vacuum followed by addition of NaBPh4 (19.5 mg, 0.06 
mmol) solution in methanol (50 mL). After stirring for next 4 h, the solvent was removed 
under pressure and residue was washed with hexane thrice to afford greenish solid. 
MS (ES-MS), m/z (rel. intensity): [M+] 871.2, [M+-CO]+ 843.2.  
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Complex 119d: 
To a solution of complex 118b (50 mg, 0.057 mmol) in chloroform (37 mL) was added 
SnCl2.2H2O (128 mg, 0.57 mmol). After stirring the mixture for 12 h, the excess of 
SnCl2.2H2O was removed by filtration. The solution was concentrated to small volume and 
again excess of SnCl2.2H2O was removed by filtration. This step was repeated 3 to 4 times. 
The resulted solvent was removed under pressure to obtain a yellowish compound. Crystals 
suitable for X-ray studies were obtained from MeOH/pentane. 
IR (KBr): υ 2966, 2160, 1472, 1440, 1338, 1172, 1021 cm-1.  
 
General procedure for the iron catalyzed asymmetric transfer 
hydrogenation: 
In a 10 mL schlenk tube, the iron complex (118, 5mol %, 15 mg, 0.0169 mmol), KOtBu (10 
equiv., 19 mg, 0.169 mmol) and 2-propanol (1.7 mL, for 0.2 M concentration of substrate) 
were stirred under nitrogen at room temperature for 5 minutes. The substrate (20 equiv.) was 
added to this mixture and stirred for the time period mentioned in the table. The conversion 
and enantiomeric excess of the products were determined by GC using decane as internal 
standard and chiral HPLC respectively. The products were also identified by 1H NMR and 
13C NMR spectroscopy and the data obtained matches with literature values. Absolute 
configuration was determined by comparison of the sign of rotation of the isolated products 
with literature value. 
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(S)-1-phenylethanol (Table 18, entry 1): 
The title compound was prepared according to the general procedure as described above in 
90% conversion. The product was analyzed by HPLC to determine the enantiomeric excess 
64% ee (OJ: 95/5, heptane/isopropanol, 1mL/min, 215-254 nm); tr (major) = 10.90 (S); tr 
(minor) = 12.49 (R) min. 
1H-NMR (300 MHz; CDCl3): δ 7.20-7.4 (m, 5H), 4.86 (q, J = 6.6, 12.8 Hz, 1H), 2.29 (s, 1H), 
1.48 (d, J = 6.3 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 25.17, 70.36, 125.44, 127.46, 128.24, 
145.88. 
 
 
 
 
 
(S)-1-phenylpropan-1-ol (Table 18, entry 2): 
The title compound was prepared according to the general procedure as described above in 
73% conversion. The product was analyzed by HPLC to determine the enantiomeric excess 
64% ee (OD-H: 99/1, heptane/isopropanol, 1 mL/min, 215 – 254 nm); tr (minor) = 16.39 (R), 
tr (major) = 19.06 (S) min. 
1H-NMR (300 MHz; CDCl3): δ 7.22-7.40 (m, 5H), 4.57 (t, J = 6.6 Hz, 1H), 2.11 (s, 1H), 
1.65-1.91 (m, 2H), 0.92 (t, J = 7.4 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 10.18, 31.89, 
76.01, 126.02, 127.49, 128.41, 144.64. 
 
  
 
 
(S)-1-phenylpropan-2-ol (Table 18, entry 5): 
The title compound was prepared according to the general procedure as described above in 
99% conversion. The product was analyzed by HPLC to determine the enantiomeric excess 
OH
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34% ee (OD-H: 99/1, heptane/isopropanol, 1 mL/min, 215 – 254 nm); tr (major) = 12.50 (S), tr 
(minor) = 14.08 (R) min. 
1H-NMR (300 MHz; CDCl3): δ 7.35-7.21 (m, 5H), 4.01 (m, 1H), 2.78 (dd, J = 13.4, 5.0 Hz, 
1H), 2.70 (dd, J = 7.8, 13.4 Hz, 1H), 2.01 (br s, 1H), 1.25 (d, J = 6.2 Hz, 3H). 13C NMR (75 
MHz, CDCl3) δ 138.5, 129.4, 128.5, 126.5, 68.8, 45.8, 22.8. 
  
  
 
 
 
(S)-2-methyl-1-phenylpropan-1-ol (Table 18, entry 3): 
The title compound was prepared according to the general procedure as described above in 
36% conversion. The product was analyzed by HPLC to determine the enantiomeric excess 
36% ee (OD-H: 99/1, heptane/isopropanol, 1 mL/min, 215 – 254 nm); tr (major) = 13.21 (S), tr 
(minor) = 15.97 (R) min. 
1H-NMR (300 MHz; CDCl3): δ 7.38-7.24 (m, 5H), 4.37 (d, J = 6.8 Hz, 1H), 1.96 (octet, 1H, J 
= 6.8 Hz), 1.82 (brs, 1H), 1.01 (d, J = 6.8 Hz, 3H), 0.80 (d, J = 6.8 Hz, 3H). 
 
 
 
 
 
(S)-1-(4-chlorophenyl)ethanol (Table 18, entry 6): 
The title compound was prepared according to the general procedure as described above in 
94% conversion. The product was analyzed by HPLC to determine the enantiomeric excess 
60% ee (OD-H: 99/1, heptane/isopropanol, 0.5 mL/min, 215 – 254 nm); tr (minor) = 
45.81(R), tr (major) = 52.46 (S) min. 
1H-NMR (300 MHz; CDCl3): δ 7.20-7.34 (m, 4H), 4.83 (q, J = 6.6, 12.8 Hz, 1H), 2.34 (s, 
1H), 1.43 (d, J = 6.3 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 25.25, 69.69, 126.82, 128.59, 
133.02, 144.26. 
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(S)-1-(3-chlorophenyl)ethanol (Table 18, entry 7): 
The title compound was prepared according to the general procedure as described above in 
>99% conversion. The product was analyzed by HPLC to determine the enantiomeric excess 
67% ee (OJ: 99/1, heptane/isopropanol, 1 mL/min, 215 – 254 nm); tr (major) = 19.85 (S), tr 
(minor) = 23.78 (R) min. 
1H-NMR (300 MHz; CDCl3): δ 7.34-7.39 (m, 1H), 7.19-7.30 (m, 3H), 4.84 (q, J = 6.6, 12.9 
Hz, 1H), 2.16 (s, 1H), 1.46 (d, J = 6.4 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 25.23, 69.79, 
123.56, 125.64, 127.53, 129.80, 134.36, 147.87. 
 
 
 
 
 
(S)-1-(2-bromophenyl)ethanol (Table 18, entry 8): 
The title compound was prepared according to the general procedure as described above in 
60% conversion. The product was analyzed by HPLC to determine the enantiomeric excess 
67% ee (OD-H: 99/1, heptane/isopropanol, 0.5 mL/min, 215 – 254 nm); tr (minor) = 40.82 
(R), tr (major) = 45.08 (S) min. 
1H-NMR (300 MHz; CDCl3): δ 7.57 (dd, J = 1.6, 7.6 Hz, 1H), 7.50 (dd, J = 1.06, 7.9 Hz, 1H), 
7.29-7.38 (m, 1H), 7.08-7.16 (m, 1H),  5,21 (q, J = 6.6, 12.8 Hz, 1H), 2.24 (s, 1H), 1.47 (d, J 
= 6.3 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 23.59, 69.19, 121.72, 126.69, 127.87, 128.78, 
132.66, 144.63. 
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(S)-1-(4-methoxyphenyl)ethanol (Table 18, entry 9): 
The title compound was prepared according to the general procedure as described above in 
50% conversion. The product was analyzed by HPLC to determine the enantiomeric excess 
58% ee (OD-H: 99/1, heptane/isopropanol, 1 mL/min, 215 – 254 nm); tr (minor) = 29.31 (R), 
tr (major) = 33.09 (S) min. 
1H-NMR (300 MHz; CDCl3): δ 7.25-7.32 (m, 2H), 6.84-6.91 (m, 2H), 4.83 (q, J = 6.6, 12.8 
Hz, 1H), 3.79 (s, 3H), 2.07 (s, 1H), 1.46 (d, J = 6.3 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 
25.04, 55.30, 69.93, 113.84, 126.69, 138.07, 158.95.  
 
 
 
 
 
 
(S)-1-(3-methoxyphenyl)ethanol (Table 18, entry 10): 
The title compound was prepared according to the general procedure as described above in 
93% conversion. The product was analyzed by HPLC to determine the enantiomeric excess 
54% ee (OD-H: 99/1, heptane/isopropanol, 1 mL/min, 215 – 254 nm); tr (minor) = 31.08 (R), 
tr (major) = 37.42 (S) min. 
1H-NMR (300 MHz; CDCl3): δ 7.22-7.30 (m, 1H), 6.90-6.96 (m, 2H), 6.80 (ddd, J = 8.20, 
2.54, 1.06 Hz, 1H), 4.84 (q, J = 6.5, 12.8 Hz, 1H), 3.80 (s, 3H), 2.20 (bs, 1H), 1.47 (d, J = 6.3 
Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 25.16, 55.22, 70.29, 110.91, 112.86, 117.72, 129.53, 
147.65, 159.75. 
OH
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(S)-1-(2-methoxyphenyl)ethanol (Table 18, entry 11): 
The title compound was prepared according to the general procedure as described above in 
56% conversion. The product was analyzed by HPLC to determine the enantiomeric excess 
52% ee (OD-H: 99/1, heptane/isopropanol, 1 mL/min, 215 – 254 nm); tr (major) = 19.28 (S), 
tr (minor) = 21.32 (R) min. 
1H-NMR (300 MHz; CDCl3): δ 7.34 (dd, J = 1.65, 7.4 Hz, 1H),  7.21-7.30 (m, 1H), 6.93-7.01 
(m, 1H), 6.85-6.92 (dd, J = 0.8, 8.2 1H), 5.09 (q, J = 6.6, 12.9 Hz, 1H), 3.86 (s, 3H), 2.7 (bs, 
1H), 1.51 (d, J = 6.6 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 22.88, 55.27, 66.51, 110.43, 
120.81, 126.11, 128.30, 133.46, 156.55. 
 
 
 
 
 
(S)-1-(naphthalen-2-yl)ethanol (Table 18, entry 12): 
The title compound was prepared according to the general procedure as described above in 
84% conversion. The product was analyzed by HPLC to determine the enantiomeric excess 
64% ee (OJ: 90/10, heptane/isopropanol, 1 mL/min, 215 – 254 nm); tr (major) = 14.34 (S), tr 
(minor) = 18.43 (R) min. 
1H-NMR (300 MHz; CDCl3): δ 7.78-7.88 (m, 4H), 7.43-7.54 (m, 3H), 5.06 (q, J = 6.3, 12.9 
Hz, 1H), 2.04 (s, 1H), 1.58 (d, J = 6.3 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 25.17, 70.55, 
123.83, 123.85, 125.83, 126.18, 127.71, 127.96, 128.34, 132.94, 133.34, 143.21. 
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(S)-1-(naphthalen-1-yl)ethanol (Table 18, entry 13): 
The title compound was prepared according to the general procedure as described above in 
48% conversion. The product was analyzed by HPLC to determine the enantiomeric excess 
41% ee (OJ: 90/10, heptane/isopropanol, 1 mL/min, 215 – 254 nm); tr (major) = 11.82 (S), tr 
(minor) = 16.35 (R) min. 
1H-NMR (300 MHz; CDCl3): δ 1.46 (d, J = 6.79 Hz, 3H), 3.09 (br s, 1H), 5.38 (q, J = 6.04, 
6.79 Hz, 1H), 7.30-7.50 (m, 4H), 7.61-7.90 (m, 3H); 13C NMR (75 MHz, CDCl3) δ 24.1, 6.5, 
121.8, 122.9, 125.2, 125.3, 125.6, 127.4, 128.5, 130.0, 133.4, 141.2. 
 
 
 
 
 
(S)-2,3-dihydro-1H-inden-1-ol (Table 18, entry 15): 
The title compound was prepared according to the general procedure as described above in 
89% conversion. The product was analyzed by HPLC to determine the enantiomeric excess 
33% ee (OJ: 99/1, heptane/isopropanol, 1 mL/min, 215 – 254 nm); tr (minor) = 24.40 (R), tr 
(major) = 28.20 (S) min. 
1H-NMR (300 MHz; CDCl3): δ 7.37-7.45 (m, 1H), 7.20-7.29 (m, 3H), 5.22 (t, J = 6.3 Hz, 
1H), 2.98-3.19 (m, 1H), 2.74-2.88 (m, 1H), 2.4-2.54 (m, 1H), 2.1-2.38 (bs, 1H), 1.85-2.0 (m, 
1H). 13C NMR (CDCl3, 75 MHz): δ 29.81, 35.86, 76.40, 124.25, 124.47, 127.35, 128.52, 
143.34, 144.98. 
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(S)-1,2,3,4-tetrahydronaphthalen-1-ol (Table 18, entry 16): 
The title compound was prepared according to the general procedure as described above in 
62% conversion. The product was analyzed by HPLC to determine the enantiomeric excess 
46% ee (OD-H: 99/1, heptane/isopropanol, 1 mL/min, 215 – 254 nm); tr (minor) = 15.91 (R), 
tr (major) = 17.33 (S) min. 
1H-NMR (300 MHz; CDCl3): δ 7.41-7.46 (m, 1H), 7.18-7.24 (m, 2H), 7.08-7.15 (m, 1H), 
4.77 (t, J = 5.2 Hz, 1H), 2.65-2.9 (m, 2H), 1.7-2.09 (m, 5H). 13C NMR (CDCl3, 75 MHz): δ 
18.83, 29.27, 32.28, 68.15, 126.19, 127.59, 128.69, 129.03, 137.14, 138.82. 
 
 
 
 
(S)-1-(2-Thienyl)ethanol (Table 19, entry 1): 
The title compound was prepared according to the general procedure as described above in 
70% conversion. The product was analyzed by HPLC to determine the enantiomeric excess 
53% ee (OJ: 99/1, heptane/isopropanol, 1 mL/min, 215 – 254 nm); tr (major) = 25.72 (S), tr 
(minor) = 33.38 (R) min. 
1H-NMR (300 MHz; CDCl3): δ 7.19-7.24 (m, 1H), 6.91-6.99 (m, 2H), 5.07 (q, J = 6.3, 12.9 
Hz, 1H), 2.94 (s, 1H), 1.56 (d, J = 6.4 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 25.25, 66.11, 
120.22, 124.37, 126.66, 149.99. 
 
 
 
 
 
(R)-1-(3-Thienyl)ethanol (Table 19, entry 2): 
The title compound was prepared according to the general procedure as described above in 
36% conversion. The product was analyzed by HPLC to determine the enantiomeric excess 
OH
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62% ee (OJ: 99/1, heptane/isopropanol, 1 mL/min, 215 – 254 nm); tr (major) = 25.08 (R), tr 
(minor) = 30.51 (S) min. 
1H-NMR (300 MHz; CDCl3): δ 1.52 (d, J = 6.8 Hz), 1.89 (s, 1H), 4.97 (q, J = 6.8 Hz,1H), 
7.09-7.10 (m, 1H), 7.18-7.20 (m, 1H), 7.29-7.31 (m, 1H). 13C NMR (CDCl3, 75 MHz): δ 
147.4, 126.1, 125.7, 120.2, 66.5, 24.5. 
 
 
 
 
 
(R)-1-(pyridin-2-yl)ethanol (Table 19, entry 3): 
The title compound was prepared according to the general procedure as described above in 
85% conversion. The product was analyzed by HPLC to determine the enantiomeric 
excess41% ee (OD-H: 99/1, heptane/isopropanol, 1 mL/min, 215 – 254 nm); tr (major) = 
18.66 (R), tr (minor) = 21.61 (S) min. 
1H-NMR (300 MHz; CDCl3): δ 8.54 (d, J = 5.3 Hz, 1H), 7.68-7.72 (m, 1H), 7.28 (d, J = 9.3 
Hz, 1H), 4.90 (q, J = 6.4 Hz, 1H), 4.34 (s, 1H), 1.5 (d, J = 6.4 Hz, 3H). 13C NMR (CDCl3, 75 
MHz): δ 24.19, 69.01, 119.82, 122.22, 136.87, 148.09, 163.25. 
 
 
 
 
 
(R)-1-(pyridin-3-yl)ethanol (Table 19, entry 4): 
The title compound was prepared according to the general procedure as described above in 
95% conversion. The product was analyzed by HPLC to determine the enantiomeric excess 
61% ee (OJ: 90/10, heptane/isopropanol, 1 mL/min, 215 – 254 nm); tr (major) = 7.21 (R), tr 
(minor) = 9.33 (S) min. 
1H-NMR (300 MHz; CDCl3): δ 8.38 (d, J = 2.4 Hz, 1H), 8.29 (dd, J = 1.3, 4.6 Hz, 1H), 7.64-
7.75 (m, 1H), 7.15-7.24 (m, 1H), 4.85 (q, J = 6.4 Hz, 1H), 4.6 (bs, 1H), 1.44 (d, J = 6.4 Hz, 
3H). 13C NMR (CDCl3, 75 MHz): δ 25.19, 67.45, 123.58, 133.60, 141.84, 146.99, 147.96. 
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(S)-1-(pyridin-4-yl)ethanol (Table 19, entry 5): 
The title compound was prepared according to the general procedure as described above in 
99% conversion. The product was analyzed by HPLC to determine the enantiomeric 
excess55% ee (AS-H: 90/10, heptane/isopropanol, 1 mL/min, 215 – 254 nm); tr (minor) = 
17.74 (S), tr (major) = 31.69 (R) min.  
1H-NMR (300 MHz; CDCl3): δ 8.42 (d, J = 4.5 Hz, 1H), 7.27 (d, J = 4.5 Hz, 2H), 4.86 (q, J = 
6.4 Hz, 1H), 4.13 (s, 1H), 1.46 (d, J = 6.4 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 25.10, 
68.53, 120.56, 149.40, 155.53. 
 
 
 
 
 
(R)-1-(furan-3-yl)ethanol (Table 19, entry 6): 
The title compound was prepared according to the general procedure as described above in 
>99% conversion. The product was analyzed by HPLC to determine the enantiomeric excess 
30% ee (OJ: 99/1, heptane/isopropanol, 1 mL/min, 215 – 254 nm); tr (minor) = 21.05 (S), tr 
(major) = 23.41 (R) min. 
1H-NMR (300 MHz; CDCl3): δ 7.35-7.40 (m, 1H), 6.32 (dd, 1H, J = 3.2 and 1.2 Hz), 6.22 (d, 
1H, J = 3.2 Hz), 4.88 (q, 1H, J = 6.4 Hz), 2.30 (br s, 1H), 1.54 (d, 3H, J = 6.8 Hz); 13C NMR 
(75 MHz, CDCl3): δ = 157.6, 141.8, 110.1, 105.0, 63.5, 21.2. 
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(R)-8-hydroxy-5, 6, 7, 8-tetrahydroquinoline (Table 20, entry 1): 
The title compound was prepared according to the general procedure as described above and 
purified by flash chromatography in 80% yield. The product was analyzed by HPLC to 
determine the enantiomeric excess 91% ee (OD-H: 99/1, heptane/isopropanol, 1 mL/min, 215 
– 254 nm); tr (major) = 15.94 (R), tr (minor) = 22.73 (S) min. 
1H-NMR (300 MHz; CDCl3): δ  8.30-8.29 (m, 1H), 7.31 (dd, J = 7.7, 0.6 Hz, 1H), 7.01 (dd, J 
= 7.7, 4.8 Hz, 1H), 5.15 (s, 1H), 4.68 (dd, J = 7.2, 5.4 Hz, 1H), 2.79-2.60 (m, 2H), 2.16-2.06 
(m, 1H), 1.98-1.65 (m, 3H). 13C NMR (CDCl3, 75 MHz): δ 158.03, 146.46, 137.05, 131.90, 
122.19, 67.85, 31.03, 28.44, 18.84. 
 
 
 
 
 
(R)-9-hydroxy-6, 7, 8, 9-tetrahydro-5H-cycloheptapyridine (Table 20, entry 2): 
The title compound was prepared according to the general procedure as described above in 
83% conversion. The product was analyzed by HPLC to determine the enantiomeric excess 
83% ee (AS-H: 99/1, heptane/isopropanol, 0.5 mL/min, 215 – 254 nm); tr (major) = 21.46 
(R), tr (minor) = 27.12 (S) min. 
 
 
 
 
 
(R)-8-hydroxy-2-phenyl-5, 6, 7, 8-tetrahydroquinoline (Table 20, entry 3): 
The title compound was prepared according to the general procedure as described above and 
purified by flash chromatography in 98% yield. The product was analyzed by HPLC to 
N
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determine the enantiomeric excess 72% ee (OD-H: 99/1, heptane/isopropanol, 1 mL/min, 215 
– 254 nm); tr (minor) = 12.54 (S), tr (major) = 31.41 (R) min. 
 
 
 
 
 
(R)-8-hydroxy-2-chloro-5, 6, 7, 8-tetrahydro-2-quionoline (Table 20, entry 4): 
The title compound was prepared according to the general procedure as described above and 
purified by flash chromatography in 93% yield. The product was analyzed by HPLC to 
determine the enantiomeric excess 84% ee (OJ: 99/1, heptane/isopropanol, 0.5 mL/min, 215 – 
254 nm); tr (major) = 25.48 (R), tr (minor) = 30.0 (S) min. 
 
 
 
 
(R)-2-phenyl-7-hydroxy- 6, 7-dihydro-5H-cyclopentapyridine (Table 20, entry 5): 
The title compound was prepared according to the general procedure as described above and 
purified by flash chromatography in 89% yield. The product was analyzed by HPLC to 
determine the enantiomeric excess 52% ee (OD-H: 99/1, heptane/isopropanol, 1 mL/min, 215 
– 254 nm); tr (major) = 32.41 (R), tr (minor) = 57.29 (S) min. 
 
Synthesis of Pyridyl Ketones: 
 
General scheme for the synthesis of six and eight membered pyridyl ketones: 
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5, 6, 7, 8-tetrahydroquinoline-N-oxide:  
To the cold solution of m-CPBA (1.2 equiv.) in dichloromethane (30 mL), 5, 6, 7, 8-
tetrahydroquinoline (1 g, 7.5 mmol) in dichloromethane was added drop wise. After 
removing the ice bath the reaction mixture was stirred at rt overnight. An additional 0.6 
equiv. m-CPBA was added and stirred for 5 h. The organic layer was washed with dilutes 
NaOH to remove remaining peroxides. The combined organic layer was dried over Na2SO4 
and concentrated under reduced pressure. The crude product was used for next step without 
further purification. 
 
 
 
 
 
8-hydroxy-5, 6, 7, 8-tetrahydroquinoline:  
Trifluoroacetic anhydride (4 mL) was added slowly to cold solution of crude 5, 6, 7, 8-
tetrahydroquinoline-N-oxide in 10 mL of dichloromethane. The reaction mixture was allowed 
to warm up to rt and was stirred overnight. The volatile compounds were removed under 
pressure and remaining organic phase was dissolved in dichloromethane and 2M LiOH 
solution was added to it. The combined organic layers were washed with water, dried over 
Na2SO4 and concentrated. The crude product was purified by column chromatography (839 
mg, 78 %). 
(Triethylamine/ethyl acetate 1:9, Rf = 0.4). 1H-NMR (300 MHz; CDCl3): δ  8.30-8.29 (m, 
1H), 7.31 (dd, J = 7.7, 0.6 Hz, 1H), 7.01 (dd, J = 7.7, 4.8 Hz, 1H), 5.15 (s, 1H), 4.68 (dd, J = 
7.2, 5.4 Hz, 1H), 2.79-2.60 (m, 2H), 2.16-2.06 (m, 1H), 1.98-1.65 (m, 3H). 13C NMR (CDCl3, 
75 MHz): δ 158.03, 146.46, 137.05, 131.90, 122.19, 67.85, 31.03, 28.44, 18.84.  
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5, 6, 7, 8-tetrahydroquinoine-8-one: 
A mixture of activated MnO2 (262 mg) and 8-hydroxy-5, 6, 7, 8-tetrahydroquinoline (25 mg, 
0.168 mmol) in chloroform (3 mL) was refluxed for 7 h. The mixture was filtered and washed 
with diethyether. The combined organic layers were concentrated under vacuum and purified 
by column chromatography to obtain white solid (22 mg, 88 %). 
 (Triethylamine/ethyl acetate 1:9, Rf = 0.2). 1H NMR (CDCl3, 300 MHz): δ 2.15 – 2.26(m, 
2H), 2.82(t, 2H, J = 6.3Hz), 3.04 (t, 2H, J = 6.03 Hz), 7.37 (dd, 1H, J = 4.4, 7.4 Hz), 4.16 - 
7.65 (dt, 1H, J = 0.8, 7.6 Hz), 8.71 (dt, 1H, J = 0.8, 4.6 Hz). 13C NMR (CDCl3, 75 MHz): δ 
22.70, 29.17, 39.68, 126.99, 137.64, 140.76, 14918. 
 
 
 
 
 
6, 7, 8, 9-tetrahydro-5H-cycloheptapyridine-N-oxide: 
To stirred solution of 6, 7, 8, 9-tetrahydro-5H-cycloheptapyridine (500 mg, 3.4 mmol) and 
methyltrioxorhenium (42.4 mg, 5 mol%) in dichloromethane (5 mL) was slowly added 
hydrogen peroxide 0.7 mL (30 % aq.) at 0 °C. The reaction mixture was allowed to warm to 
rt and catalytic amount of MnO2 was added to destroy the remaining hydrogen peroxide. The 
mixture was filtered and the aqueous phase was extracted with dichloromethane. The 
combined organic layers were dried over Na2SO4 and concentrated. The crude product was 
used for next step without further purification. 
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9-hydroxy-6, 7, 8, 9-tetrahydro-5H-cycloheptapyridine: 
Trifluoroacetic anhydride (10 mL) was added slowly to cold solution of 6, 7, 8, 9-tetrahydro-
5H-cycloheptapyridine-N-oxide in dichloromethane. The reaction mixture was allowed to 
warm up to rt and was stirred overnight. The volatile compounds were removed under 
pressure and remaining organic phase was dissolved in dichloromethane and 2M LiOH 
solution was added to it. The combined organic layers were washed with water, dried over 
Na2SO4 and concentrated. The crude product was purified by column chromatography (299 
mg, 54 %).  
1H NMR (CDCl3, 300 MHz): δ 1.03 – 1.20(m, 1H), 1.22 – 1.40 (m, 1H), 1.65 – 1.82 (m, 1H), 
1.83 – 2.03 (m, 2H), 2.06 – 2.19 (m, 1H), 2.53 – 2.73(m, 2H), 4.66 (dd, 1H, J = 2.4, 11 Hz), 
5.81 (s, 1H), 7.02 (dd, 1H, J = 4.9, 7.5 Hz), 7.30 – 7.37 (m, 1H), 8.24 (dd, 1H, J = 1.5, 4.9 
Hz). 13C NMR (CDCl3, 75 MHz): δ 27.03, 29.01, 34.32, 36.31, 72.17, 122.08, 135.67, 137.20, 
144.35, 160.93. 
 
 
 
 
6, 7, 8, 9-tetrahydro-5H-cycloheptapyridine-9-one: 
To a stirred solution of oxalyl chloride (0.056 mL, 0.652 mmol) in dichloromethane (1.4mL) 
was slowly added DMSO (0.093 mL, 1.304 mmol) at -78 °C, and the resulting mixture was 
stirred for 30 min at this temperature. A solution of 9-hydroxy-6, 7, 8, 9-tetrahydro-5H-
cycloheptapyridine (95 mg, 0.582mmol) in dichloromethane (1 mL) was added to this 
mixture slowly, and then triethylamine (0.4mL, 2.62 mmol) was added drop wise. The 
reaction mixture was allowed to warm to rt and then quenched with water. After extraction 
with dichloromethane, the organic layer was washed with HCl, sat. Na2CO3 solution. The 
organic layer was dried over Na2SO4 and concentrated under pressure to afford the crude 
product. The crude product was purified by column chromatography to obtain desired 
product (56 mg, 60 %).  
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1H NMR (CDCl3, 300 MHz): δ 1.73 – 1.92(m, 4H), 2.64 – 2.77 (m, 2H), 2.80 – 2.90 (m, 2H), 
7.20 – 7.31 (m, 1H), 7.52 (dd, 1H, J = 0.6, 7.7 Hz), 8.5 – 8.6 (m, 1H). 13C NMR (CDCl3, 75 
MHz): δ 21.17, 24.99, 30.96, 40.38, 125.76, 136.42, 138.08, 148.31, 154.84, 204.7. 
 
General scheme for the synthesis of five membered pyridyl ketones : 
 
 
 
 
 
 
 
 
 
 
 
 
Cyclopentanone morpholine enamine: 
The solution of cyclopentanone (12.5 g, 0.15 mol), morpholine (19.5 mL, 0.23 mol) in 
toluene (38 mL) was refluxed using dean-stark trap until water formation stopped. The 
solvent was removed under vacuum and crude product was purified by distillation (16 gm, 70 
%). 
 1H-NMR (300 MHz; CDCl3): δ 4.40 (s, 1H), 3.68 (t, J = 4.9 Hz, 4H), 2.83 (t, J = 4.9 Hz, 
4H), 2.33-2.25 (m, 4H), 1.88-1.78 (m, 2H). 13C NMR (CDCl3, 75.5 MHz): δ 151.71, 98.28, 
66.64, 49.04, 31.33, 30.29, 22.50. 
O
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3-dimethylamino-1-phenyl-propan-1-one hydrochloride: 
A mixture of N, N-Dimethyleneiminium chloride (2 g, 22 mmol) and acetophenone (4.2 mL, 
22 mmol) in acetonitrile (11 mL) was refluxed for 1 h. After cooling to rt the product was 
recrystallized immediately (82 %). 
 1H NMR (CDCl3, 300 MHz): δ 2.79(s, 6H), 3.4(m, 2H), 3.65 (t, 2H, J = 7.1 Hz), 7.52 – 
7.61(m, 2H), 7.64- 7.73 (m, 1H), 7.98 – 8.05 (m, 2H), 10.95 (s, 1H). 13C-NMR (75.5 MHz; 
DMSO-d6): δ 196.65, 135.83, 133.65, 128.74, 127.94, 51.61, 42.04, 33.07. IR (Neat): 3487, 
3398, 2949, 2666, 2570, 2471, 1674, 1628, 1597, 1467, 1426, 1385, 1334, 1223, 1137, 1078, 
1037, 1003, 958,754, 688, 652.  
 
 
 
 
 
2-(3-oxo-3-phenyl-propyl)-cyclopentanone: 
3-dimethylamino-1-phenyl-propan-1-one hydrochloride (2.5 g, 11.7 mmol) was suspended 
dioxane (15 mL). After addition of cyclopentanone morpholine enamine (1.79 g, 11.7 mmol) 
the reaction mixture was refluxed for 16 h. After cooling to rt, water was added and refluxed 
for additional one hour. The water phase was extracted with dichloromethane and the 
combined organic layers were washed with diluted HCl, dried over Na2SO4 and concentrated. 
The crude product was purified by column chromatography (1.06 mg, 42 %). 
1H-NMR (300 MHz; CDCl3): δ 7.94 (dd, J = 7.1, 1.5 Hz, 2H), 7.55-7.50 (m, 1H), 7.46-7.40 
(m, 2H), 3.09 (m, 2H), 2.27-1.92 (m, 6H), 1.83-1.68 (m, 2H), 1.61-1.48 (m, 1H). 13C NMR 
(CDCl3, 75.5 MHz): δ 220.96, 199.86, 136.82, 133.07, 128.62, 128.08, 48.23, 38.15, 36.20, 
29.94, 24.28, 20.70. 
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2-phenyl-6, 7-dihydro-5H-[1]pyridine: 
The solution of 2-(3-oxo-3-phenyl-propyl)-cyclopentanone (1.0 g, 4.63 mmol) and 
hydroxylamine hydrochloride (0.321 g, 4.63 mmol) in ethanol (20 mL) was refluxed for 3 h. 
After 3 h, the reaction mixture was neutralized by sodium carbonate solution and water and 
the water phase was extracted with dichloromethane. The combined organic layers were dried 
over Na2SO4 and concentrated to yield crude brown oil, which was purified by column 
chromatography (787 mg, 87 %). 
 1H-NMR (300 MHz; CDCl3): δ 7.92 (d, J = 6.9 Hz, 2H), 7.51 (d, J = 7.9 Hz, 1H), 7.45-7.32 
(m, 4H), 3.06 (t, J = 7.7 Hz, 2H), 2.93 (t, J = 7.5 Hz, 2H), 2.13 (quintet, J = 7.5 Hz, 2H). 13C 
NMR (CDCl3, 75.5 MHz): δ 165.90, 155.92, 140.07, 135.47, 132.62, 128.69, 128.40, 126.96, 
118.29, 34.51, 30.57, 23.32. 
 
 
 
 
 
2-phenyl-6, 7-dihydro-5H-[1]pyridine-N-oxide: 
To the cold solution of m-CPBA (1.2 equiv.) in dichloromethane (10 mL), 2-phenyl-6, 7-
dihydro-5H-[1]pyridine (0.5 g, 2.56 mmol) in dichloromethane was added drop wise. After 
removing the ice bath the reaction mixture was stirred at rt overnight. An additional 0.6 
equiv. m-CPBA was added and stirred for 5 h. The organic layer was washed with dilutes 
NaOH to remove remaining peroxides. The combined organic layer was dried over Na2SO4 
and concentrated under reduced pressure. The crude product was used for next step without 
further purification. 
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7-hydroxy- 6, 7-dihydro-5H-cyclopentapyridine: 
Trifluoroacetic anhydride (0.7 mL) was added slowly to cold solution of crude 2-phenyl-6, 7-
dihydro-5H-[1]pyridine-N-oxide  in dichloromethane (20 mL). The reaction mixture was 
allowed to warm up to rt and was stirred overnight. The volatile compounds were removed 
under pressure and remaining organic phase was dissolved in dichloromethane and 2M LiOH 
solution was added to it. The combined organic layers were washed with water, dried over 
Na2SO4 and concentrated. The crude product was purified by column chromatography (454 
mg, 84 %).  
1H-NMR (300 MHz; CDCl3): δ  7.94-7.90 (m, 2H), 7.54 (q, J = 7.6 Hz, 2H), 7.46-7.35 (m, 
3H), 5.25 (t, J = 6.7 Hz, 1H), 4.80-4.72 (m, 1H), 3.04-2.94 (m, 1H), 2.82-2.71 (m, 1H), 2.50 
(m, 1H), 2.05 (m, 1H). 13C-NMR (75.5 MHz; CDCl3): δ 164.96, 156.51, 139.48, 134.98, 
133.83, 128.67, 127.12, 120.13, 74.58, 33.13, 27.29. 
 
 
 
 
 
2-phenyl-6, 7-dihydro-5H-cyclopentapyridine-7-one: 
To a stirred solution of oxalyl chloride (0.073 mL, 0.85 mmol) in dichloromethane (1.8mL) 
was slowly added DMSO (0.129 mL, 1.81 mmol) at -78 °C, and the resulting mixture was 
stirred for 30 min at this temperature. A solution of 7-hydroxy- 6, 7-dihydro-5H-
cyclopentapyridine (160 mg, 0.76mmol) in dichloromethane (1.3 mL) was added to this 
mixture slowly, and then triethylamine (0.5mL, 3.42 mmol) was added drop wise. The 
reaction mixture was allowed to warm to rt and then quenched with water. After extraction 
with dichloromethane, the organic layer was washed with HCl, sat. Na2CO3 solution. The 
organic layer was dried over Na2SO4 and concentrated under pressure to afford the crude 
product. The crude product was purified by column chromatography to obtain desired 
product (124 mg, 78 %).  
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1H NMR (CDCl3, 300 MHz): δ 2.78 – 2.85(m, 2H), 3.15 – 3.22 (m, 2H), 7.40 – 7.52 (m, 3H), 
7.925 (q, 2H, J = 8.3, 11.2 Hz), 8.09 (dd, 2H, J = 1.9, 8.3 Hz). 13C NMR (CDCl3, 75 MHz): δ 
23.28, 35.34, 124.7, 127.4, 128.8, 129.6, 135.9, 138.2, 148.24, 158.7, 205.7. 
 
General scheme for the synthesis of phenyl substituted six membered pyridyl ketones: 
 
 
 
 
 
 
 
 
 
 
 
 
Cyclohexanone pyrrolidine enamine: 
The solution of cyclohexanone (26 mL, 0.25 mol), pyrrolidine (32 mL, 0.38 mol) in toluene 
(75 mL) was refluxed using dean-stark trap until waster formation stopped. The solvent was 
removed under vacuum and crude product was purified by distillation in quantitative yield. 
  1H NMR (CDCl3, 300 MHz): δ 1.47 – 1.58(m, 2H), 1.6 – 1.73(m, 2H), 1.811 (q, 4H, J = 6.6 
Hz), 2.02 – 2.12 (m, 2H), 2.13 – 2.21 (m, 2H), 2.97 (t, 4H, J = 6.3 Hz), 4.26 (s, 1H). 13C 
NMR (CDCl3, 75 MHz): δ 23.00, 23.35, 24.52, 27.02, 27.52, 41.96, 47.40, 51.22, 93.51, 
143.36. 
O
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2-(3-oxo-3-phenyl-propyl)-cyclohexanone: 
3-dimethylamino-1-phenyl-prpan-1-one hydrochloride (4 g, 16.4 mmol) was suspended 
dioxane (40 mL). After addition of cyclohexanone pyrrolidine enamine (2.5 g, 16.4 mL) the 
reaction mixture was refluxed for 16 h. After cooling to rt, water was added and refluxed for 
additional one hour. The water phase was extracted with dichloromethane and the combined 
organic layers were washed with diluted HCl, dried over Na2SO4 and concentrated. The crude 
product was purified by column chromatography (1.2 gm, 31 %). 
 1H NMR (CDCl3, 300 MHz): δ 1.34 – 1.52(m, 1H), 1.59 – 1.76(m, 3H), 1.78 – 1.92 (m, 1H), 
1.98 – 2.20 (m, 3H), 2.22 – 2.50 (m, 3H), 2.88 – 3.03 (m, 1H), 3.04 – 3.19 (m, 1H), 7.38 – 
7.48 (m, 2H), 7.49 – 7.57 (m, 1H), 7.92 – 8.00(m, 2H). 13C NMR (CDCl3, 75 MHz): δ 24.51, 
25.13, 28.19, 34.68, 36.36, 42.32, 49.9, 128.1, 128.6, 133.0, 136.8, 200.4, 213.4. 
 
 
 
 
2-phenyl-5, 6, 7, 8-tetrahydroquinoline: 
The solution of 2-(3-oxo-3-phenyl-propyl)-cyclohexanone (2.6 g, 11 mmol) and 
hydroxylamine hydrochloride (0.8 g, 11 mmol) in ethanol (20 mL) was refluxed for 3 h. After 
3 h, the reaction mixture was neutralized by sodium carbonate solution and water and the 
water phase was extracted with dichloromethane. The combined organic layers were dried 
over Na2SO4 and concentrated to yield crude brown oil which was purified by column 
chromatography (0.898 gm, 38 %).  
1H NMR (CDCl3, 300 MHz): δ 1.79 – 2.01(m, 4H), 2.80(t, 2H, J = 6.3 Hz), 3.03 (t, 2H, J = 
6.4 Hz), 7.35 – 7.51 (m, 5H), 7.94 – 8.00 (m, 2H). 13C NMR (CDCl3, 75 MHz): δ 22.86, 
23.27, 28.60, 32.92, 117.94, 126.86, 128.30, 128.67, 130.75, 137.47, 139.95, 154.68, 157.26. 
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2-phenyl-5, 6, 7, 8-tetrahydroquinoline-N-oxide: 
To the cold solution of m-CPBA (2.47 gm, 14.3 mmol) in dichloromethane (10 mL), 2-
phenyl-5, 6, 7, 8-tetrahydroquinoline (2.50 g, 12 mmol) in dichloromethane was added drop 
wise. After removing the ice bath the reaction mixture was stirred at rt overnight. An 
additional 0.6 equiv. m-CPBA was added and stirred for 5 h. The organic layer was washed 
with dilutes NaOH to remove remaining peroxides. The combined organic layer was dried 
over Na2SO4 and concentrated under reduced pressure. The crude product was used for next 
step without further purification. 
 
 
 
 
 
8-hydroxy-2-phenyl-5, 6, 7, 8-tetrahydroquinoline: 
Trifluoroacetic anhydride was added slowly to cold solution of 2-phenyl-5, 6, 7, 8-
tetrahydroquinoline-N-oxide (1.4 gm, 6.2 mmol) in dichloromethane (20 mL). The reaction 
mixture was allowed to warm up to rt and was stirred overnight. The volatile compounds 
were removed under pressure and remaining organic phase was dissolved in dichloromethane 
and 2M LiOH solution was added to it. The combined organic layers were washed with 
water, dried over Na2SO4 and concentrated. The crude product was purified by column 
chromatography (1.2 gm, 87 %).  
1H NMR (CDCl3, 300 MHz): δ 1.72 – 1.93(m, 2H), 1.95 – 2.11(m, 1H), 2.30 – 2.45 (m, 1H), 
2.76 – 2.94 (m, 2H), 4.37 (s, 1H), 4.73 (dd, 1H, J = 5.3, 9.2 Hz), 7.37 – 7.52 (m, 4H), 7.57 (d, 
1H, J = 8.0 Hz), 7.97 – 8.03 (m, 2H). 13C NMR (CDCl3, 75 MHz): δ 19.72, 28.02, 30.67, 
69.20, 119.19, 126.69, 128.74, 128.88, 137.76, 138.92, 154.22, 157.65. 
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2-phenyl-5, 6, 7, 8-tetrahydroquinoine-8-one: 
To a stirred solution of oxalyl chloride (0.2 mL, 2.5 mmol) in dichloromethane (5mL) was 
slowly added DMSO (0.4 mL, 5.3 mmol) at -78 °C, and the resulting mixture was stirred for 
30 min at this temperature. A solution of 8-hydroxy-2-phenyl-5, 6, 7, 8-tetrahydroquinoline 
(500 mg, 2.22 mmol) in dichloromethane (4 mL) was added to this mixture slowly, and then 
triethylamine (1.4 mL, 10 mmol) was added drop wise. The reaction mixture was allowed to 
warm to rt and then quenched with water. After extraction with dichloromethane, the organic 
layer was washed with HCl, sat. Na2CO3 solution. The organic layer was dried over Na2SO4 
and concentrated under pressure to afford the crude product. The crude product was purified 
by column chromatography to obtain desired product (461 mg, 93 %).  
1H NMR (CDCl3, 300 MHz): δ 2.22(q, 2H, J = 6.6 Hz), 2.84 (t, 2H, J = 6.03 Hz), 3.06 (t, 2H, 
J = 6.03 Hz), 7.38 – 7.51 (m, 3H), 7.72 (d, 1H, J = 8 Hz), 7.83(d, 1H, J = 8 Hz), 8.02 – 8.09 
(m, 2H). 13C NMR (CDCl3, 75 MHz): δ 22.77, 29.04, 39.96, 124.0, 127.22, 128.77, 129.32, 
138.52, 139.23, 147.92, 156.74, 196.86. 
 
General scheme for the synthesis of chloro substituted six membered pyridyl ketones: 
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5, 6, 7, 8-tetrahydro-2-quinolone: 
To a cold 97 % suphuric acid (20 mL) was added dropwise 3-(2-
oxocyclohexyl)propanenitrile (3 gm, 19.4 mmol). After the addition, the reaction mixture was 
stirred at room temperature for 3 h. The reaction mixture was poured into cold water and 
extracted with chloroform to remove polymeric impurities and unaromatized material. The 
resulting aqueous solution was neutralized with aqueous ammonia. A white solid precipitated 
which was extracted with chloroform. The organic layers were dried over Na2SO4 and 
concentrated under vacuum to obtain white solid product. The pure product was obtained 
after column chromatography (1.4 gm, 49 %). 
1H-NMR (300 MHz; CDCl3): δ 13.33 (s, 1H), 7.10 (d, J = 9.1 Hz, 1H), 6.29 (d, J = 9.1 Hz, 
1H), 2.62 (t, J = 5.7 Hz, 2H), 2.39 (t, J = 5.5 Hz, 2H), 1.71-1.64 (m, 4H). 13C NMR (CDCl3, 
75 MHz): δ 165.07, 143.73, 143.21, 116.64, 114.44, 26.67, 26.05, 22.51, 21.55. 
 
 
 
 
2-chloro-5, 6, 7, 8-tetrahydro-2-quionoline: 
A mixture of POCl3 (6.6 mL, 19.8 mmol) and 5, 6, 7, 8-tetrahydro-2-quinolone (1 gm, 6.6 
mmol) was refluxed under nitrogen overnight. The mixture was cooled, poured into 2M cold 
NaOH and extracted with dichloromethane. The organic layer was dried over Na2SO4 and 
concentrate under pressure. The crude product was purified by column chromatography in 
quantitative yield. 
1H NMR (CDCl3, 300 MHz): δ 1.6 – 1.85 (m, 4H), 2.62 (t, 2H, J = 6.1 Hz), 2.77 (t, 2H, J = 
6.2 Hz), 6.92 (d, 1H, J = 8 Hz), 7.20 (d, 1H, J = 8 Hz). 13C NMR (CDCl3, 75 MHz): δ 22.34, 
22.62, 27.98, 32.19, 121.1, 131.0, 139.5, 147.6, 158.0. 
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2-chloro-5, 6, 7, 8-tetrahydro-2-quionoline-8-acetate: 
To 2-chloro-5, 6, 7, 8-tetrahydro-2-quionoline (526 mg, 3.5 mmol) was added glacial acetic 
acid (2.5 mL) and the mixture was stirred at 82 °C. 30 % aqueous hydrogen peroxide (0.53 
mL) was added slowly to the reaction mixture and stirred further for 5 h at 82 °C, after which 
additional hydrogen peroxide (0.09 mL) was added. The resulting mixture was stirred for 12 
h at this temperature and then cooled to room temperature. The excess hydrogen peroxide 
was destroyed by adding catalytic manganese dioxide and stirred for one more hour at room 
temperature. Water and acetic acid were removed under pressure. The residue was poured 
into water and neutralized with Na2CO3 and then extracted with dichloromethane. The 
combined organic layers were washed with water, dried over Na2SO4 and concentrated in 
vacuum to afford corresponding pyridine N-oxide, which was used directly for the next step 
without further purification. The crude pyridine N-oxide was dissolved in acetic anhydride 
(4mL) and stirred at 85 °C for 5 h. The resulting reaction mixture was then cooled to room 
temperature and concentrated under vacuum to afford crude acetate product. Column 
chromatography afforded the desired compound colorless oil (545 mg, 77 %). 
1H NMR (CDCl3, 300 MHz): δ 1.68 – 1.98 (m, 3H), 1.99 - 2.04 (s, 3H), 2.05 – 2.18 (m, 1H), 
2.56 – 2.83 (m, 2H), 5.76 (t, 1H, J = 3.6 Hz), 7.09 (d, 1H, J = 6.7 Hz), 7.34 (d, 1H, J = 6.5 
Hz). 13C NMR (CDCl3, 75 MHz): δ 18.05, 21.4, 27.7, 28.6, 70.4, 123.9, 132.5, 140.0, 148.8, 
153.7, 170.2. 
 
 
 
 
 
8-hydroxy-2-chloro-5, 6, 7, 8-tetrahydro-2-quionoline: 
To a stirred solution of 2-chloro-5, 6, 7, 8-tetrahydro-2-quionoline-8-acetate (153 mg, 0.67 
mmol) in ethanol (0.4 mL), a solution of KOF (54 mg) in ethanol (1 mL) was added. The 
resulting mixture was stirred at rt for 30 min and then the solvent was removed under vacuum 
to yield dark solid, which was treated with water and extracted with dichloromethane. The 
N Cl
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combined organic layers were dried over Na2SO4 and concentrated. The residue was purified 
by column chromatography to obtain 8-hydroxy-2-chloro-5, 6, 7, 8-tetrahydro-2-quionoline 
(116 mg, 93 %). 
1H NMR (CDCl3, 300 MHz): δ 1.6 – 1.84 (m, 2H), 1.85 – 2.01 (m, 1H), 2.05 – 2.2 (m, 1H), 
2.57 – 2.8 (m, 2H), 3.8 (s, 1H), 4.62 (dd, 1H, J = 4.0, 16.3 Hz), 7.05 (d, 1H, J = 8.0 Hz), 7.31 
(d, 1H, J = 8.0 Hz). 13C NMR (CDCl3, 75 MHz): δ 18.03, 16.8, 29.3, 67.4, 75.7, 121.9, 129.6, 
138.9, 147.3, 157.6. 
 
 
 
 
 
2-chloro-5, 6, 7, 8-tetrahydro-2-quionoine-8-one: 
To a stirred solution of oxalyl chloride (0.19 mL, 2.3 mmol) in dichloromethane (4.6 mL) 
was slowly added DMSO (0.35 mL, 4.90 mmol) at -78 °C, and the resulting mixture was 
stirred for 30 min at this temperature. A solution of 8-hydroxy-2-chloro-5, 6, 7, 8-tetrahydro-
2-quionoline (375 mg, 2.04 mmol) in dichloromethane (3.7 mL) was added to this mixture 
slowly, and then triethylamine (1.43mL, 9.18 mmol) was added drop wise. The reaction 
mixture was allowed to warm to rt and then quenched with water. After extraction with 
dichloromethane, the organic layer was washed with HCl, sat. Na2CO3 solution. The organic 
layer was dried over Na2SO4 and concentrated under pressure to afford the crude product. 
The crude product was purified by column chromatography to obtain desired product 2-
chloro-5, 6, 7, 8-tetrahydro-2-quionolone. (363 mg, 98%).  
1H NMR (CDCl3, 300 MHz): δ 2.19(q, 2H, J = 6.3 Hz), 2.78 (t, 2H, J = 6.03 Hz), 7.40 (d, 
1H, J = 8.0 Hz), 7.63 (d, 1H, J = 7.99 Hz). 13C NMR (CDCl3, 75 MHz): δ 22.5, 28.5, 39.3, 
128.2, 139.6, 140.6, 148.1, 150.9, 195.0. 
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p-toluolsulfonyl azide: 
To an ice cooled solution of p-toluolsulfonyl chloride (5.0 g, 26 mol) in acetone/water (1/1, 
149 mL, 6 mL/mmol) was added sodium azide (1.7 g, 26 mol). The reaction mixture was 
stirred for 2 h at 0°C and the acetone was then evaporated. The phases were separated and the 
aqueous layer was extracted with diethyl ether. The combined phases were dried and 
concentrated to afford p-toluolsulfonyl azide (2.24 g, 43 %) pale yellow oil which was stored 
in deep freeze. 
(Rf 0.76 hexanes/ethyl acetate 1/1). 1H NMR (CDCl3, 300 MHz): δ = 2.74 (s, 3H), 7.40 (d, J 
= 8.4 Hz, 2H), 7.84 (d, J = 8.4 Hz, 2H). 13C NMR (CDCl3, 75.5 MHz): δ = 21.7, 128, 130, 
136, 146.   
 
 
 
 
 
Ethyl phenyldiazoacetates: 
To an ice cooled solution of p-toluolsulfonyl azide (2.24 g, 11.33 mmol) and ethyl 
phenylacetate (1.8 mL, 11.33 mmol) in acetonitrile (24 mL) was added DBU (2.24 mL, 15 
mmol) and the reaction was warmed to room temperature and stirred overnight. The solvent 
was evaporated and was dissolved in dichloromethane followed by washing with NH4Cl, 
water and brine. Desired product was obtained after purification by column chromatography 
in quantitative yield. 
1H NMR (CDCl3, 300 MHz): δ = 1.35 (t, 3H), 4.34 (q, 2H), 7.18 (m, 1H), 7.39 (m, 2H), 7.50 
(m, 2H). 13C NMR (CDCl3, 75.5 MHz): δ =14.53, 61, 123.97, 125.7, 128.9, 165.2. 
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Typical procedure for cyclopropanation catalyzed by Cu(I)- tBuBINC 
complex: 
A mixture of CuPF6 (CH3CN)4 (4 mg, 0.011 mmol), tBuBINC (4 mg, 0.012 mmol), styrene 
(100 mg, 0.96 mmol) in ethylacetate (0.5 mL) was stirred at room temperature for 2 h. The 
resulting mixture was heated to 40 °C and then 4 Å MS (100 mg) was added. To this solution 
was injected ethyl phenyldiazoacetates (41 mg, 0.213 mmol) in 1 mL ethyl acetate via a 
syringe pump within 6 h. After the reaction was complete (monitored by TLC), the mixture 
was filtered through a small plug of silica gel and eluted with DCM. The filtrate was 
concentrated and the residue was purified by chromatography to afford the desired product.  
                                                                                
                                                                                                                
 
 
(1S, 2R)-ethyl 1, 2-diphenylcyclopropanecarboxylate: 
1H NMR (CDCl3, 300 MHz): δ = 1.19 (t, 3H), 1.89 (dd, J = 7.3, 4.8 Hz, 1H), 2.15 (dd, J = 
9.2, 4.72 Hz, 1H), 3.12 (dd, J = 9.2, 7.1 Hz, 1H), 4.06 - 4.24 (m, 2H), 6.74 - 6.82 (m, 2H), 
7.03 - 7.16 (m, 8H). 13C NMR (75.5 MHz): δ = 14.18, 20.28, 32.91, 37.59, 61.29, 126.25, 
126.90, 127.59, 127.67, 128.05, 131.92, 134.84, 136.49, 173.78. Mass EI-MS (m/e) 266.2 
(M+.) 
 
              
  
 
 
2-tert-butyl 6-ethyl 6-phenyl-2-azabicyclo[3.1.0]hex-3-ene-2,6-dicarboxylate. 
1H NMR (CDCl3, 300 MHz): δ = 1.07-1.19 (m, 3 H), 1.44-1.58 (two singlet, 9 H), 3.26 -3.34 
(m, 1 H), 4.0-4.15 (m, 2 H), 4.55-4.74 (m, 1 H), 5.07-5.21 (m, 1 H), 5.93-6.16 (m, 1 H), 7.05-
7.16 (m, 2 H), 7.19-7.28 (m, 3 H). 13C NMR (75.5 MHz): δ = 14.20, 28.27, 29.74, 38.04, 
39.26, 49.13, 61.19, 81.69, 107.43, 127.22, 127.77, 130.6, 131.28, 132.56, 151.3, 173.44. 
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[Rh(COD)2]BF4: 
To a dichloromethane solution (2 mL) of [Rh(COD)Cl]2 (99 mg, 0.2 mmol) and 1,5- 
cyclooctadiene (0.5 mL, 4.07 mmol), AgBF4 ( 92.5 mg, 2.37 mmol ) was added. The 
resulting slurry was stirred in the dark for 2 h, subsequently filtered through celite and 
washed wth CH2Cl2 (2 mL). The solution was concentrated and anhydrous Et2O (15 mL) was 
added to precipitate the complex. The red solid formed was filtered, washed with cold Et2O 
(3 x 10 mL) and dried (73 mg, 90 %). 
1H NMR (CDCl3, 300 MHz): δ = 2.57 (m, 8H, CH2), 5.35 (m, 4H, CH). 13C NMR (75.5 
MHz) 29.93 (s, CH2), 107.7 (d, CH). 
 
                                                                                 
 
 
 
 
 
 
 
[Rh(COD)(tBu BINC)]BF4 (120): 
To a solution of [Rh(COD)2]BF4  (25 mg, 0.062 mmol ) in dichloromethane (1 mL ) tBu- 
BINC ( 23 mg, 0.062 mmol ) was added. The reaction mixture was left stirring for 4 h after 
which the solvent was evaporated under vacuum. The resulting bright red solid was washed 
twice with ether and dried (33.2 mg, 80 %).  
 IR (neat): υ: 2967, 2169, 1245, 993, 516 cm-1.  
1H NMR (CDCl3, 300 MHz): δ = 1. 04 (s, 18 H), 2.46 (m, 8H), 3.99 (dd, 1H, J = 3.27 Hz, 8.5 
Hz), 4.09- 4.21 (m, 2H), 4.31- 4.48 (m, 3 H), 5.38- 5.58 (m, 4H), 7.54- 7.66 (m, 3 H), 7.91- 
7.98 (m, 2H). 13C NMR (151 MHz): δ = 26.29, 26.38, 30.38, 30.61, 33.21, 33.65, 64.33, 
64.97, 67.16, 68.26, 99.29, 99.53, 99.68, 100.39, 125.59, 129.22, 132.03, 133.47. 31P NMR 
(CDCl3, 121.5 MHz): δ = 19.27. MS (LSI-MS), m/z (rel. intensity): [M+] 587.3. 
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[Ir (COD) (tBu BINC)]BARF (121): 
Na(BARF) (118 mg, 0.133 mmol) was added to a solution of [Ir(COD)Cl]2 (45 mg, 0.0665 
mmol) in dichloromethane ( 4 ml) and stirred for 30 min followed by addition of tBu-BINC 
(50 mg, 0.133 mmol) .The reaction mixture was stirred for 4 h after which the solvent was 
evaporated under vacuum. Crude complex was passed through a small plug of silica using 
dichloromethane. Quantitative yield was obtained.  
IR (neat): υ: 2970, 2196, 1354, 1273, 1113 cm-1. 1H NMR (CDCl3, 300 MHz): δ = 0.987 (s, 
9H), 1.03 (s, 9H), 2.25-2-47 (m, 8H), 3.89-4.0(m, 2H), 4.09-4.14 (m,2 H), 4.22-4.29 (m, 1H), 
4.49 (quartet, 1 H, J = 10 Hz, 19.6 Hz), 5.02-5.21 (m, 4H), 7.46-7.56 (m, 6 H), 7.60- 7.83 ( 
m, 11 H). 31P NMR (CDCl3, 121.5 MHz): δ = 22.02. MS (LSI-MS), m/z (rel. intensity): 
[M+H+- BARF] 677.2. HRMS: calcd. for C28H39O3N2PIr193 [M.+ ]: 675, found: 675.233. 
 
Na{B[3,5-(CF3)2C6H3]4} Na(BARF): 
Slow addition of a solution of 3,5-bis (trifluromethyl)bromobenzen (1 gm, 3.4 mmol) in ether 
(5 mL) to Mg turnings (99.4 mg, 4.09 mmol) in ether (3 mL), followed by refluxing for 30 
min, gave a dark gray solution of aryl Grignard reagent. Upon addition of NaBF4 ( 53 mg, 
0.48 mmol ), the heterogenous reaction mixture was stirred for 48 h, during which time the 
solution became brown and a fine precipitate formed. The reaction mixture was added to 
Na2CO3 (8.5 g) in water (100 ml), stirred for 30 min and filtered. The aqueous layer was 
extracted with ether (3 x 25 mL), and the combined organic layer was dried over sodium 
sulfate and treated with decolorizing charcoal. The mixture was filtered and the ether was 
removed under vacuum. The remaining oily solid was dissolved in 100 mL benzene, and 
water was removed with a stark trap by azeotropic distillation for 2 h. The solvent volume 
was reduced to 50 mL and solution was cooled to room temperature and the solvent was 
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decanted to remove unreacted starting materials. The remaining off white solid was dried 
under vacuum (2.5 g, 84 %).  
1H NMR (acetone, 300 MHz): δ = 7.67 (s, 4H), 7.79 (br, 8H). Mass (ESMS): 863.1(M-Na+)-. 
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1H and 13C NMR spectra 
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(S)-t-Butyl-2-oxazoline (71b) 
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 (S)-2-(dibenzylamino)-3-methylbutan-1-ol (77) 
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 (2R,3S)-3-(dibenzylamino)-4-methylpentan-2-ol (78) 
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 (4S,5R)-4-isopropyl-5-methyl-4,5-dihydrooxazole (71e) 
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Adamantylphosphonic dichloride (74) 
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Bis((S)-2-isocyano-3-methylbutyl) phenylphosphonate (72c) 
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13C DEPT-135 and  31 P NMR 
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Bis((S)-2-isocyano-3,3-dimethylbutyl) phenylphosphonate (72b) 
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13C DEPT-135 and  31 P NMR 
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Bis((S)-2-isocyano-3-phenylpropyl) phenylphosphonate (72a) 
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13C DEPT-135 and  31 P NMR 
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Bis((1S,2S)-2-isocyano-1-phenylpropyl) phenylphosphonate (72d) 
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Bis((2R,3S)-3-isocyano-4-methylpentan-2-yl) phenylphosphonate (72e) 
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Bis((1R,2S)-1-isocyano-2,3-dihydro-1H-inden-2-yl) phenylphosphonate (72f) 
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Bis((S)-2-isocyano-3-methylbutyl) admantylphosphonate (72g) 
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 (R)-2,2'-diisocyano-1,1'-binaphthyl (87) 
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 (R)-5,5',6,6',7,7',8,8'-Octahydro-1,1'-Binaphthyl-2,2'-diamine (84) 
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(R)-2,2'-diisocyano-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl (89) 
 
 
                                                                     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NC
NC
 
Appendix 
186 
 
 
1.
80
28
3.
60
42
3.
82
88
3.
97
34
8.
00
00
In
te
gr
al
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5
(ppm)
102030405060708090100110120130140
(R)-3,3'-Dibromo-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diamine (90) 
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 (R)-3,3'-Dibromo-1,1'-binaphthyl-2,2'-diamine (91) 
 
 
                                                                 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NH2
NH2
Br
Br
 
Appendix 
188 
 
 
3.
93
45
3.
94
66
4.
09
19
2.
06
24
4.
94
90
1.
99
98
4.
17
97
In
te
gr
al
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0
(ppm)
102030405060708090100110120130140
(R)-3,3'-Diphenyl-1,1'-binaphthyl-2,2'-diamine (92) 
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1,6-anhydro-2-deoxy-2-iodo-ß-D-glucopyranose (100) 
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1,6-anhydro-2-deoxy-2-azido-ß-D-glucopyranose (101) 
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1, 6-anhydro-2-azido-3,4-di-O-benzyl-2-deoxy-ß-D-glucopyranose (102) 
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1, 6-anhydro-2-azido-3-O-benzyl-2-deoxy-ß-D-glucopyranose (103) 
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1, 6-diacetae-2-azido-3,4-di-O-benzyl-2-deoxy-ß-D-glucopyranose (104) 
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6-acetae-2-azido-3,4-di-O-benzyl-2-deoxy-ß-D-glucopyranose (105) 
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6-acetae-2-azido-3,4-di-O-benzyl-2-deoxy-ß-D-glucopyranose  
trichloroacetimidate (106) 
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13C DEPT-135 and  31 P NMR 
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[PdCl2(iPrBINC)] (105c) 
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2, 2,6-trimethyl-6-(2-oxopropyl)-cyclohexanone 
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4-nitrobiphenyl 
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Biphenyl-4-carbaldehyde 
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Complex 118b: 1H NMR   
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9-hydroxy-6,7,8,9-tetrahydro-5H-cycloheptapyridine 
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2-phenyl-7-hydroxy-6,7-dihydro-5H-cyclopentapyridine 
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8-hydroxy-2-phenyl-5,6,7,8-tetrahydroquinoline 
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8-hydroxy-2-chloro-5,6,7,8-tetrahydro-2-quionoline 
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2-tert-butyl 6-ethyl 6-phenyl-2-azabicyclo[3.1.0]hex-3-ene-2,6-dicarboxylate 
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2. X-Ray Diffraction Structure 
 
         
 
 
 
 
 
 
 
Table 1:  Crystal data and structure refinement for 72b 
   
Crystal Data   
 
Empirical formula    C20H29N2O3P  
Formula weight    376.42  
Crystal size     0.330 x 0.320 x 0.250 mm  
Crystal description    parallelepiped  
Crystal colour     colourless  
Crystal system     Orthorhombic  
Space group     P 21 21 21  
Unit cell dimensions    a = 6.02119(6) Ǻ    α = 90° 
                                                             b = 18.63424(18) Ǻ  β = 90°  
                                                             c = 19.10723(18) Ǻ γ = 90°  
Volume                                                 2143.84(4) Ǻ3  
Z, Calculated density                              4, 1.166 Mg/m3  
Absorption coefficient                            1.298 mm-1  
F(000)                                                     808  
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Data Collection  
   
Measurement device type                    Oxford Diffraction Gemini Ultra  
Measuremnet method                           omega-scan  
Temperature                                          123 K  
Wavelength                                           1.54184 Ǻ  
Monochromator                                    graphite  
Theta range for data collection             3.31 to 62.23° 
Index ranges                                         -6<=h<=6, -18<=k<=21, -19<=l<=21  
Reflections collected / unique               9780 / 3285 [R(int) = 0.0231]  
Reflections greater I>2\s(I)                   3077  
Absorption correction                           Semi-empirical from equivalents  
Max. and min. transmission                  1.00000 and 0.74366  
   
Refinement   
   
Refinement method    Full-matrix least-squares on F2  
Hydrogen treatment    
Data / restraints / parameters                3285 / 0 / 241  
Goodness-of-fit on F^2                        1.097  
Final R indices [I>2sigma(I)]               R1 = 0.0278, wR2 = 0.0750  
R indices (all data)                                R1 = 0.0296, wR2 = 0.0757  
   
Absolute structure parameter                 0.029(17)  
Largest diff. peak and hole                    0.171 and -0.171 e.Ǻ-3 
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Table 2:  Crystal data and structure refinement for 105b.  
   
 Crystal Data  
   
Empirical formula    C20H29Cl2N2O3PPd,C6H6  
Formula weight                                       631.85  
Crystal size                                              0.160 x 0.050 x 0.050 mm  
Crystal description                                   platelike  
Crystal colour     colourless  
Crystal system                                         Orthorhombic  
Space group                                             P 21 21 21  
Unit cell dimensions                                a = 10.0888(3) Ǻ    α = 90° 
                                               b = 13.1038(3) Ǻ     β = 90°  
                                               c = 23.1132(5) Ǻ    γ = 90° 
 Volume                            3055.60(13) Ǻ3  
 Z, Calculated density       4, 1.373 Mg/m3  
Absorption coefficient                            7.223 mm-1  
F(000)                                                     1296  
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Data Collection  
   
Measurement device type   Oxford Diffraction Gemini Ultra  
Measurement method                             omega-scan  
Temperature                                     123 K  
Wavelength                                          1.54184 Ǻ  
Monochromator                                      graphite  
Theta range for data collection               3.82 to 66.59° 
Index ranges                                           -10<=h<=11, -15<=k<=15, -26<=l<=27  
Reflections collected / unique                 13503 / 4998 [R(int) = 0.0367]  
Reflections greater I>2\s(I)                     4711  
Absorption correction                              Semi-empirical from equivalents  
Max. and min. transmission                      1.00000 and 0.58188  
 
Refinement  
   
Refinement method    Full-matrix least-squares on F2  
Hydrogen treatment  
Data / restraints / parameters                    4998 / 0 / 316  
Goodness-of-fit on F^2                             1.046  
Final R indices [I>2sigma(I)]                    R1 = 0.0332, wR2 = 0.0799  
R indices (all data)                         R1 = 0.0355, wR2 = 0.0810  
Absolute structure parameter                     0.017(8)  
Largest diff. peak and hole                        1.061 and -0.284 e. Ǻ-3 
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Table 3:  X-ray structure of complex 119d (Cl atoms on Sn were omitted for clarity).  
   
Crystal Data  
 
Empirical formula    C40H54Cl6FeN4O6P2Sn2  
Formula weight                                     1254.79  
Crystal size                                            0.18 x 0.14 x 0.08 mm  
Crystal description                                 prism  
Crystal colour                                        yellow  
Crystal system                                       Monoclinic  
Space group                                           P 21  
Unit cell dimensions                              a = 11.1616(18) Ǻ    α = 90° 
                                                               b = 21.663(5) Ǻ     β = 101.547(17)°  
                                                               c = 11.9040(16) Ǻ    γ = 90°  
Volume                                                  2820.1(9) Ǻ3  
Z, Calculated density                             2, 1.478 Mg/m3  
Absorption coefficient                           1.515 mm-1  
F(000)                                                    1256  
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Data Collection   
   
Measurement device type   STOE-IPDS diffractometer  
Measuremnet method                                    rotation  
Temperature                                                  297(1) K  
Wavelength                                                   0.71073 Ǻ  
Monochromator                                            graphite  
Theta range for data collection                     1.86 to 25.30° 
Index ranges                                                 -13<=h<=13, -25<=k<=26, -13<=l<=13  
Reflections collected / unique                       33590 / 9649 [R(int) = 0.1039]  
Reflections greater I>2\s(I)                           4594  
Absorption correction                                   Analytical  
Max. and min. transmission                          0.8093 and 0.6981  
 
Refinement 
 
Refinement method                                       Full-matrix least-squares on F2  
Hydrogen treatment  
Data / restraints / parameters                         9649 / 1 / 550  
Goodness-of-fit on F^2                                  0.836  
Final R indices [I>2sigma(I)]                        R1 = 0.0559, wR2 = 0.1119  
R indices (all data)                                         R1 = 0.1206, wR2 = 0.1302  
Absolute structure parameter                         0.02(4)  
Largest diff. peak and hole                            0.767 and -0.608 e. Ǻ-3 
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